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SUMMARY 
The consumption of functional foods offers potential in the prevention and management of 
prevalent and worldwide diseases of concern. The known health-related properties of onion 
have revealed its promising value in the prevention of risk factors and reduction of symptoms 
associated to several diseases, including cardiovascular disease (CVD) and liver disease. This 
motivates the design of commercially stable onion products with a high content of 
phytochemicals, which includes those processed by non-thermal technologies, such as high-
pressure processing. However, the examination of those effects in vivo requires both the 
understanding of individual pathologies and the use of new high-throughput analytical tools 
able to provide solid scientific evidence. In this sense, metabolomics allows for phenotype-
characterization of live systems or organisms under specific conditions, where the effect of the 
diet can also be linked to specific metabolic patterns associated to either health status or disease 
evolution. The metabolome, understood as the metabolic result of a complex network of 
dynamic interconnected pathways, reflects the end point of gen-transcription-protein-
metabolite interactions and allows the traceability of the changes induced by both epigenetic 
stimuli and adaptive responses to disease development. These responses can be modulated to a 
big extent by medical treatments and/or diet interventions. 
In this context, the main purpose of this PhD Thesis was to study the potential preventive 
effect of high-pressure processed onion in cardiovascular and liver diseases from an innovative 
perspective. The assessment of biological functions and mapping of the metabolome in a model 
of diet-induced hypercholesterolemia has driven the research and motivated an interest to 
explore new approaches involving the mechanism of action and elucidate the metabolic 
pathways impaired by nutritional imbalance. This would contribute to generate novel 
hypothesis about the mechanisms of action behind the consumption of onion at the core of 
prevalent diseases and raise awareness about the importance of including complementary 
approaches that allow data integration in the experimental design. Moreover, the need to 
address different analytical platforms to improve the understanding of diet and supplementation 
in the differential phases of disease progression is discussed throughout this thesis as a sound 
basis to redirect future research of nutrition within integrative system biology. 
Therefore, to achieve this objective, the PhD Thesis has been divided into three sections 
organised according to the sequence of research, the analytical methodology and the 
metabolomic strategy followed: 
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i) Biochemical, vascular and microbiological analyses to determine vascular and
hepatic impairment and the preventive role of onion on well-known biomarkers.
ii) Non-targeted metabolomics studies (fingerprinting) describing metabolic
impairments associated to hypercholesterolemia and potential modulating effects of
onion.
iii) Targeted metabolomics studies (profiling) addressing specific pathways of interest.
Whereas the first section has mainly addressed oxidative stress, vascular reactivity and 
specific markers of hepatic and CVD functions, the second has focused on the metabolic 
modifications induced by a high-cholesterol diet and the prevention obtained by the onion 
ingredient included in the diet. This work was undertaken by a multiplatform of metabolic 
fingerprinting accomplished by LCMS, CEMS and GCMS. 
In the third section relevant pathways potentially involved in inflammation and assimilation 
of nutrients, also indicated by the non-targeted approaches (lipid mediators and bile acids) were 
selected and analysed by LCMS targeted approaches in different biological samples (plasma, 
tissuesliver, spleen, heart and faecal material). Each section is embodied by the research 
papers compiling these studies, classified in chapters with one additional chapter, which 
integrates the results from all the experiments into a comprehensive discussion. 
In conclusion, the current PhD Thesis highlights the benefits of the consumption of 
functional ingredients such as high-pressurized onion in the two prevalent pathologies studied 
(CVD and liver disease). It makes a strong emphasis on the use of metabolomics, which is 
pivotal to the research and evidences the advantages and promising aspects of the application 
of metabolomics to the understanding of the close relationship between diet and disease. It 
opens new perspectives to manage health status by tackling risk factors such as inflammation 
and other impairments associated to disease through the inclusion of functional ingredients in 
the diet. Furthermore, it reinforces the path toward the use of new tools of diagnosis and 
prognosis of disease with predictive analysis towards an individual nutritional assessment 
designed to prevent risk and achieve an optimal personalised nutrition. 
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RESUMEN 
El consumo de alimentos funcionales ofrece nuevas posibilidades de estudio dirigidas a la 
prevención y el tratamiento de enfermedades altamente prevalentes en la población a nivel 
mundial. Las propiedades beneficiosas de la cebolla en la salud han mostrado potencial en la 
prevención de factores de riesgo y la reducción de los síntomas asociados a múltiples 
enfermedades, entre las que se incluyen las enfermedades cardiovasculares y hepáticas. Estas 
circunstancias motivan el diseño de productos de cebolla que sean comercialmente estables y 
con un elevado contenido en sustancias fitoquímicas, destacando para ello, la aplicación de 
tecnologías de procesado no térmico y más concretamente el procesado por alta presión 
hidrostática. No obstante, el análisis de los efectos de la cebolla in vivo requiere entender cada 
patología a nivel individual y el uso de tecnologías analíticas de alto rendimiento, capaces de 
proporcionar sólidas evidencias científicas. En este sentido, las técnicas metabolómicas 
permiten la caracterización fenotípica de sistemas vivos u organismos, bajo condiciones 
específicas, permitiendo así la asociación entre el efecto de la dieta con perfiles metabólicos 
específicos, asociados a un estado concreto de salud o cierta fase en la evolución de una 
enfermedad. 
El metaboloma, entendido como el resultado metabólico de un complejo entramado de rutas 
metabólicas interconectadas, refleja el punto final de las interacciones ocurridas entre los genes, 
la transcripción, la formación de proteínas y metabolitos. Este conocimiento facilita la 
trazabilidad de los cambios inducidos por los estímulos epigenéticos y las respuestas 
adaptativas en el desarrollo de cualquier enfermedad, permitiendo además considerar el grado 
de modulación de las respuestas fisiológicas ante tratamientos médicos  combinados o no con 
intervenciones dietéticas. 
En este contexto, el objetivo principal de la presente Tesis Doctoral fue el estudio del posible 
efecto preventivo de un ingrediente de cebolla procesada por alta presión hidrostática en 
enfermedades cardiovasculares y hepáticas desde un punto de vista innovador. La evaluación 
de las funciones biológicas y el mapeado de los cambios inducidos en el metaboloma de un 
modelo animal de hipercolesterolemia inducida por la dieta han sido los temas principales de 
la investigación realizada en esta Tesis, explorarando nuevos enfoques sobre los cambios y 
alteraciones inducidas en rutas metabólicas a través de la dieta, así como en los posibles 
mecanismos de acción involucrados. Este enfoque facilitará la formulación de nuevas hipótesis 
sobre los mecanismos de acción involucrados en los efectos derivados del consumo de cebolla 
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en la prevención y evolución de enfermedades altamente prevalentes. Además,  los resultados 
obtenidos demuestran la necesidad e importancia de integrar simultáneamente distintos 
enfoques experimentales, desde el diseño experimental hasta la posterior integración de los 
datos y su interpretación. A lo largo de esta Tesis se discute la necesidad de utilizar diferentes 
plataformas analíticas para mejorar el conocimiento sobre el efecto de una dieta y la 
suplementación en diferentes fases de la intervención y de la progresión de una enfermedad, 
como las bases fundamentales para redirigir futuras investigaciones en nutrición hacia el 
estudio integral de sistemas biológicos.  
Por lo tanto, con la finalidad de lograr dichos objetivos, la presente Tesis Doctoral ha sido 
estructurada en tres secciones, organizadas de acuerdo a la secuencia seguida para su 
realización, teniendo en cuenta la metodología analítica empleada y las estrategias analíticas 
aplicadas de acuerdo a las posibilidades que ofrece la metabolómica: 
i) Análisis de carácter biológico/bioquímico, vascular y microbiológico para determinar
disfunciones vasculares y hepáticas, así como el rol preventivo del ingrediente de cebolla
en biomarcadores de función conocida.
ii) Estudios metabolómicos no dirigidos (fingerprinting) que describen alteraciones
metabólicas asociadas a hipercolesterolemia y el potencial efecto modulador de la
cebolla.
iii) Estudios metabolómicos dirigidos (profiling) enfocados a rutas metábolicas de interés
específico.
Mientras que en la primera sección se evalúan estrés oxidativo, reactividad vascular y 
marcadores de función hepática y cardiovascular específicos, en la segunda sección el estudio 
se centra en las modificaciones metabólicas inducidas por una dieta rica en colesterol y el efecto 
preventivo ejercido por la incorporación simultánea del ingrediente de cebolla en la misma 
dieta. Para la realización de este trabajo se utilizó una multiplataforma de fingerprinting 
metabólico compuesta por tres técnicas diferentes de separación y análisis: cromatografía 
líquida (LC), electroforesis capilar (CE) y gases (GC), acopladas a espectrometría de masas 
(MS). 
Así mismo, la tercera sección recoge los estudios realizados en rutas metabólicas 
involucradas en los procesos de inflamación y asimilación de nutrientes (mediadores lipídicos 
y ácidos biliares) que fueron seleccionadas con anterioridad en base a los resultados obtenidos 
en los análisis no dirigidos. Estos estudios fueron realizados en plataformas seleccionadas de 
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análisis dirigidos por cromatografía líquida acoplada en tándem a espectrometría de masas 
(LCMS/MS), en diferentes muestras biológicas (plasma, tejidos hígado, bazo, corazón y 
contenido fecal). 
Así, cada sección está constituida por una serie de artículos científicos que recogen dichos 
estudios, clasificados en capítulos y un capítulo final adicional que integra los resultados de 
todos los experimentos en una discusión global. 
En conclusión, la presente Tesis Doctoral subraya los beneficios del consumo de 
ingredientes funcionales como es el ingrediente de cebolla procesada por alta presión descrito 
en esta memoria, en dos patologías prevalentes, enfermedad cardiovascular y hepática. 
Haciendo especial énfasis en el empleo de técnicas de metabolómica como pilar fundamental 
de la investigación realizada, evidenciando las ventajas y aspectos prometedores de la 
aplicación de técnicas metabolómicas para entender la estrecha relación entre la dieta y los 
diferentes estadios de una enfermedad. Dicha estrategia abre nuevas perspectivas para el 
mantenimiento de un estado de salud óptimo, abordando factores de riesgo como inflamación 
y otros desequilibrios asociados a la progresión de las enfermedades, a través de la 
incorporación de ingredientes funcionales en la dieta. Además, los resultados obtenidos en esta 
Tesis refuerzan el camino hacia el uso de nuevas herramientas de diagnóstico y pronóstico de 
enfermedades mediante la creación de modelos de análisis predictivo que se dirigen a posibilitar 
una evaluación nutricional individualizada para prevenir riesgos y alcanzar un estado 
nutricional personalizado óptimo. 
Metabolomic-­‐driven  evaluation  of  processed  onion  in  the  prevention  of  cardiovascular  and  
liver  disease  in  a  model  of  diet-­‐induced  hypercholesterolemia	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1. NUTRACEUTICALS/FUNCTIONAL FOODS IN HEALTH AND DISEASE
PREVENTION. THE POTENTIAL OF ONION
The interest in nutraceuticals and functional foods has become fashionable and is growing 
in popularity. The concept of “functional foods and nutraceuticals” has gained support and 
worldwide acceptance reinforcing the link between nutrition and health. These supplementary 
foods show promise in both the prevention and clinical therapy of diseases, as they have the 
potential to significantly reduce either the risk and symptoms of diseases or the side effects 
associated with treatments. An example of this is the etiology of cardiovascular or liver 
disease, which reveals many risk factors that may be alleviated by nutraceutical or functional 
food intervention. The benefits of these functional products have an impact not only on 
individual health, but also enhance the overall health of the general population offering 
possible reductions in the global cost of the health care system. Therefore, the ability of 
nutraceuticals/functional foods to have a positive influence on cardiovascular, hepatic and 
other risk factors needs to be recognized as an enormous opportunity in the health promotion 
and the disease prevention. 
The progress in this field has been developed by research focusing on the identification of 
the chemical and biological properties that characterize functional substances. As a result, this 
will permit the development of potential applications to promote health and well-being in 
response to the interest and concerns of the general public as well as satisfying the demand of 
consumers. 
In this area, many foods may attract the attention of scientists due to their potential 
properties on health. However, given the favourable conditions for the growth of some crops 
and the unique features of the Mediterranean diet in Spain, the functional properties of onion 
have been chosen, since it is cultivated on a large scale and used extensively as an ingredient 
in traditional cuisine. 
In this sense, there are positive human health effects linked to the consumption of onion 
which are attributed to its bioactive composition. Both the individual bioactive components 
found in onion and the complex composition of the whole onion matrix with potential 
synergistic effects have a proven influence in multiple physiological mechanisms. Therefore, 
antioxidant, antiinflammatory, anticancer, antibacterial and a long etc. of other onion 
biological properties remain under exploration as potential regulators of the health status and 
the onset and progression of disease at both the in vitro and in vivo system levels of research. 
Chapter  1  
4 
1.1. Definition of terms: nutraceuticals or functional foods? −  Regulations for health 
claims related to functional foods in the EU Framework 
The concept of functional foods and nutraceuticals allows for different interpretations. The 
definitions have been transformed with time, depending on the point of view of the authors 
and the purpose and design of the new products. As a result, there is as yet, no universally 
accepted definition. 
In general, a functional food can be defined as a food recognized to have one or more 
compounds with biochemical and physiological functions beneficial to human health. 
Whereas, a nutraceutical is considered a food, or part of a food, that provides medical or 
health benefits, including the prevention and/or treatment of a disease (Brower, 1998). Indeed, 
the latter term was coined from “nutrition” and “pharmaceutical” to encourage clinical 
research and trials aimed at examining the true health effects of these substances. However, 
this term which has also been commonly used in marketing, still lacks a firm regulatory 
definition; whereas the term “functional foods” may not be the ideal descriptor for this 
emerging food category, it has been recognized as the term more readily preferred by 
consumers in comparison with other terms such as “nutraceutical” or “designer foods” (IFIC, 
2002).  
Therefore, this widespread use and general acceptance of the term “functional foods” by 
the media, scientists, and consumers has led the major organizations to work within this 
framework rather than introduce a new, more descriptive term. However, several 
organizations have attempted to define this emerging food category. The position statements 
and definitions from the most relevant worldwide organizations have briefly been compiled 
(Figure 1.1). 
According to all these declarations, it is necessary clarify that unmodified whole foods 
such as fruit and vegetables, including bulbs, represent the simplest form of functional food. 
For example, broccoli, carrots, tomatoes or onions would be considered functional foods 
because they are rich in physiologically active components such as sulforaphane, β-carotene, 
lycopene and flavonols, respectively. Modified foods, including those that have been fortified 
with nutrients or enhanced with phytochemicals also fall within the realm of functional foods. 
In the future, food biotechnology will continue to provide new venues for functional food 
development. 
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The European Commission Concerted Action on Functional Food Science in 
Europe (FUFOSE) reflected on its consensus document “Scientific Concepts of 
Functional Foods in Europe” the following working definition: “A food can be 
regarded as ‘functional’ if it is satisfactorily demonstrated to affect beneficially one or 
more target functions in the body, beyond adequate nutritional effects, in a way that is 
relevant to either an improved state of health and well-being and/or reduction of risk of 
disease.” Then, “Functional foods must remain foods and they must demonstrate their 
effects in amounts that can normally be expected to be consumed in the diet: they are not 
pills or capsules, but part of a normal food pattern.” (Diplock, 1999; Stein & 
Rodríguez-Cerezo, 2008). 
The Academy of Nutrition and Dietetics presented its position by saying: “although 
all foods provide some level of physiological function, the term functional foods is 
defined as whole foods along with fortified, enriched, or enhanced foods that have a 
potentially beneficial effect on health when consumed as part of a varied diet on a 
regular basis at effective levels based on significant standards of evidence.” Thus, “The 
Academy supports Food and Drug Administration approved health claims on food labels 
when based on rigorous scientific substantiation.” (Crowe & Francis, 2013). 
The American Dietetic Association (ADA) stated: “functional foods, including 
whole foods and fortified, enriched, or enhanced foods, have a potentially beneficial 
effect on health when consumed as part of a varied diet on a regular basis, at effective 
levels.” In this regard, “The Association supports research to define further the health 
benefits and risks of individual functional foods and their physiologically active 
components. Dietetics professionals will continue to work with the food industry, the 
government, the scientific community, and the media to ensure that the public has 
accurate information regarding this emerging area of food and nutrition science.” 
(Hasler et al., 2004). 
Information concerning the position adopted by The International Food Information 
Council (IFIC), The International Life Sciences Institute of North America (ILSI), Health 
Canada, The Institute of Medicine of the National Academy of Sciences, Institute of 
Food Technologists, International Life Sciences Institute and The Japanese Ministry of 
Health, Labour, and Welfare, can be found gathered in the documents cited above. 
Figure 1.1.  Position statement and “functional food” definitions from relevant worldwide 
organizations 
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Nowadays, the market offers an extensive range of functional foodstuff with multiple 
purposes in which health claims, along with other allegations, must be scientifically 
demonstrated. In Europe, the organization responsible for the regulation of nutritional claims 
and their conditions of use is the “European Food Safety Authority” (EFSA), which also acts 
as a feedback to motivate research. Thus, the EFSA is the organism that evaluates the safety 
of regulated food ingredients before they can be authorised for use on the European market. 
The legal framework, which was founded on the basis established by FUFOSE and 
PASSCLAIM initiatives to underpin the criteria for the scientific substantiation of nutrition 
and health claims (Aggett et al., 2005; Diplock, 1999), has been established since December 
2006, when the EU adopted the Regulation (EC) Nº 1924/2006 on nutrition and health claims 
made on foods. This regulation lays down EU-wide rules for the use of health or nutritional 
claims on foodstuffs based on their nutrient profiles. The regulation stated by the Commission 
Regulation (EC) No 353/2008 implements rules for the application for authorisation of health 
claims and the Commission Regulation No 1169/2009 amends the previous (EC) Nº 353/2008. 
Moreover, the list of permitted health claims established by the Commission Regulation (EU) 
No 432/2012 is regularly updated with newly authorised health claims subject to individual 
application submitted in pursuant of Article 13(5) of Regulation (EC) No 1924/2006, ensuring 
that any claim made on a food label in the EU is clear and substantiated by scientific 
evidence. 
In this context, according to the European Commission, a health claim is any statement 
about a relationship between food and health. In more detail, it refers to any statement on 
labels, advertising or other forms of marketing claiming that health benefits may result from 
consuming a given food, such as claiming that a food product may help reinforce the body’s 
natural defences or enhance learning abilities. It should be born in mind that health claims 
differ from nutrition claims which state or suggest that a food has beneficial nutritional 
properties (e.g. “low fat”, “no added sugar” and “high in fibre”).  
The Health Claims are classified into the following types: 
− 'Function Health Claims' (Article 13): Health claims other than those referring to the
reduction of disease risk a) relating to the growth, development and functions of the body; b) 
referring to psychological and behavioural functions and c) on slimming or weight-control. 
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− 'Risk Reduction Claims' (Article 14) on reducing a risk factor in the development of a
disease. For example: "Plant stanol esters have been shown to reduce blood cholesterol. 
Blood cholesterol is a risk factor in the development of coronary heart disease". 
− Health 'Claims referring to children's development' (Article 14). For example:
"Vitamin D is needed for the normal growth and development of bone in children". 
1.2. Perspective of onion and derived products as functional ingredients in the market – 
From the beginnings to our table today 
Although it is unable to determine the exact time and place for the first cultivation of 
onions, written records locate the origin in central Asia, from where it spreads across the 
entire world. 
The tolerance of onions to grow in a wide range of soil types and climates together with 
the ease of drying, preservation and storage during winter has made this species of the Allium 
genus a useful source of food since the earliest civilizations. Numerous citations reveal their 
use in both traditional and religious ceremonies of many cultures, with references to their 
prophylactic and therapeutic properties (Chutani & Bordia, 1981; Fenwick & Hanley, 1985). 
In fact, from the empirical observation of popular use, the transformation and consumption of 
onion has been transformed into a rigorous field of scientific research. 
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To date, the Food and Agriculture Organization (FAO) of the United Nations recognizes 
the growth of onions in at least 175 countries, although average production varies greatly 
(Figure 1.2A-C, FAOSTAT, 2014). China is the first producer of onion in the world, followed 
by India and the USA (Figure 1.2B, FAOSTAT, 2014). These three countries produce about 
50% of the total world production, which was recorded in 2014 at 88 million tonnes 
(FAOSTAT, 2014). 
In a EU-28 context (2015), the onion production ranges at around 6.1 million tonnes which 
represents 7% of the world volume, with Spain being positioned as the second largest 
producer after the Netherlands. Spain holds an important potential for production, exporting 
both within the EU (Germany, UK, Portugal, France) as well as outside (Brazil and UAE). 
In Spain, the harvest of onion is mainly from the regions of Castilla-La Mancha, 
Andalucía, Comunidad Valenciana and Aragón, with a cultivated surface extension of onions 
which has remained more or less constant of 22-24,000 hectares (with the exception of 2008). 
The onion consumed in Spain has also remained stable with the cultivar ‘Grano de oro or 
Valenciana’ positioned at the top of the onion ranking for crop production (MAPAMA, 
Figure 1.2. 
A) Production quantities by country.
Average 2013-2014
B) Production of 5 top producers.
Average 2014
C) Production share of dry onion by
region. 2014
Source: FAOSTAT, 2014 
Statistic Division (Feb 22, 2017) 
B C
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2013). According to the Ministry of Agriculture, Food and Environment (©Statista 2016), the 
volume of fresh onions consumed in Spain from 2008 to 2015 ranged from 328 to about 369 
million kilograms. 
In terms of human consumption, the domestic uses are widely extended, without 
overlooking a growing application in commercial chains and institutional caterings. Onion, 
which can be found in yellow, red or white coloured bulbs (FAO, 2003), adds value to many 
dishes due to its flavour and nutritional value used either raw, cooked or in transformed 
forms. It is usually consumed in tender state, raw, ripe, pickled or in the form of powder and 
is added in soups, stews, gazpachos, sauces, dips and fries among other cooked products. The 
wide application of onion in commercial channels has extended the ways of presentations in 
easy-to-use format, which maintain active the processing and manufacture of onion in the 
food industry. 
Already in 2002, plant extracts (including herbal extracts, oleoresins, essential oils and 
fruit and vegetable extracts) had a market value of over €1 billion in Western Europe. The 
market share for fruit and vegetable extracts and powders was around €410 million (Stein 
Alexander Jivraj, 2008). More recently, a European Market report gave a general overview of 
the European market for phytochemicals and plant extracts and estimated a growth at a 
CAGR of 8.4% from 2014 to 2019. Until 2014, this European market was dominated by 
Germany, followed by France and Italy. However, Cargill Inc. (U.S.), Chr. Hansen 
(Denmark), Arboris LLC (U.S.), and BASF SE (Germany), among others, are some of the 
new key companies investing heavily in this high-growth market (Micro Market Monitor, 
2015). 
Following this tendency, the producers have also developed modern methods for the 
transformation of onions using both bulb onions and derived by-products to satisfy the 
demands of the market. Product innovation is continuously involved in a competitive 
environment of research and development. 
Thus, innovation in cultivation and harvesting (Tocmo, Lin, & Huang, 2014), new 
emerging technologies of processing (e.g. high-pressure processing, microwave-assisted 
extraction (Kumar et al., 2014; Li et al., 2015; Vazquez-Gutierrez et al., 2013), and storage 
under different atmospheric, temperature and light conditions (Islek, Nilufer-Erdil, & 
Knuthsen, 2015) allow to reach new onion products as dry products, oils or extracts (Antunes, 
et al., 2014; Jung et al., 2015; Mnayer et al., 2015). In consequence, the onion 
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commercialization continues to expand as the fields of investigation, development and 
innovation offer new insights into the possibilities for use and applications of onion. 
The perspectives of a growing market for onion utilised as a functional ingredient let to 
conclude that the field of onion transformation focus its efforts on the addition of value over 
both regular products and by-products from manufacturing. With this aim, food processing is 
developed in order to optimize and improve the quality, nutritional composition and content 
in phytochemicals of the new processed products (Perez-Gregorio et.al., 2014). 
1.3. Onion nutritional and bioactive composition 
Allium cepa L. var. cepa, is the most widely cultivated specie of the genus Allium, it 
belongs to the Liliaceae family within the order of Liliales (Figure 1.3). 
    Allium cepa L. var. cepa	  
Figure 1.3.  Classification from Kingdom Plantae to the Specie Allium cepa L. USDA 
Natural Resources Conservation Service- United State Department of Agriculture 
Onion (Allium cepa L.) has a high content of water (∼ 90%) and a low content in calories 
(∼ 40 kcal/100 g). This is mainly due to the amount of dietary fibre and sugars and the low 
content of lipids and amino acids. Arginine and glutamic acid are exceptions in the 
composition which are found at higher levels. In terms of vitamins and minerals, the sodium 
content is low, while vitamins B6 and C, folic acid, calcium, magnesium, phosphorus and 
potassium content are relatively high. The nutritional content of raw onion is shown in Table 
1.1. However, the composition differs between varieties and is affected by several elements, 
such as the agronomic factors. Moreover, the application of processing technologies also 
affects the nutritional composition. While some thermal processing technologies may degrade 
the nutritional composition, others such as high-pressure (HP), freeze-drying and 
Levels −  Classification 
- Kingdom −Plantae  (Plants)
- Subkingdom  − Tracheobionta (Vascular plants)
- Superdivision  − Spermatophyta (Seed plants)
- Division − Magnoliophyta  (Flowering plants)
- Class − Liliopsida (Monocotyledons)
- Subclass − Liliidae
- Order  − Liliales
- Family − Liliaceae (Lily family)
- Genus  − Allium L. (onion)
- Species − Allium cepa L. (garden onion)
General  Introduction	  
11 
pulverization may affect cell wall structure favouring the extraction, bioaccessibility and 
absorption of certain nutrients. 
Table 1.1 Raw onion (Allium cepa L.) composition in 100 grams of edible portion 
Proximates Units Value ± S.E. Vitamins Units Value ± S.E. 
Water g 89.11 ± 0.248 Vitamin C, total ascorbic acid mg 7.4 ± 0.053 
Energy Kcal 40 ± 0 Thiamin mg 0.046 ± 0.001 
Energy KJ 166 ± 0 Riboflavin mg 0.027 ± 0.002 
Protein g 1.10 ± 0.036 Niacin mg 0.116 ± 0.003 
Total lipid (fat) g 0.10 ± 0.005 Pantothenic acid mg 0.123 ± 0.002 
Ash g 0.35 ± 0.003 Vitamin B-6 mg 0.120 ± 0.004 
Carbohydrate g 9.34 ± 0 Folate, total µg 19 ± 0.059 
Fibre, total dietary g 1.7 ± 0.048 Choline, total mg 6.1 ± 0 
Sugars, total g 4.24 ± 0 Betaine mg 0.1 ± 1 
Sucrose g 0.99 ± 0.050 Carotene, beta µg 1 ± 0 
Glucose (dextrose) g 1.97 ± 0.054 Vitamin A, IU IU 2 ± 0 
Fructose g 1.29 ± 0.052 Lutein + zeaxanthin µg 4 ± 0 
Minerals Units Value ± S.E. Vitamin E (α-tocopherol) mg 0.02 ± 0 
Calcium, Ca mg 23 ± 0.568 Vitamin K (phylloquinone) µg 0.4 ± 0.011 
Iron, Fe mg 0.21 ± 0.08 Lipids Units Value ± S.E. 
Magnesium, Mg mg 10 ± 0.152 Fatty acids, total saturated g 0.042 ±  − 
Phosphorus, P mg 29 ± 0.584 14:0 g 0.004 ± 0.00 
Potassium, K mg 146 ± 2.951 16:0 g 0.034 ± 0.003 
Sodium, Na mg 4 ± 0.158 18:0 g 0.004 ± 0.00 
Zinc, Zn mg 0.17 ± 0.004 Fatty acids, total Monounsaturated g 0.013 ± − 
Copper, Cu mg 0.039 ± 0.002 18:1 undifferentiated g 0.013 ± 0.002 
Manganese, Mn mg 0.129 ± 0.004 Fatty acids, total Polyunsaturated g 0.017 ± − 
Selenium, Se µg 0.5 ± 0.143 18:2 undifferentiated g 0.013 ± 0.002 
Fluoride, F µg 1.1 ± 0.100 18:3 undifferentiated g 0.004 ± 0.00 
Amino Acids Units Value ± S.E. Phytosterols mg 15 ± − 
Tryptophan g 0.014 ± − Flavonoids (Flavonols) Units Value ± S.E. 
Threonine g 0.021 ± − Isorhamnetin mg 5.0 ± 690 
Isoleucine g 0.014 ± − Kaempferol mg 0.7 ± 100 
Leucine g 0.025 ± − Quercetin mg 20.3 ±780 
Lysine g 0.039 ± − 
Methionine g 0.002 ± − 
Cystine g 0.004 ± − 
Phenylalanine g 0.025 ± − 
Tyrosine g 0.014 ± − 
Valine g 0.021 ± − 
Arginine g 0.104 ± − 
Histidine g 0.014 ± − 
Alanine g 0.021 ± − 
Aspartic acid g 0.091 ± − 
Glutamic acid g 0.258 ± − 
Glycine g 0.025 ± − 
Proline g 0.012 ± − 
Serine g 0.021 ± − 
USDA National Nutrient Database for Standard 
Reference, Release 28 (2017). Food Group: Vegetables 
and Vegetable Products. Raw onion (Allium cepa L.) 
Refuse: 10% (Stem ends, sprouts and defects). 
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Although the content of phytochemical found in onion may cover a wide spectrum of 
chemical groups and functions, those which are found in higher concentrations and which 
have properties related to beneficial health effects have received the most attention and been 
subjected to greater study in depth. The potential effects of onion consumption have been 
primary attributed to three groups of bioactive compounds: flavonoids, organosulfur 
compounds (OSCs) and dietary fibre. 
1.3.1. Flavonoids. Quercetin and quercetin glucosides 
Flavonoids are a large family of polyphenolic secondary plant metabolites contributing 
substantially to the non-caloric part of the human diet (Noteborn et al., 1997). The flavonoids 
of dietary significance are usually divided into six principal classes, termed flavones, 
flavonols, flavanones, isoflavones, flavanols (including catechins and tannins), and 
anthocyanins (Harborne & Williams, 2000). Flavonoids are generally found in high 
concentrations in the Allium genus; onion (Allium cepa) is characterized by a higher 
concentrations compared with others cultivated plant species such as garlic (Allium sativum) 
and leek (Allium porrum) (Fattorusso et al., 2002). However, only two flavonoid subgroups 
are usually found in onion, anthocyanins which are characterised by the red/purple colour of 
some varieties and flavonols such as quercetin and its derivatives which are responsible for 
the yellow and brown skin colours of many other varieties (Griffiths, et al., 2002). 
In general, the non-edible skin part of the onion bulb is richer in total flavonoids compared 
to the edible flesh. The flavonoids present in the skin are mainly aglycones due to flavonol 
glucoside hydrolysis during the formation of the outer skin layers (Price & Rhodes, 1997; 
Takahama & Hirota, 2000). The onion bulb contains a wide range of quercetin, isorhamnetin, 
and kaempferol derivatives in varying proportions (Bilyk, Cooper & Sapers, 1984) with a 
tend to increasing contents of quercetin glucosides from the inner to outer scales (Nemeth & 
Piskula, 2007; Patil & Pike, 1995; Tsushida & Svzuki, 1996; Wiczkowski et al., 2003). 
Of at least 25 flavonols that have been characterized, quercetin and quercetin derivatives 
are the most important forms in all onion cultivars, with their glycosyl moieties (β-O-
glycosides, usually D-glucose), mainly attached to the 4', 3, and/or 7-positions of the 
aglycones (Figure 1.4). Analogous derivatives of kaempferol and isorhamnetin have also been 
identified as minor onion pigments (Slimestad, Fossen & Vagen, 2007). 
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Figure 1.4. Chemical structure of quercetin 
Quercetin 3,4'-diglucoside and quercetin 4'-glucoside represent about the 90% of the 
overall contents in different types of Allium species (including Allium cepa L. and Allium 
ascalonicum Hort.) (Bonaccorsi et al., 2008). However, the ratios and distribution of 
quercetin and its glycosides within the onion bulbs differs among cultivars and are modified 
by factors such as onion processing, cooking and exposure to light (Ewald et al., 1999; 
Mogren et al., 2008; Mogren, Olsson & Gertsson, 2007; Nemeth & Piskula, 2007).  
The metabolism of quercetin and its glycosides undergoes several and complex processes 
on consumption beginning in the oral cavity and continuing through the stomach, small 
intestine, colon, and liver until the partial elimination by the urinary pathway, all of which 
together affects the final bioavailability of flavonoid metabolites (Nemeth & Piskula, 2007). 
The mechanism proposed for the absorption of quercetin glucosides from the gastrointestinal 
tract involves deglycosylation by luminal lactase phloridzin hydrolase and/or cleavage within 
the enterocyte by cytosolic β-glucosidase (Day, et al., 2003). Then, this is followed by 
metabolism of the aglycone which leads to the appearance of quercetin sulphate and 
glucuronide conjugates in the circulatory system (Day & Williamson, 2003). 
Moreover, it has been demonstrated in several studies that quercetin glycosides are 
absorbed more efficiently than quercetin aglycone (Hollman et al., 1995; Moon et al., 2000) 
irrespective of the position of the glucose moiety (Olthof et al., 2000). The efficiency of 
intestinal absorption of flavonoids is strongly affected by the food compositions and 
compound’s solubility in the vectors (Piskula & Terao, 1998). A more recent study by Mullen 
et al., (2006) also demonstrates that extensive modification of quercetin glucosides occurs 
after ingestion of onion which involves a complex combination of deglycosylation, 
glucuronidation, sulfation, methylation and possibly deglucuronidation steps, with the 
subsequent appearance of metabolites in the blood stream and urine. However, the sequence 
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and location where these modifications occur after the initial deglycosylation is a matter of 
speculation and a topic that still requires further investigation. 
1.3.2. Organosulfur compounds (OSCs) 
The S-alk(en)yl-L-cysteine sulfoxides (ACSOs), also referred to as flavour precursors, are 
produced by cellular disruption by the enzyme alliinase (EC 4.4.1.4) in the cytoplasm (Block, 
1992). When the tissue is disrupted, the ACSOs are enzymatically degraded to 
iminopropionic acid, which spontaneously hydrolyses to form ammonia and pyruvic (non-
flavour compounds) and unstable alk(en)yl cysteine sulfenic acids (flavour compounds). 
These sulfenic acids (methyl-, propyl- and prop-1-enyl sulfenic acid) decompose 
spontaneously (non-enzymatically) to form thiosulfinates which evolve to thiosulfonates, 
zwiebelanos and cepaenes; while prop-1-enyl sulfenic acid is responsible for thiopropanal S-
oxide formation, the onion lachrymatory factor (Block et al., 1993) (Figure 1.5). These sulfur 
compounds are responsible for the ‘onion pungency’, well manifested by the strong smell, 
burning sensation in the back of the mouth and throat, or in milder cases, the pleasant flavour 
typical to onion. 
Three ACSO compounds are naturally occurring and commonly found in onion: trans-(+)-
S-(1-propenyl)-L-cysteine sulfoxide (PRENCSO), (+)-S-methyl-L-cysteine sulfoxide (MCSO) 
and (+)-S-propyl-L-cysteine sulfoxide (PCSO) (Lancaster and Boland, 1990). Thiosulfinates 
themselves are unstable and decompose to form a complex mixture of compounds, in which 
mono-, di-, tri- and tetra-sulfides predominate (Rose, Whiteman, Moore & Zhu, 2005). 
Dipropyl disulfide, dipropyl trisulfide, and propenil disulfides are the major constituents of 
onion volatiles, although many others compounds have been identified, including dipropyl 
sulfide and dipropenyl sulfide (Munday & Munday, 2001). 
The biological effects of organosulfur compounds of the Allium genus of vegetable (in 
particular garlic and onion) have been associated with the prevention of multiple pathologies, 
including cancer, cardiovascular disease and inflammatory disorders (Rose et al., 2005). 
Among the anticarcinogenetic properties described in the literature in association with the 
consumption of onion, the capacity to modify the enzymatic activity (such as that of the phase 
II detoxification enzymes), the inhibition of tumour cell proliferation and induction of 
apoptosis in cancer cells and the modulation of inflammatory cascades are a subject of keen 
interest (Rose et al., 2005). Moreover, the antioxidant properties of individual sulfur 
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compounds such as diallyl sulfide (DAS), diallyl disulfide (DADS), S-methylcysteine (SMC) 
and S-propylcysteine as inhibitors of the damage caused by free-radical agents, together with 
the antimicrobial, antifungal and anti-parasitic properties which are derived from the use and 
consumption of onion are constantly under study (Corzo-Martínez & Villamiel, 2012; Kumari 
& Augusti, 2002; Llana-Ruiz-Cabello et al., 2015; Senthilkumar et al., 2015). 
Figure 1.5. Scheme of organosulfur formation in processed onion (Allium cepa L.) 
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1.3.3. Fructans and fructooligosaccharides (FOS) 
Onion is a perennial herbaceous plant rich in fructooligosaccharides (FOS) inulin (IN) type 
structure. FOS/IN are generally referred to as fructans belonging to the category of non-
digestible carbohydrates (Roberfroid, 2005). It is generally accepted that FOS is a common 
term used only to refer to fructose oligomers that are mainly composed of kestose (GF2), 
nystose (GF3) and fructofuranosylnystose (GF4), in which fructosyl units (F) are bound by β-
linkage at the position of the sucrose (glucose+fructose-GF) (Jaime et al., 2001). 
In onion, the predominant non-structural carbohydrates are glucose, fructose, sucrose and 
low-molecular-weight fructans, while starch and raffinose are absent. FOS appear as the main 
carbohydrate reserve of onion comprising polyfructosyl sucroses of varying molecular size. 
These FOS accumulate during bulb formation and are then catabolized during regrowth and 
sprout development of the bulbs (Benkeblia, 2005). 
It is particular characteristic of onion tissue to have a predominance of kestose (GF2) and 
an absence of highly polymerized fructans. The degree of fructan polymerization in a typical 
onion bulb ranges mainly between 3 and 15 (Kahane et al., 2001). The tissues richest in 
fructans are the fleshy part of the onion bulbs, which explains why the outer two fleshy layers 
constitute a useful by-product of onion and is a source of fructans and FOS (Jaime et al., 
2001; Jaime et al., 2002). 
The content, distribution and structure of FOS in onion bulb were initially investigated by 
Bacon (1959) and Darbyshire and Henry (Darbyshire & Henry, 1981; Darbyshire & Henry, 
1978). Nowadays, short chain fructans (with a degree of polymerization less than 5) are 
potentially used as natural low-calorie sweeteners, while onion bulbs with of a high degree of 
fructan polymerization may be used for lipid replacement with consequential health benefits 
(Kahane et al., 2001). The quantification of fructans and FOS is undertaken in the study and 
control of prebiotics, while their properties are tested in relation to several physiological 
situations. FOS are fermented to a high degree by Bifidobacterium into short-chain carboxylic 
acids in the large intestine. This produces a decrease in pH and changes in gastric emptying 
and intestinal motility, which are associated with important physiological properties, as for 
example a decrease in circulating levels of cholesterol, triglycerides and phospholipids (Jaime 
et al., 2001). 
Moreover, the presence of fructans in the tract stimulates the growth of the beneficial 
microbiota usually constituted by Bifidobacteria and Lactobacilli and also produces positive 
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results in the colon, including effects on colonic inflammation and increased intestinal 
absorption of calcium and magnesium leading to improved bone density (Lara-Villoslada et 
al., 2006; Ernst & Feldheim, 2000; Roberfroid, 2007). In more recent studies, the 
immunomodulatory properties of onion have also been attributed to the presence of FOS. For 
example, structural and in vitro results have indicated that onion FOS comprising tri- to 
hexasaccharide units promote immunostimulatory activity towards murine lymphocytes and 
macrophages (Kumar, Prashanth & Venkatesh, 2015). 
1.3.4. Other bioactive onion compounds 
Although classical phenolic and organosulfur compounds have accumulated most of the 
attention, still new compounds are being isolated from onion with new functions and 
characteristics which are being described in the scientific publications.  
Saponins have gained much attention due to their antispasmodic activity, which helps 
explain the traditional use of onion and garlic in the treatment of intestinal spasms, instigating 
the study of in vivo effects of the isolated metabolites in models of intestinal hyperactivity 
(Lanzotti, 2012). 
In 2008, four furostanol saponins, two of which were new compounds, termed ceparoside 
A and ceparoside B were isolated from the seeds of Allium cepa L. (Yuan et al., 2008; Yuan 
et al., 2009). Some years later, three new furostanol saponins metabolites, ceposides A-C, 
were also isolated and structurally determined, and were shown to have significant antifungal 
activity related to the resistance of A. cepa to pathogen attack (Lanzotti et.al., 2012). 
Xiao and Parking (2007) were able to isolate and identify five potentially active cancer 
chemopreventive agents, related to the induction phase II enzymes, from methanolic extracts 
of green onion: 5-hydroxy-3-methyl-4-propylsulfanyl-5H-furan-2-one was reported as a new 
compound, in addition to four others known as 5-(hydroxymethyl) furfural, acetovanillone, 
methyl 4-hydroxyl cinnamate and ferulic acid methyl ester (Xiao & Parkin, 2007). 
A gamma-glutamyl peptide from onion was mentioned as a possible inhibitor of the 
resorption activity of osteoclasts in vitro (Langos et al., 2007; Wetli et al., 2005). 
More recently, onionin A (1) has been identified as a new stable, sulfur-containing 
compound isolated from acetone extracts of onion bulbs (Allium cepa). The structure is 
characterized as 3,4-dimethyl-5-(1E-propenyl)-tetrithydrothiophen-2-sulfoxide-S-oxide (El-
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Aasr et al., 2010). In addition, two more stable sulfur-containing compounds identified as the 
stereoisomers of onionin A(1), classified as onionins A(2) and A(3) were also isolated, 
showing the potential to suppress tumour-cell proliferation by inhibiting the polarization of 
M2 alternatively activated macrophages (Nohara et al., 2014). Onionin A has been shown to 
inhibit epithelial ovarian cancer proliferation by the suppression of STAT3 activation in 
tumour cells and macrophages (Nakao et al., 2014) and is currently considered as a useful 
additional treatment for patients with ovarian cancer owing to its suppression of the 
protumour activation of TAMs and direct cytotoxicity against cancer cells (Tsuboki et al., 
2016). 
1.4. Effects of onion consumption in health and disease 
As mentioned above, the particular composition of onion Allium cepa L. var. cepa makes 
this vegetable an important source of elements for the organisms with direct repercussion on 
human health. The health promoting benefits of consuming onion have been supported by in 
vitro, in vivo, and ex-vivo experimentation. Antioxidant, antiinflammatory, anticarcinogenic, 
hypolipidemic, hypoglycaemic, or antiaggregatory properties of onion have been 
demonstrated by a large number of investigations (Ali, Thomson & Afzal, 2000; Griffiths et 
al., 2002; Suleria et al., 2015; Wilson & Demmig-Adams, 2007). Antimicrobial effects of 
onion and substances isolated from these plants have also been described, showing their 
effectiveness against pathogenic microbes (Lanzotti, Bonanomi & Scala, 2013) and 
modulating properties on the gut microflora. Moreover, the consumption of onions has been 
related to a reduction of the risk of several illness, including cardiovascular disease, hepatic 
impairments, diabetes mellitus, metabolic syndrome, asthma and different types of cancer 
(Akash, Rehman & Chen, 2014; Nicastro, Ross & Milner, 2015; Suleria et al., 2015). 
Enhancement of the immune system has been associated with components of onion such as 
FOS (Kumar, Prashanth & Venkatesh, 2015) and research into the effects on immunological 
cells in rats is being undertaken (Mirabeau & Samson, 2012) as well on experimental 
infections such as in Schistosoma mansoni (Mantawy, Ali & Rizk, 2011). 
Less well-understood but not for that less interesting properties of onion are those shown 
by Matheson et al. (2009) and Law et al. (2016), reporting that onion and onion juice 
consumption seems to have a beneficial effect on bone density and inhibits osteoclastogenesis 
and its differentiation in premenopausal and postmenopausal women and in healthy middle-
aged subjects. Likewise, studies by Sakakibara et al. (2008) suggest that onion exert 
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antidepressant-like activity in a behavioural model of depression (Law et al., 2016; Matheson, 
Mainous & Carnemolla, 2009; Sakakibara et al., 2008). 
All these findings make the consumption of onions not only recommendable as a healthy 
food product to be included in our diet for the health promotion and disease prevention, but 
also for use as a complementary approach for tackling some of the side-effects resulting from 
the treatment of several pathologies. Thus, onion supplementation has promise as a functional 
ingredient contributing to future nutritional and dietary interventions. 
1.4.1. The role of onion in hypercholesterolemia, inflammation and oxidative stress 
Hypercholesterolemia, inflammation and oxidative stress are highly prevalent disorders 
associated with the initiation and onset of disease. The occurrence of inflammation and 
oxidative stress also appears as response to hypercholesterolemia, and as 
hypercholesterolemia acts as a feedback it leads to permanent damage and the progression of 
disease. 
In this regard, atherosclerosis is a well-defined pathology that can be used as a clear 
illustration of the implication and close link between these impairments. Although the exact 
cause of atherosclerosis is not well known, its aetiology point it to be classified as a systemic 
inflammatory disease where hypercholesterolemia is one of the major risk factors for its 
promotion (Tall & Yvan-Charvet, 2015). At the same time, the inflammatory processes 
triggered are characterized by induced oxidative stress and a reduced cellular antioxidant 
capacity (Khansari, Shakiba & Mahmoudi, 2009). 
Dietary habits have been largely related with these three factors as well as with the 
prevention and prevalence of diseases. The dietary habit of eating onion has attracted a lot of 
attention in this field and there are many publications describing this relationship: 
• The hypolipidemic, hypocholesterolemic or more generally lipid-lowering effects of
onion have been widely documented in a diversity of preparations: fresh or treated onion, 
onion powder, onion juice, essential oils, aqueous extracts or skin by-products. Decreased 
blood cholesterol concentration has generally been observed in the majority of these studies, 
taking into account either genetically modified models or dietary interventions under 
conditions of a normal, high-fat, high-cholesterol or high-sucrose diet. However, findings are 
heterogeneous as they depend on several factors such as the model of study, experimental 
design, time of intervention, subject and variety of onion tested in the experiments. By way of 
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example, the hypolipidemic effect of onion skin was studied in ob/ob mice concluding that it 
could be beneficial on hyperlipidemia and hepatic lipid accumulation (Kang et al., 2010). A 
dehydrated onion product was evaluated in experimental Wistar rats, showing significant 
reductions of cholesterol (LDL) and triglycerides and an increase in HDL cholesterol 
(Vidyavati et al., 2010). Anti-obesity effects of an onion extract were determined in obesity 
and diabetes-prone Zucker diabetic fatty rats by measuring diverse markers, which revealed 
reduced triglyceride and free fatty acid serum levels in the onion-fed groups, despite not 
finding significant differences in the levels of cholesterol (Yoshinari, Shiojima & Igarashi, 
2012). The effect of ultra-high pressure processed onion extracts was also tested on serum 
cholesterol levels in high cholesterol-fed rats showing its capacity to prevent hyperlipidemia 
by improving lipid metabolism via decreased liver lipid contents and increased fecal lipid 
excretion (Jung et al., 2015). Likewise, a quercetin rich onion juice was able to markedly 
suppress cholesterol levels and elevate total antioxidant status in mildly hypercholesterolemic 
subjects after eight weeks of intervention (Lu et al., 2015). 
• Onion has also been established as having antiinflammatory effects, intervening in
different mechanisms of action. It is briefly exemplified by various studies (Suleria et al., 
2015; Wilson & Demmig-Adams, 2007): 
The antiinflammatory effect of some of its bioactive components such as quercetin was 
initially investigated by Wagner et al. (1990), on prostaglandins, leukotrienes, histamine 
release, and subsequent antiasthmatic activity. The organosulfur compounds of onions such as 
thiosulfinates and capaenes have been related to antiinflammatory activities by means of 
modification of enzyme activities (COX, LOX), blood platelet aggregation and inhibition of 
the arachidonic acid metabolic pathway. The discoveries about the inhibitory effect of onion 
on the conversion of arachidonic acid into eicosanoids metabolism were summarized by Ali et 
al. (2000). Furthermore, diverse components of onion such as quercetin derivatives have 
evidenced its protective effect by modulating the release of proinflammatory mediators and 
vasoactive biomarkers e.g. cytokine, nitric oxide, endothelin-1, etc. (Brüll et al., 2015; Ford et 
al., 2016; Sekhon-Loodu et al., 2015). 
• Generation of reactive oxygen species (ROS) and other free radicals during
metabolism is a normal process which is ideally compensated by the antioxidant defence 
system. Nevertheless, an imbalance in these mechanisms leads to an overproduction of free 
radicals that cause oxidative stress and damage at different levels. ROS induce lipid 
peroxidation in cellular membranes by generation of lipid peroxides, whereas endothelial cell 
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injury is induced by hydrogen peroxide, superoxide anion, and hydroxyl radicals and is often 
observed in the early stages of many pathological disorders (Pham-Huy, He & Pham-Huy, 
2008; Zorov, Juhaszova & Sollott, 2014). 
Oxidative stress is now believed to be the primary cause for not only many degenerative 
diseases, such as cardiovascular diseases, inflammatory diseases, cancer, cataracts, type-2 
diabetes, neurodegenerative diseases, etc., but also the inevitable process of aging. The 
relationship between diet and chronic diseases has been increasingly understood in recent 
decades and dietary onion seems to have important applications as a natural antioxidant agent 
by delaying or suppressing oxidative stress, in both animals and humans (Srinivasan, 2014). 
To cite a few recent examples, the antioxidant and antigenotoxic properties of onion peel 
extracts were demonstrated in both non-cellular and cellular systems  (Kim, Kim & Park, 
2013). Hur et al. (2013) studied the effect of an onion extract in mouse brain lipids and its 
structural change during in vitro human digestion, finding that the antioxidative effect of 
onion extract was greater in high-fat-fed mouse brain lipids than that in low-fat-fed mouse 
brain lipids. Another study showed that onion extract therapy reduced Cd-induced oxidative 
stress and apoptosis (Alpsoy et al., 2014). Onion juice consumption showed a significant 
positive change in the levels of alkaline phosphatase (ALP), free radicals, total antioxidant 
capacity (TEAC) and various antioxidants in middle-aged and post-menopausal healthy 
subjects (Law et al., 2016). However, as previously mentioned, results present great 
variability. In this sense, Jeon et al. (2013) assayed the effect of onion juice supplementation 
on antioxidant status in participants with mild hypercholesterolemia, failing to find any 
antioxidant effect of onion supplementation in subjects with mild hypercholesterolemia. 
In this context, we have to cite previous studies undertaken by our research group that have 
also shown the lipid lowering, antiinflammatory and antioxidant properties of diverse onion 
products submitted in this case to diverse treatments of high-pressure processing (González-
Peña et al., 2013; Roldán-Marín et al., 2010; Roldán-Marín et al., 2009a; Roldán-Marín et al., 
2009b, Roldán et al., 2008; Vázquez-Gutiérrez et al., 2013). 
1.4.2. Onion in atherosclerosis and cardiovascular disease (CVD) prevention 
Cardiovascular disease (CVD) groups together a series of disorders of the heart and blood 
vessels, including coronary and rheumatic heart disease, cerebrovascular disease, congenital 
heart disease, deep vein thrombosis and pulmonary embolism (WHO, 2016). This set of 
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pathologies is recognized as the main cause of death in the world, while atherosclerosis is the 
major and prevalent cause of CVD initiation and progression. Multiple risks such as 
cholesterol, hypertension, Angiotensin II, smoking or diabetes are pointed as inducers for its 
development and cholesterol is investigated as a key risk factor in cardiovascular prevention 
strategies. 
Atherosclerosis involves the 
development of atheromatous 
plaques on the inner lining of the 
arteries (Figure 1.6). This process, 
which has been recently represented 
by Libby et al. in Nature (Libby, 
Ridker & Hansson, 2011), starts 
with an initial qualitative change in 
the monolayer of endothelial cells 
that lines the inner arterial surface, 
when subjected to an irritative 
stimuli (e.g. dyslipidaemia, 
hypertension or proinflammatory 
mediators). Arterial endothelial cells 
express adhesion molecules that 
capture leukocytes on their surfaces 
in parallel to changes in endothelial 
permeability and the composition of 
the extracellular matrix, which 
beneath the endothelium promote 
the entry and retention of 
cholesterol-containing low-density 
lipoprotein (LDL) particles in the 
artery wall (Figure 1.6B). 
Biochemical components of 
these particles induce leukocyte 
adhesion, and monocyte-derived Figure 1.6. Schematized phases in the development of 
atherosclerosis.  
Adapted from  Libby et al. (2011) 
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macrophages undergo endocytosis, which leads to the accumulation of intracellular 
cholesterol. The migration of the bound leukocyte is directed by chemoattractant mediators 
within the tunica intima while the monocytes in the artery wall differentiate into tissue 
macrophages. These mononuclear phagocytes engulf lipoprotein particles and become foam 
cells (Figure 1.6B). Macrophages in the atheroma may also have proinflammatory functions, 
which produce high levels of effectors such as the cytokines interleukin-1β (IL-1β) and 
tumour-necrosis factor (TNF-α). Some mononuclear phagocytes in plaques act with the 
antigen-presenting functions of dendritic cells, while other leukocyte classes (such as 
lymphocytes) and mast cells also accumulate in atheromata. 
The atheroma formation also involves the recruitment of smooth muscle cells (SMCs) from 
the tunica media into the tunica intima and some proliferate in response to mediators such as 
platelet-derived growth factor. SMCs produce extracellular matrix molecules in the intima, 
including interstitial collagen and elastin, which form a fibrous cap that covers the plaque 
with massive macrophage-derived foam cells, some of which die (for example, by apoptosis) 
and release lipids that accumulate extracellularly (Figure 1.6C). 
The inefficient clearance of dead cells (efferocytosis) can promote the accumulation of 
cellular debris and extracellular lipids, forming a lipid-rich pool called the necrotic core of the 
plaque. Plaques generally cause clinical manifestations by producing flow-limiting stenosis 
that leads to tissue ischaemia, or by provoking thrombi that can interrupt blood flow locally or 
embolize and lodge in distal arteries. Complications arise with the physical disruption of the 
plaque triggering thrombosis. Infiltrated inflammatory cells interact with the intrinsic arterial 
cells promoting lesion formation and complications (text summarized from Libby et al., 2011). 
It seems to be clear that some foods and nutraceuticals are able to intercede at different 
stages in the development of atherosclerosis and CVD. In this sense, onion and some of its 
bioactive compounds such as flavonols and organosulfur compounds have been linked with 
the amelioration of these pathologies. The cardioprotective effects of onion also rely on its 
antioxidant, antiinflammatory, hypolipidemic and antitrombotic properties (Suleria et al., 
2015). Additionally, the anti-apoptotic effects of onion have been explored; administering a 
daily dose of 1 mL onion (Allium cepa) extract for 14 proved to be a suitable cardioprotector 
against the toxic effects of doxorubicin (DOX) (Alpsoy et al., 2011). 
The first study in Mediterranean countries on the relationship between onion and garlic 
intake and acute myocardial infarction was recently reported by Galeone et al. (2009), 
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suggesting that a diet rich in onions may have a favourable effect on this risk. Nevertheless, 
investigation into the effects of onions and its compounds on several biomarkers leading to a 
comprehension of cardiovascular events began at a much earlier date. 
The description of quercetin properties can be used as a good example since it is one the 
best documented and predominant flavonol constituents of onions, which may be considered a 
potential therapeutic agent against atherosclerosis (Gormaz, Quintremil & Rodrigo, 2015). 
Dietary polyphenols such as quercetin act as regulators of endothelial function (Yamagata, 
Tagami & Yamori, 2015). Studies of quercetin in a variety of models have shown that it can 
exert an antioxidant activity through different mechanism of action, such as the enhancement 
of antioxidant-defence mechanisms, direct radical scavenging, modulation of nitric oxide 
production or inhibition of xanthine oxidase activity (Nijveldt et al., 2001). Quercetin also 
favours a diminishing formation of inflammatory metabolites involved with the 
cyclooxygenase (COX) and lipoxygenase (LOX) activities as well as showing a capacity to 
inhibit platelet aggregation in vitro and to reduce thromboxane synthesis in vivo (Hubbard et 
al., 2004; Nijveldt et al., 2001). The lipid lowering properties of onion, although not always 
evidenced, have been demonstrated in several studies, where either whole onion, extracts or 
some of its fractions were administered under differential pathological conditions, leading to 
improvements at a vascular level. As examples, red onion consumption had a positive result 
in women with polycystic ovary syndrome (Ebrahimi-Mamaghani et al., 2014); a dehydrated 
onion product proved significant cholesterol lowering in experimental hypercholesterolemic 
rats (Vidyavati et al., 2010) and a daily supplementation with onion peel extract, improved 
blood lipid profiles, glucose, and blood pressure in healthy male smokers, suggesting a 
beneficial role against cardiovascular risk (Lee et al., 2011). 
However, taking into consideration the possible interactions and synergistic effects of 
onion components, it is interesting to mention that the consumption of whole onion can offer 
benefits over the consumption of its individual components. This fact should direct the use of 
whole onion products and complex mixed with components to design new products useful as 
a supplement to prevent or treat vascular dysfunction linked to initial stages of 
atherosclerosis. 
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1.4.3. Effects of onion on liver disease 
Non-alcoholic fatty liver disease (NAFLD) has increased significantly over the last 
decades and is the most prevalent chronic liver disease worldwide. NAFLD is caused by an 
excessive accumulation of fat in liver hepatocytes (>5% of liver weight or volume) which is 
prone to progression to non-alcoholic steatohepatitis (NASH), and in severe cases to cirrhosis 
and hepatocellular carcinoma (Katsiki, Mikhailidis & Mantzoros, 2016). 
The intrahepatic lipid accumulation occurs in the form of droplets as a result of lipid 
metabolism abnormalities such as an increased lipolysis, free fatty acid (FFA) liver uptake, 
very low density lipoprotein (VLDL) synthesis, reduced FFA oxidation and triglyceride (TG) 
export (Katsiki et al., 2016). All these alterations in lipid metabolism are linked to an 
induction of inflammation and oxidative stress as well as to abnormal adipokine and cytokine 
production that affect signaling pathways and involve endothelial dysfunction. Although the 
mechanisms by which NAFLD contributes to CVD are not fully understood, the association 
with an increased mortality due to cardiovascular disease make NAFLD a priority for 
consideration as an independent cardiovascular risk factor (Francque, van der Graaff & 
Kwanten, 2016). However, it must be clear that NAFLD is usually part of a complex 
multisystem disease with multiple relationships (Figure 1.7). 
Figure 1.7. Schematic representation of some interlinked factors influencing NAFLD 
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Furthermore, dietary habits are the largest environmental factor that has a substantial 
influence on several risks leading to hepatic dysfunction. The diet alters the microbiota 
composition in the gut, which simultaneously is linked to multiple functions that involve the 
regulation of cardio-metabolic disorders such as diabetes, obesity, NAFLD/NASH, and 
atherosclerosis among others. Recognition and understanding of these relationships will led to 
new discoveries about the complex human host physiology and disease, motivating and 
driving the search for new biomarkers in the microbiome and testing of innovative therapeutic 
approaches (Zamparelli et al., 2016). 
The particular effects of onion consumption have been explored in the treatment of 
NAFLD in experimental models of disease (El-Din et al., 2014; Emamat et al., 2016). 
Moreover, several hepatic markers have shown to be ameliorated by the consumption of 
onion products. For example, it has been demonstrated that the consumption of an onion peel 
extract containing high quercetin improves the hypoglycemic and insulin-sensitizing capacity 
by alleviating metabolic dysregulation of FFA, suppressing oxidative stress, and down-
regulating inflammatory gene expression in liver in high fat diet/streptozotocin-induced 
diabetic rats (Jung et al., 2011). Red onion and onion powder (Allium cepa L.) improved the 
protective barriers against oxidative stress in Sprague-Dawley rats and suppressed oxidative 
stress and the formation of preneoplastic foci in diethylnitrosamine-induced rat hepatocellular 
carcinogenesis, respectively (Bang & Kim, 2010; Lee, Jung & Kim, 2012). The 
hepatoprotective effects of onion peel extracts have been indicated in CCl4-induced liver 
injuries by reducing lipid peroxidation, improving blood cholesterol profiles and enhancing 
antioxidant properties (Chyun, Park & Yim, 2013). 
In this sense, the beneficial effects of flavonoid consumption in NAFLD have been 
prominent in both animal and human studies. In general, the underlying protective 
mechanisms against hepatosteatosis have pointed an increased fatty acid oxidation in the liver 
and a decrease in fat deposition in visceral tissues and body weight. The antioxidant 
properties of flavonoids are also related to the inhibition of nuclear factor kappa B (NF-κB), 
attenuating the release of inflammatory cytokines and the increase in adiponectin, which 
improve insulin sensitivity, glucose tolerance, ameliorate dyslipidemia and blood pressure in 
patients with NAFLD (Akhlaghi, 2016). More specifically, the role of quercetin − as 
important flavonol present onion−, has reported favorable effects against hepatosteatosis in 
terms of decreased lipid accumulation and peroxidation in liver, plasma glucose, insulin 
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resistance, inflammatory cytokines, and hepatic enzyme levels in animal models of NAFLD 
and NASH ( Kim et al., 2015; Vidyashankar, Sandeep Varma & Patki, 2013). 
2. METABOLOMICS, NUTRIMETABOLOMICS AND FOODOMICS
Nutritional and food research is undergoing a remarkable transformation driven by new
technologies. The complexity of the metabolome requires the application of advanced and 
comprehensive high-throughput approaches, which provide large amounts of data which need 
to be analysed and interpreted based on their dynamic biochemical networks. The interaction 
of food and its components in living organisms also modifies the metabolic responses, which 
can be measured in the metabolome by identifying and quantifying the metabolites (small 
molecule <1500 Da). These metabolites are considered the end products synthetized by the 
cellular regulatory processes (Bagchi, Lau & Bagchi, 2010; Lindon, Nicholson & Holmes, 
2006).   
Omics technologies have attracted much attention since they adopt a holistic view and 
have a broad range of applications. These differ from traditional studies, which are largely 
hypothesis-driven or reductionist.  
The evolution of the omics cascade (Figure 1.8) reflects why metabolomics has gained 
such a considerable position in biomedical research. The reasoning was clearly exposed by 
Patty et al. 2012 in Nature Reviews Molecular Cell Biology with the following statement 
“Whereas genes and proteins are subject to regulatory epigenetic processes and post-
translational modifications, respectively, metabolites represent downstream biochemical end 
products that are closer to the phenotype. Accordingly, it is easier to correlate metabolomic 
profiles with the phenotype compared to genomic, transcriptomic and proteomic profiles” 
(Patti, Yanes & Siuzdak, 2012). Therefore, the finality of studying the metabolome includes 
the discovery of biomarkers, but also the comprehension of the mechanisms of biological 
processes and from a nutritional perspective, an understanding of the role of food in health 
and disease. 
Chapter  1  
28 
Figure 1.8. Flow of omics technologies in biomedical research 
In this regard, the impressive development of omics technologies in combination with the 
interest in food science and nutrition have led to new and complementary disciplines, which 
coin new terms such as nutrimetabolomics and foodomics. Metabolomics, considered as the 
baseline of these metabolite studies, frequently overlaps in both objectives and methodologies 
with these current nutritional or food −omics categories, which can lead to a certain degree of 
confusion with the use of all these interchangeable terms. To clarify, a quick revision of the 
situation follows: 
The term “metabolomics” was coined in the late 1990s, following the use of the term 
“metabolome” which was used for the first time in 1998 by Oliver et al., (1998). 
Metabolomics aims to obtain the complete quantitative and qualitative analysis and 
identification of all metabolites present in an organism or a biological system, under a given 
set of conditions (Fiehn, 2001). Since its apparition, it has been the focus of multiple authors 
and has received increasing attention by the scientific community in nutritional studies [e.g. 
(Astarita & Langridge, 2013; Bagchi et al., 2010; Gibbons, O'Gorman & Brennan, 2015; 
Jones, Park & Ziegler, 2012; McGhie & Rowan, 2012; Rezzi et al., 2007; Scalbert et al., 
2009; Wishart, 2008)]. 
In the years 2007-2009 the term “nutrimetabolomics” started to be used in some 
publications as an alternative term for metabolomics studies referring to nutritional 
interventions, while the use of the term “foodomics” also began to appear in different 
webpages and scientific meetings. However, a formal definition for foodomics was not 
published in an SCI journal until 2009, when Cifuentes (2009) outlined foodomics as a “new 
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discipline that studies the food and nutrition domains through the application of advanced 
omics technologies to improve consumer´s well-being, health, and confidence”. Thus, the 
scope of nutrimetabolomics was limited to the discovery of new biomarkers in human 
nutritional research, which lead to a further classification into three main categories: I) the 
assessment of nutritional and dietary interventions, II) the monitoring of diet exposure and 
food consumption and III) the phenotype and metabolic impact of diet on health (Llorach et 
al., 2012). Whereas in comparison, the term foodomics was presented as a wider global 
discipline that brings together all working areas involving food, nutrition and advanced omics 
tools (Table 1.2) (Cifuentes, 2013).  
However, a point in common to all these metabolomics-type studies is that they rely 
primarily on mass spectrometry (MS) coupled with chromatography or the use of nuclear 
magnetic resonance (NMR) generating huge amount of data. 
Table 1.2. Areas covered by foodomics applying omics tools (genomics, epigenomics, 
transcriptomics, proteomics and metabolomics) 
Nutrition 
Gene-based differences among individuals in response to a specific dietary 
pattern 
Biochemical, molecular, and cellular mechanisms that underlie the 
beneficial or adverse effects of certain bioactive food components 
Effect of bioactive food constituents on crucial molecular pathways 
Identity of genes involved in the stage previous to the onset of the disease, 
and therefore possible molecular biomarkers 
Global role and functions of gut microbiome 
Safety 
Quality 
Traceability 
Effects in GM crops 
Stress adaptation responses of food-borne pathogens to ensure food 
hygiene, processing and preservation  
Use of food microorganisms as delivery systems including the impact of 
gene inactivation and deletion systems 
Comprehensive assessment of food safety, quality, and traceability ideally 
as a whole  
Agronomy 
Environmental 
factors 
Molecular basis of biological processes with agronomic interest and 
economic relevance such as the interaction between crops and pathogens, as 
well as physicochemical changes that take place during the ripening of fruit 
Postharvest phenomena through a global approach than links genetic and 
environmental response and identifies the underlying biological networks 
Adapted text from Cifuentes (2013) 
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At the moment, in order to understand the biological meaning of the complex information 
obtained from metabolomics platforms and all complementary omics disciplines, the 
information is being encompassed into a bigger category called “Systems Biology”. Thus, 
Systems Biology has born as an integrative approach that aims to unify all information 
concerning molecules, cells, organs and individuals generated by genomics, proteomics and 
metabolomics, resulting in the most complex level of comprehension available today. 
Moreover, it is also considered pivotal for the development of rational intervention strategies 
for the prevention of disease in a nutritional context (Panagiotou & Nielsen, 2009). 
2.1. Strategies for metabolomics screening 
Different strategies are designed to obtain and handle the amount of data generated from 
metabolomics studies. These are divided into non-targeted and targeted studies. Non-targeted 
approaches are applied to hypothesis-generating studies, while targeted assays are usually 
applied to validations and to the confirmation of the novel discoveries after an initial 
hypothesis-generating study. 
2.1.1. Non-Targeted studies 
A non-targeted approach attempts to detect as many metabolites as possible in a given set 
of samples. The signal of each possible entity detected is assigned as a feature, which is noted 
as a peak area used to perform statistical analysis. The complete set of features constitutes a 
characteristic pattern of the studied biological system or situation. When the signal obtained 
for each pattern is compared among groups, unexpected changes may be observed and further 
interrogated until the structure can be identified. The biological interpretation is performed at 
the end of the experimental procedure and allows for the creation of new hypothesis, thus 
justifying the stage as “hypothesis-generating”. However, one single analytical method cannot 
detect all the metabolites in a biological system. It is therefore desirable to combine multiple 
analytical approaches to maximise the number of metabolites detected and increase the 
coverage of the metabolome.  
In this modality, there is no comparison with calibration curves constructed with chemical 
standards, so the annotations are referred to as relative quantification. However, the screening 
can be done against a comprehensive library of compounds whether or not, where unknown 
compounds may be new chemical structures in need of structural elucidation. Metabolite 
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identification is currently one of the major limitations and highly debated topics in 
metabolomics. 
Currently, the platforms widely used in non-targeted metabolomics include proton nuclear 
magnetic resonance (1H NMR) spectroscopy, direct infusion mass spectrometry (DIMS), and 
mass spectrometry (MS) combined with a separation technique, for example GC–MS, LC–
MS and CE–MS, which allow for the detection of metabolites of different chemical classes. 
However, there are multiple analytical techniques that can be applied in metabolomics studies 
(Table 1.3). 
− Metabolic Fingerprinting is the most commonly used strategy in non-targeted studies. It
is an unbiased global analysis, based on obtaining characteristic patterns considered as 
“fingerprints” of metabolites that change in response to disease or stress exposure, and also 
reflect the effects in the phenotype from multiple epigenetic factors such as environment, 
microbiome, diet, drugs, etc. The intention is not to identify each compound observed but to 
compare patterns, often NMR, mass spectra or chromatograms. This is performed using 
statistical tools such as hierarchical cluster analysis or multivariate analysis (Kosmides et al., 
2013; Fiehn, 2002). 
− Metabolic footprinting differs from metabolic fingerprinting because it does not rely on
the measurement of intracellular metabolites. The strategy focuses on analysing and 
monitoring the changes in metabolites produced by the cells or tissues in the surrounding 
medium either by absorption or excretion. This approach is also called exo–metabolome or 
secretome and the growth medium produced in batch cultures is usually analysed by using 
DIMS (Hollywood, Brison & Goodacre, 2006; Kell et al., 2005). 
Table 1.3. Summary of analytical techniques applied in metabolomics 
Abbreviated name Technique References 
1H NMR Proton nuclear magnetic resonance Beckonert et al., 2007 
(HR−MAS) NMR High resolution−magic angle spinning NMR Beckonert et al., 2010 
LC−MS Liquid chromatography−mass spectrometry Zhou et al., 2012 
UPLC−MS Ultra−performance liquid chromatography−MS 
Want et al., 2010 
LC−EC LC−electrochemical array Gamache et al., 2004 
LC−NMR LC−nuclear magnetic resonance Wolfender et al., 2003 
HILIC−UPLC−MS Hydrophilic interaction−UPLC−MS Spagou et al., 2011 
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LC x LC−MS Two-dimensional LC−MS Guo et al., 2001;  Donato et al., 2012 
GC−MS Gas chromatography−mass spectrometry García et al., 2011 
GC x GC−MS Two-dimensional GC−MS Mal et al., 2012 
FTIR Fourier transform infrared spectroscopy Ellis et al., 2006 
DIMS Direct infusion−MS Han et al., 2003 
MALDI−MS Matrix assisted laser desorption−MS Milne et al., 2013; Vaidyanathan et al., 2006 
FT−ICR−MS 
Fourier transform ion cyclotron 
resonance−MS 
Aharoni et al., 2002 
CE−MS Capillary electrophoresis−MS Ramautar et al., 2009 
CE−UV CE−ultraviolet detector Barbas et al., 2011 
CE-LIF Capillary electrophoresis-laser-induced fluorescence Barbas et al., 2011 
Table adapted from Hollywood et al. (2006) and Villaseñor (2014) 
2.1.2. Targeted studies 
A targeted approach analyses a relatively small and specific number of metabolites. These 
metabolites are chemically characterised and biochemically annotated with known biological 
importance at the start of the study, before data acquisition is performed. The methods used in 
a targeted mode have a greater selectivity and sensitivity than non-targeted methods. 
Quantification of the metabolites is performed through the use of internal standards and 
authentic chemical standards to construct calibration curves for each of the metabolites. In 
this case, sample preparation can be optimised to retain the metabolites of interest and to 
remove other biological species and analytical artefacts which are excluded from the 
downstream analysis. This simplifies the analysis of the data and interpretation of the 
biological significance.  
The strategy is especially useful to answer well defined biological questions. However, a 
targeted study cannot be performed unless an authentic chemical standard of the target 
metabolite is available. 
− Metabolic Profiling is the term utilised when target metabolites are selected previously
and they are assessed using specific analytical methods. The metabolite search always focuses 
on the analysis of a group of metabolites related to a specific metabolic pathway or analyses 
metabolites with similarities in their chemistry (e.g. amino acids, FFA, etc.) (Dunn & Ellis, 
2005; Hollywood et al., 2006). 
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2.2. Metabolomics in cardiovascular and liver disease: hypercholesterolemia, 
inflammation and oxidative stress 
Among its multiple potential uses, the application of metabolomics in the area of 
prevention, diagnostic and prognostic of cardiovascular and liver diseases (and associated 
metabolic impairments) has occupied an outstanding position during recent decades. 
Cardiovascular disease (CVD) is the first cause of death worldwide, representing the 31% 
of all global deaths (WHO, 2016). Although CVD may be partly prevented by addressing 
behavioural risk factors (e.g. tobacco, diet, physical inactivity, alcohol, etc.), it is expected 
that the prevalence of CVD will rise as the population ages. Therefore, the need for early 
detection and management in which more than one risk factor (like hypertension, diabetes or 
hyperlipidaemia) becomes a priority. In addition, non-alcoholic fatty liver disease (NAFLD) 
and non-alcoholic steatohepatitis (NASH) have now been identified as the first cause of liver 
disease in numerous western countries. This disease confers additional risk to vascular 
dysfunction, the development of atherosclerosis and in final instance, cardiovascular-related 
mortality (Long et al., 2015). 
As a result, the search for new cardiovascular biomarkers is an active area of investigation, 
in which metabolomics and proteomics offer useful approaches for potential biomarkers 
screening. This is due to their expected capability to improve the knowledge of disease and 
atherosclerosis-associated mechanisms, in diagnosis and the possibility to predict future 
cardiovascular events (Gerszten & Wang, 2008). 
Metabolomics has been already applied in cardiology for the analysis of gene 
modifications, substrate selection or toxicity monitoring. Moreover, and given the metabolic 
basis behind cardiovascular events, changes in metabolic patterns have been used to detect 
blood plasma and urine metabolites highly correlated to CVD under specific conditions 
(atherosclerosis, myocardial ischemia and infarction or diabetic cardiomyopathy) (Griffin, 
Atherton, Shockcor, & Atzori, 2011). A recent review by Kordalewska & Markuszewski 
(2015) illustrates the potential of metabolomics to study pathomechanisms of cardiovascular-
related disorders. In this work, the authors show a collection of studies related to the use of 
metabolomics in the analysis of atherosclerosis, prevention and diagnosis of coronary heart 
disease, stroke and heart failure, hypertension, atrial fibrillation, pulmonary heart disease, 
peripheral arterial disease, kidney and metabolic disorders. They also include a list of altered 
metabolites detected by untargeted and targeted analyses. The impact of diet in the onset of 
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disease also launches the applications of metabolomics in CVD. Overall, it is known that a 
given common dietary component not only influence the health status, but can also be 
converted by the gut microbiota into harmful metabolites linked to heart disease (Rak & 
Rader, 2011).  
In parallel, a major effort is being made to use high-throughput metabolomics techniques 
to identify potential biomarkers for hepatic disease, which should be used when applied to 
clinical practice. Although no simple biomarkers have yet been validated, it has been stated 
that “a metabolomic window has been opened into the changing biochemistry occurring in 
the transitional phases between a healthy liver and hepatocellular carcinoma or 
cholangiocarcinoma” (Beyoǧlu & Idle, 2013). Figure 1.9 represents the metabolic 
remodelling produced in the transition from a healthy liver (Phase 0) to liver carcinoma 
(Phase 3).  
Figure 1.9. Metabolic remodelling induced as response to different stimuli in the 
progression of liver disease. Adapted from Beyoǧlu & Idle (2013) 
Different reviews have summarized the work done in metabolomics analysing the 
development of non-alcoholic fatty liver disease (NAFLD), including a broad spectrum of 
liver abnormalities such as non-alcoholic steatohepatitis (NASH), cirrhosis, hepatocellular 
carcinoma (HCC), cholangiocarcinoma (CCA), alcoholic liver disease (ALD), viral hepatitis, 
cholecystitis, cholestasis, liver transplantation, and acute hepatotoxicity, in both human and 
animal models (Beyoǧlu & Idle, 2013; Crişan et al., 2015; Holmes et al., 2015; Nie et al., 
2016; Verhelst et al., 2013; Wang, Zhang & Sun, 2013). 
General  Introduction	  
35 
Of the tools available for liver diagnosis, a liver biopsy gives definitive results, along with 
some approaches that combine several parameters to develop a predictive test. Nevertheless, 
these tools have a negative consideration due to the invasive nature, costs and risk of 
complications, as well as an incapacity to identify those patients at risk of NASH and 
advanced fibrosis (Ariz et al., 2010). These limitations open the way for new opportunities in 
the use of metabolomics-mediated phenotyping strategies taking advantage of the possibility 
to accurately identify and stratify early stages of liver disease (Holmes et al., 2015), as well as 
studying the underlying mechanisms by which nutrients and diet influence on NAFLD and 
progression into NASH (De Wit et al., 2012). 
Common to these prevalent pathologies and for countless other health disorders is the 
impact of hypercholesterolemia, oxidative stress and inflammation which are either 
evaluated as individual risk factors or joined together in a complex network of related 
pathways. These three features, as previously presented, play a key role in the initial stages of 
atherosclerosis and hepatic impairments, and they have been highlighted as accelerators in the 
progression and deterioration of CVD and NAFLD. 
Diet remains an important metabolic contributor to these pathogenesis, with a remarkable 
direct implication in: (I) the development of hypercholesterolemia (JAMA, 2001; Mannu et 
al., 2013); (II) the influence of oxidative stress, which is a key mechanism in vascular 
functions and liver damage (Ariz et al., 2010; Santilli, D'Ardes & Davi, 2015); and (III) the 
modulation of inflammatory regulators and proinflammatory signaling cascades involved in 
atherosclerosis, liver inflammation and disease progression (Galland, 2010; Kritchevsky, 
1976; Oliveira et al., 2016; Saita, Kondo & Momiyama, 2015; Sullivan, 2010). In addition, 
hypercholesterolemia and inflammation are closely linked processes, which are clearly 
implicated in non-alcoholic fatty liver disease and atherosclerosis (Kleemann et al., 2007). 
This explains why these multiple interactions are key objectives in the application of 
metabolomics studies. Therefore, metabolomics shows promise, monitoring relative risk and 
tracking the effect of treatments by associating the changes caused by hypercholesterolemia, 
oxidative stress and inflammation and both cardiovascular and liver diseases. These new 
possibilities will drive the basic understanding of the metabolic cascades which lead to 
pathophysiology. 
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2.3. Metabolomics for the evaluation of nutraceuticals/functional foods 
Functional foods and nutraceuticals are natural or modified foods that claim to improve 
health, quality of life, or wellbeing. However, the evidence supporting a health claim must 
meet certain standards and these foods need to be fully evaluated to make sure they meet 
current scientific and regulatory standards. Thus, the objective of any evaluation is to obtain a 
body of sound and relevant scientific data and evidence. This is achieved firstly by 
discovering or verifying the relevant properties or functions and secondly, by being able to 
support the validity of different substance/health relationships. Metabolomics may be of help 
in supporting all the stages of research such as for example, the demonstration of safety (an 
essential requirement that must be satisfied before any further research into uses and 
applications of a functional ingredient) and/or the discovery of biomarkers. 
2.3.1. Food safety and discovery of biomarkers 
The studies conducted to support the safety of functional ingredients are product-specific 
and can include multiple analytical choices: compositional analysis, structure/toxicity 
analysis, evaluation of historical and intended exposure, animal studies, 
clinical/epidemiologic studies and evaluation of special considerations of potential adverse 
food or drug interactions (Kruger & Mann, 2003). Despite the complexity and regardless of 
the regulatory framework, nutraceuticals and functional ingredients may be substantiated by 
few basic concepts (Table 1.4). 
Table 1.4. Basic concepts in the use of nutraceuticals/functional foods 
I  
A range of outcomes may be produced in the body at different levels of intake. Different 
dose levels may provoke responses ranging from insufficient physiological action passing 
through desirable therapeutic effects but then extend on to acute toxicity. It is important to 
be able to predict the result by understanding the pharmacologic activity and toxicological 
potential 
II  
The composition may vary from single component ingredients to complex extracts of either 
derived or processed products; it is essential to undertake analysis of the composition to 
determine the safety on a case-by-case basis 
III  
The intended use and potential exposure must be compared to a safe level of ingestion in 
accordance with the compound in question, historical exposure and/or scientific studies 
(animal toxicology, absorption, distribution, metabolism and excretion (ADME), clinical 
trials) 
IV   The potential for contraindicated drug and food interactions should be determined when 
possible 
Text adapted from Kruger & Mann (2003) 
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To support all these aspects with the purpose of ensuring the safety of the functional 
ingredients multiples approaches have been assayed. However, it is of relevant importance to 
highlight the role and possibilities played and offered by the application of metabolomics.  
The metabolic analysis is a potentially powerful tool that can be used to address both 
applied and basic research questions. Likewise, metabolomics studies can participate in the 
demonstration of safety as well as being applied to obtain further information such as that 
concerning mechanisms of action, effectivity, or the discovery of new interesting biomarkers 
and compounds. 
As early examples of these potential applications, the scientific publications describe the 
successful effects of the nutraceutical rosemary extract plus ω-3 PUFAs in diabetic children 
(Balderas et al., 2010); the analytical profiling of bioactive constituents from herbal products 
(Satheeshkumar et al., 2012); the metabolomics driven analysis of artichoke leaf and its 
commercial products (Farag et al., 2013); the determination of polyphenols in grape-based 
nutraceutical (Lopez-Gutierrez et al., 2016); or the metabolic fingerprint after acute and under 
sustained consumption of a functional beverage based on grape skin extract in healthy human 
subjects (Khymenets et al., 2015). 
A special emphasis must be made on the applications of metabolomics for the discovery of 
dietary biomarkers (O’Gorman, Gibbons & Brennan, 2013). Two different approaches taken 
to explore for potential candidates are illustrated in Figure 1.10. 
Figure 10. Metabolomics strategies followed in dietary biomarker discovery. 
Adapted from O’Gorman, Gibbons & Brennan, 2013 
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It has to be mentioned that among the possible sources of functional foods, plants have 
been demonstrated to be of outstanding importance. In this area, metabolomics has been 
applied to demonstrate the general principle that a plant-based diet, based on cereals and rich 
in fruit and vegetables can reduce the risk of chronic disease (Andres-Lacueva et al., 2015; 
Rangel-Huerta & Gil, 2016). Likewise, metabolomics is used to examine the composition of 
foodstuff in specific phytochemicals and to demonstrate the properties of crops such as oats, 
soy, flaxseed, Cruciferae and Solanaceae family vegetables (such as onion, garlic, tomatoes), 
citrus fruits, berries (e.g. grapes, cranberries) as well as derived products including oils, juices 
and wine (Arbona, Iglesias & Gómez-Cadenas, 2015; D’Urso et al., 2016; O’Gorman, 
Gibbons & Brennan, 2013; Schmidtke et al., 2013; Simó et al., 2014; Song et al., 2014). 
Other aspects facilitates by metabolomics are, for example, the possibility to predict 
sensory attributes of food and its applications in food authentication. 
2.3.2. Challenges faced in nutritional metabolomics 
First of all, it must remain clear that any metabolomic application has to face realistic 
challenges such as the fact that no unique technology will measure all metabolites present in a 
given biological sample. Each of the different technology platforms provides differential but 
also complementary information and each has its own advantages and disadvantages 
(Brennan, 2008). Likewise, the validation of the results in an independent study to confirm 
the discovery of a specific biomarker is a crucial step to substantiate the finding and confirm 
reliability and support further usage. Several factors such as lifestyle and physiological factors 
could distort the measure of biomarkers, taking into account that even the sampling procedure 
or the analytic methodology could be the cause of a trend and influence the results (Gibbons 
& Brennan, 2016). 
More specific issues are the difficulties to interpret the information from different models 
and in particular to translate results from an animal model to humans. Equally variations 
within the human population also complicate any conclusions that may be drawn from results. 
All of which demonstrates how much there is still to be understood about the influence of 
genetic background, host–microbial interactions and other phenotypic characteristics such as 
body composition on metabolic profiles.  
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Other issues are the consideration of surrogate end points that do not always correlate with 
clinically important health benefits; the size of clinical studies and the lack of involvement of 
more than one centre will also considerably reduce the success of a study (Heyland, 2001). 
Furthermore, the response to food is multifactorial, given that food delivers thousands of 
nutrients, phytochemicals and elements that will elicit multiple organ responses. Thus, the 
influence of diet and food ingredients with all the constituents on metabolic profiles should 
not be underestimated in the effects on many diseases. Finally, topping all the challenges 
facing the advancement of metabolomics in human nutritional research there is the ability to 
make a correct interpretation of the metabolites identified in a biologically relevant and 
meaningful manner (Gibbons & Brennan, 2016). 
2.3.3. Nutraceuticals and functional foods to prevent or ameliorate cardiovascular 
and liver disease: opportunities offered by the application of metabolomics 
Nutraceuticals and functional foods may be considered new complementary tools in the 
management of cardiovascular and liver disease. These bioactive products help handle and 
prevent serious risk factors such as hyperlipidemia or hypercholesterolemia using targeted 
strategies, especially those addressing lipid lowering or lipid profile improvement, e.g. 
reducing total cholesterol, triglyceride, and low-density lipoprotein cholesterol or elevating 
high-density lipoprotein cholesterol (Chen et al., 2014; Hunter & Hegele, 2017; Mannarino, 
Ministrini & Pirro, 2014). Likewise, the improvement of redox status (Serafini & Peluso, 
2016; Xu et al., 2017), prevention of metabolic syndrome (Peluso, Romanelli & Palmery, 
2014), reduction of obesity or management of insulin resistance syndrome, type 2 diabetes or 
NAFLD (Saez-Lara et al., 2016) are also areas where the use of bioactive products offer 
benefits. 
Sharma and Singh (2010) showed examples of nutraceuticals with their corresponding 
benefits in different cardiovascular diseases and mechanisms of cardioprotective action. A 
recent review has evidenced, with a collection of in vitro and clinical studies, the potential 
cardiovascular benefits of nutraceuticals such as ω-3 and ω-6 PUFA, hydroxytyrosol, allicin, 
phytosterols, flavanols, vitamins C and E and dietary fibre, extolling the advantageous effects 
at different stages. Other less-consumed nutraceuticals including carnosine, coenzyme Q10, 
curcumin, lycopene, resveratrol, and berberine were also mentioned as possible therapies for 
atherosclerosis (Moss & Ramji, 2016). 
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Likewise, natural antioxidants for NAFLD such as phenolic compounds, e.g. flavonols 
(quercetin, rutin and troxerutin), flavanols (flavan-3-ols from green and black tea), 
polyphenols, anthocyanins, flavones/isoflavones (luteolin, baicalein, genistein, daidzein), 
flavanones (naringenin, hesperitin), etc. have been tested in in vitro and in vivo models of 
NAFLD and in patients with NAFLD (Salomone, Godos, & Zelber-Sagi, 2016).  
All these applications and growing perspectives for the use of bioactive foods and new 
ingredients/nutraceuticals in the prevention of cardiovascular and liver disease, serve as the 
guide to conduct some of the new applications of metabolomics. 
Therefore, metabolomics applied to the study of nutraceutical and/or functional foods 
shows potential in the following directions: 
− Associating products or phytochemical consumption with biomarkers for intake
and/or biomarkers of physiological response, allowing not only for the study of
prevention but also regression in the state of disease.
− Identifying whether the cardio- or hepato-protective effects of an individual’s diet are
attributable to a specific compound or the result of a combination of elements.
− Elucidating the biochemical mechanism of action underlying the cardio- and hepato-
protective effects.
In addition and most importantly, the use of metabolomics could guide research towards 
the answers to major issues that remain as yet unresolved and will be critical for the 
continuity in the use of nutraceuticals and functional foods, such as the analysis of the side 
effects, the dosage and associated mechanism of action, and the establishment of guide lines 
for efficient and effective usage. 
3. METABOLOMICS APPLIED TO THE STUDY OF ONION
The evidence linking the functional properties of onion with positive human health effects
have stimulated exploration of its uses as a potential regulator of health status and limiter of 
the onset and progression of disease. However, to advance into the possible applications, the 
investigation of both intrinsic and altered metabolites by consumption in both, in vitro and in 
vivo systems, are needed to elucidate the complex nutritional mechanisms underlying the 
simple action of adding onion to our diet with the objective of improving our dishes with 
some extra flavor. 
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Metabolomics may pave the way towards understanding the effects of onions by shedding 
new light on metabolite composition and its association with metabolite pathways altered by 
its consumption. For this reason, the possibilities of metabolomics in this field are divided 
into two separated blocks, firstly concerning the screening of the raw or processed product, 
and secondly for the final detection of changes in metabolites related to onion consumption 
and, when possible, in association with improved health status. 
3.1. Metabolomics applied to the study of raw or processed onion 
In recent years, the study of metabolomics has expanded into food analysis. The 
application of metabolomics in the study of onion has reported advantages at multiple levels, 
from the characterization of composition among cultivars to the discovery of substances and 
the prediction of sensory attributes.  
In this sense, the increasing evidence that flavonols exert beneficial properties for human 
health has promoted the analyses of content and characterization of phytochemicals present in 
onion. Profiling and quantification of flavonols such as quercetin glucosides in onion varieties 
(Allium cepa L.) and treated or processed onion have been performed using capillary zone 
electrophoresis (CE) and high performance liquid chromatography procedures (HPLC-DAD 
and HPLC-ESI-MS) (Caridi et al., 2007; González-Peña et al., 2013; Pérez-Gregorio et al., 
2011; Pérez-Gregorio et al., 2010; Rodrigues et al., 2009; Rodrigues et al., 2010; Sharma et 
al., 2014). Analysis of the distribution of flavonoids in the different parts of the onion bulb 
(inner, middle and outer layers) has also been determined using HPLC–DAD in 16 onion 
cultivars (Beesk et al., 2010). 
On the other hand, the determination of volatile compounds in onion has been mainly 
performed by gas chromatography-mass spectrometry (GC−MS) (e.g. Colina-Coca, et al., 
2013). Combination of liquid chromatography−Fourier transform ion cyclotron resonance-
mass spectrometry (LC−FTICR-MS) with 13C−Labeling has been also used for the chemical 
profiling of sulfur-containing metabolites in onion bulbs (Nakabayashi et al., 2013). Liquid 
chromatography electrospray ionization-tandem mass spectrometry (LC/ESI-MS/MS) has 
been applied to study the changes in organosulfur compounds in onion and the quality of heat 
processing by analyzing the S-alk(en)yl-L-cysteine sulfoxides (ACSOs) methiin, isoalliin, 
propiin, and cycloalliin after different heat treatments (boiling, frying, steaming, and 
microwaving) (Kim et al., 2016). Table 1.5 summarizes a list of methods developed for the 
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analysis of volatile compounds from onion. Moreover, the metabolite profiling of volatiles in 
onion bulbs, analysed by GC−MS, has been proposed for the development of rule based 
models to distinguish infections produced by pathogens, such as Erwinia carotovora ssp. 
carotovora, Fusarium oxysporum and Botrytis allii (Prithiviraj et al., 2004). 
Table 5. Methods for the analysis of volatile compounds from onion 
Technique Full name Reference 
E/RSD Extraction / Rapid spectrophotometric determination 
Freeman & Whenham, 
1975 
E/HPLC CHIRAL E / High performance liquid chromatography with chiral column Bauer et al., 1991 
E/HPLC/1H-NMR E / HPLC / Proton nuclear magnetic resonance Block et al., 1992,1993 
E/HPLC−UV (DAD) E / HPLC−UV with a diode−array detection Mondy et al., 2001 
E/GC E / Gas chromatography Schmidt et al., 1996 Hong et al., 2000 
SC-CO2/GC−MS 
Supercritical extraction with CO2 / Gas 
chromatography− mass spectrometry 
Sinha et al., 1992 
SD/GC-MS Steam distillation / GC−MS Sinha et al., 1992 
E/CRYOGENIC GC−MS E / Cryogenic GC−MS Block et al., 1992,1993 
SFE-MS Supercritical fluid extraction−Mass spectrometry Calvey et al., 1994 
SFE/GC−MS Supercritical fluid extraction / GC−MS Calvey et al., 1994b 
SFE/LC−MS 
Supercritical fluid extraction / Liquid 
chromatography−MS 
Calvey et al., 1997 
E/GC−MS   E / Gas chromatography−mass spectrometry 
Mondy et al., 2001 
Zhang et al., 2014 
Li et al.,  2011 
SPME/GC−MS Solid phase micro extraction / GC−MS Mondy et al., 2002 Soto et al., 2015 
SPME/LC−MS Solid phase micro extraction / LC−MS Mondy et al., 2002 
E/PTV−GC−AED 
E / programmed temperature vaporization 
injection- gas chromatography− atomic 
emission spectrometry 
Junyapoon et al., 1999	  
PTV−GC−ITD/MS 
Programmed temperature vaporization 
injection− Gas chromatography with ion 
trap mass spectrometer 
Junyapoon et al., 1999 
E/HS GC−MS E / Head space GC−MS Colina-Coca et al., 2013 
GSA   Gas sensor array Li et al., 2009	  
E/DART E / Direct analysis in real time Li, 2012 
Table updated from Lanzotti, 2012 
At other levels of complexity, more comprehensive and integrative approaches have 
contemplated the analysis of large number of bioactive metabolites simultaneously. For 
example, the combined use of constrained total-line-shape 1H NMR and LC–MS/MS in 
yellow onion and other different edible Allium species has permitted the identification and 
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quantification of amino acids, organic acids, sugars and flavonols (Soininen et al., 2014; 
Soininen et al., 2012). Gas chromatography–mass spectrometry (GC–MS) has been used for 
the unbiased profiling of primary metabolites in plants and the characterization of cultivar and 
regional differences in the metabolite composition of onion bulbs (Kimura et al., 2014). 
GC−MS based metabolic profiling of onion has been used to demonstrate the existence of 
biochemical differences among 11 different onion varieties in India (Das et al., 2015). 
The integration of multiple omics approaches also allows for the interpretation of 
associations between metabolites and genes, improving the understanding of some metabolic 
response. Focusing on the study of onion, profiling of non-digestible carbohydrate products 
has been applied to a complete set of alien monosomic addition lines to explain the genetic 
controls over the metabolism, suggesting the possibility of controlling non-digestible 
carbohydrate content in the bulbs via assisted selections of the key candidate genes (Yaguchi 
et al., 2009). Transcriptome and target metabolome obtained by liquid chromatography–
tandem mass spectrometry (LC−MS/MS) provides insight into the adaptability to abiotic 
stress in doubled haploids of Allium cepa (Abdelrahman et al., 2015). 
Furthermore, these technologies may be applied to the tracking of substances affecting the 
quality and safety of the onion products including issues related to manipulation. LC−MS/MS 
methods have been recently developed for the simultaneous determination of pesticides such 
as spinosad, thiacloprid and pyridalyl in spring onions and the estimation of their degradation 
time (Dasenaki et al., 2016). Likewise, with regard to the prevention of contamination in the 
consumption and manipulation of onions from elevated mycotoxin concentrations on the 
onion skins and the risk of airborne endotoxin exposure, the detection and quantification of 
mycotoxins has been streamlined with the use of LC−MS/MS in risk assessment (Mayer et 
al., 2016).  
3.2. Detection of metabolites and effects related to onion exposure 
The advance in the knowledge in food composition has also attracted the interest of further 
studies focused on the detection of specific substances in models in vivo and humans. 
Initially, the studies addressing the consumption of onion in the identification of 
metabolites were directed at establishing the bioavailability of certain phytochemicals in bio-
fluids such as urine and blood. Subsequent, studies were then carried out to detect and 
quantify the biomarkers of onion exposure. Finally, studies have been designed to detect both 
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outstanding and subtle changes in dietary patterns which leads to the suggestion of 
biomarkers affected and which are modulated in a positive manner by the consumption of 
onion. 
Furthermore, the presence and inconvenience of chelating agents and the beneficial 
potential of synergistic effects can be considered present and future challenges to be 
addressed. 
3.2.1. Onion bioactive compounds bioavailability and onion intake biomarkers 
The interest in the metabolites derived from food such as onion or garlic has attracted 
attention for many years. This section summarises chronologically a set of relevant studies 
focused on metabolites derived from onion consumption.  
In 1987, Jandke and Spiteller reported the presence in urine of “unusual” peaks due to 
nutritional status. GC−MS allowed for the detection of urinary organic acids after the 
consumption of onion and garlic, with the detection and identification of N-acetyl-S-(2-
carboxypropyl)cysteine and N-acetyl-S-allylcysteine, which were described as “metabolites of 
peptides introduced with onion or garlic”. 
However, it was not until the late 90s when the advantage of omics allowed for the study in 
greater depth of the metabolites derived from onion metabolism. Flavonols such as quercetin 
and its derivatives along with sulfur compounds have been the main families of metabolites 
screened by a wide range of metabolic approaches. 
Gross et al. (1996) developed one of the first high performance liquid chromatography 
(HPLC) based assay for quantification of quercetin metabolites in human urine. The platform 
included the metabolic products 3,4-dihydroxyphenylacetic acid (homoprotocatechuic acid), 
metahydroxyphenylacetic acid, and 4-hydroxy-3-methoxyphenylacetic acid (homovanillic 
acid). Nevertheless, the production of these metabolites was not only derived from the diet but 
mainly produced by the metabolism of catecholamines and certain amino acids. In addition, 
the fact that multiple flavonols from an identical parent compound, quercetin, may yield 
several identical phenolic metabolites add complexity in the interpretation of human dietary 
studies. 
The absorption and excretion of conjugated flavonols was tested in a study where five 
healthy volunteers were given 300 g of lightly fried yellow onions. Urine and plasma were 
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collected over a 24 h period and were analysed by HPLC and post-column derivatization. This 
study showed that there was a proportionally higher accumulation of isorhamnetin-4'-
glucoside than quercetin conjugates, including quercetin-3,4'-diglucoside and quercetin-4'-
glucoside, in the plasma and urine samples (Aziz et al., 1998). 
The potential use of plasma concentrations and urinary excretion of quercetin and 
kaempferol as biomarkers of dietary intake was studied in humans fed with either black tea 
(1600 mL/d) or fried onions (129 g/d) for 3 d. Flavonols were determined by HPLC with 
detection by fluorescence. The authors concluded that “flavonols in plasma and urine 
reflected short-term flavonol intake and that quercetin could distinguish between high and 
low flavonol consumption in epidemiologic studies” (de Vries et al., 1998). 
Noroozi et al. (2000) also concluded that the presence of flavonols in plasma and urine 
could possibly be used for the prediction of dietary flavonol consumption. The trial quantified 
the flavonols by reversed-phase HPLC in the diets and biological samples from ten patients 
with type 2 diabetes administered with either a low flavonoid diet or a diet supplemented with 
tea and 400 g fried white onion in olive oil with or without ketchup and herbs. 
In 2001, Wittig et al. published a method for the identification of the quercetin 
glucuronides in plasma samples after the consumption of fried onion by means of HPLC–
UV–MS/MS. 
In 2004, Hong & Mitchell were able to identify twenty-one phase II metabolites of 
quercetin as conjugates, or mixed conjugates, of glucuronic acid, sulfate or a methyl group by 
LC/ESI-MS/MS in human urine after the consumption of 200 g of cooked onion. This study 
reinforced the potential of monitoring quercetin metabolites to obtain biomarkers to probe the 
individual response to dietary manipulation. 
In a similar study, also using LC/ESI−MS/MS, the glutathione-related conjugates 
(mercapturic acids) were also observed. These mercapturic acid derivatives (dihydroxyacetic 
acid, dihydroxypropionic acid, hydroxycinnamic acid, dihydroxytoluene, and 
dihydroxybenzaldehyde) were degradation products of quercetin as a result of colonic 
microbial activity. Quercetin metabolites in human urine revealed evidence for the 
glutathionylation of quercetin. This was supported by the observation that mercapturic acids 
of common hydroxyphenylacetic acids generated by the microbial degradation of quercetin 
exist after the consumption of 200 g of cooked onion (∼ 74 mg of quercetin) (Hong & 
Mitchell, 2006). 
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Plasma and urine from six volunteers after recent ingestion of lightly fried red onions (270 
g) were analysed by reversed-phase HPLC with photodiode array and tandem mass 
spectrometric detection HPLC–DAD UV–MS2. This was the first study using full scan MS2 
rather than HPLC using either MS2 with selected reaction monitoring or single stage MS in 
the selected ion monitoring mode to analyse flavonol. This enabled the detection of twenty-
three flavonols including sulphate, methyl, glucuronide and glucoside derivatives of quercetin 
(Mullen et al., 2004).
Not long afterwards, Mullen et al. (2006) designed a new experiment collecting plasma 
and urine over a 24 h period after consumption of lightly fried onions containing 275 mmol 
flavonol (principally quercetin-4'-glucoside and quercetin-3,4'-diglucoside). Samples were 
also analysed by HPLC-DAD−MS/MS detection, providing detailed quantitative 
concentrations of twenty-three metabolites of methyl-, glucuronyl- and sulpho-conjugates of 
quercetin in the plasma and urine of human subjects after ingestion of onions, thus revealing 
data of great importance in understanding the role of dietary flavonols in the prevention of 
chronic disease (Mullen et al., 2006). 
In 2009, Winning et al. evaluated the metabolome of thirty-two rats following ingestion of 
onion by-products. Urine samples collected over 24 h were analysed using 1H NMR 
spectroscopy identifying dimethyl sulfone and 3-hydroxyphenylacetic acid as two dietary 
biomarkers of onion intake, possibly beneficial as a control in diet intervention studies. 
An ultrahigh pressure liquid chromatography accurate mass quadrupole time-of-flight mass 
spectrometry with electrospray ionization (UHPLC-(ESI)QTOF MS/MS) method was also 
developed for measuring individual quercetin metabolites in human plasma. In this case, 
volunteers were either fed apple peel powder-enriched applesauce (AP) or onion powder-
enriched applesauce (OP) for breakfast (Lee et al., 2012). 
The profile of quercetin metabolites in pigs has also been studied. In this case, urine from 
seventeen pigs was collected and analysed by HPLC-MS/MS with similar results as those 
from humans after ingestion of dry onion skin (Wiczkowski et al., 2014). 
More recently, a two-period, two-sequence cross over study in humans was conducted to 
compare the bioavailability of quercetin in the form of a fresh red onion meal (onion soup 
made from 100 g fresh red onion containing naturally glycosylated quercetin) compared with 
a dietary supplement (aglycone quercetin). Urine samples were collected over 24 h and 
quantified by LC-MS providing both a guideline for the design of future human studies when 
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using supplements and foods and facilitating a comparison of studies in existing publications 
(Shi & Williamson, 2015). 
3.2.2. Detection of biomarkers influenced and regulated by onion consumption 
The consumption of onion has been linked with the prevention and improvement of 
multiple disorders. In consequence, raw, cooked, onion juice, powdered onion flesh, onion 
skin or other onion extracts and by-products have been extensively studied in the search for 
associations between their consumption and the ameliorations of health status related markers. 
The effects of onion consumption and some of its components have been tested as 
biomarkers of antioxidant, antihypertensive, hypolipidemic, hypercholesteraemic, 
antiinflammatory, antithrombotic, antipathogenic, antidepressant, antidiabetic, 
hepatoprotective and cardioprotective activities. However, the number of in vivo studies is 
limited. In this sense, it is remarkable how the study of metabolites by high-throughput 
technologies and statistical tools has facilitated the work detecting modifications and 
quantifying the magnitude of the effect provoked.  
To sum up the evolution of this field, Table 1.6 summarizes in chronological order some of 
the findings obtained in in vivo studies through the use of diverse technologies, highlighting 
with an asterisk those studies where the detection of metabolites by the use of 
chromatography and mass spectrometry were indispensable. 
The goal for most of these studies was to confirm a hypothesis by targeted driven 
approaches. Equally, most studies were directed at markers of risk with some influence or 
directly related to the development of cardiovascular disease and/or its associated 
impairments. 
However, from a different perspective, studies of the modifications caused by the 
consumption of onion have scarcely been undertaken by non-targeted approaches. In this 
sense, the multi-metabolomics approaches presented in this PhD Thesis have been one of the 
first studies directed to reveal the influence of onion consumption at different levels of the 
metabolome, indicating new potential affected markers that may help create new hypothesis 
to focus further research.  
Therefore, this PhD Thesis strengthens the use of metabolomics, which is pivotal to the 
research and evidences the advantages and possible applications of these techniques to 
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understand the effects of onion at a multi-organic level. This knowledge would help to 
establish new links with the modifications reflected in plasma, facilitating the generation of 
hypothesis to explain the close relationship between supplementation with onion and the 
benefits promoted in health, and at a more general level, the understanding of the relationship 
between diet and the progression of disease. Thus, the present work contributes to establish 
the basis to redirect further research assessing the effects of functional ingredients. It also 
shows the usefulness of considering metabolomics as a tool for early diagnosis and the 
management of health status by tackling risk factors, such as inflammation and other 
impairments associated to disease, by including functional ingredients at the core of 
personalized diets. These diets are expected not too far into the future to be designed to attend 
individual nutritional requirements and thus to achieve an optimal personalised nutrition. 
Table 1.6. In vivo studies related to effects of onion consumption 
Product Model / Type of sample Effect or marker studied Authors 
Raw / boiled Welsh 
onion juice 
Male Sprague-Dawley rats / 
Blood-plasma Antithrombotic effects Chen et al., 2000 
Cooked onion slices Human (women, 20-21 years) / Blood-plasma 
Accumulation of quercetin 
conjugates Moon et al., 2000 
Onion powder Male Wistar rats /              Blood-plasma 
Effect of lipids and 
emulsifiers on the 
accumulation of quercetin 
metabolites 
Azuma et al., 2003 
Yellow and white  
chopped, dry-fried 
onions 
Healthy human (men-women; 
24-35 years) /
Blood-plasma, lymphocytes 
Effect of quercetin 
metabolites in COX-2 
mRNA expression 
de Pascual-Teresa et 
al., 2004 
Green-leafy and 
white-sheath types 
of Welsh onion  
(Allium fistulosum L.) 
Old male Sprague-Dawley rats 
/ Blood-plasma, thoracic aorta 
Antioxidative and 
antihypertensive effects 
Yamamoto et al., 
2005 
Yellow-type freeze-
dried pulverized 
onion  
Streptozotocin-Induced 
Diabetic Rats− Old male 
Wistar rats / Blood-plasma, 
urine, liver 
Effect on oxidative stress 
biomarkers Azuma et al., 2007* 
Onion peel, flesh 
freeze-dried powder 
and ethanol extract  
Male 16-months-old Sprague 
Dawley rats / Blood-plasma, 
kidney, liver 
Effect on antioxidant status 
in aged Park et al., 2007* 
Yellow-type onion 
‘Doctor Quercy’ 
freeze-dried and 
pulverized 
9-week-old male Wistar rats /
Blood-plasma/serum, liver,
kidney-urine
Antioxidative effect in high 
cholesterol-fed rats Azuma et al., 2010* 
Powdered freeze-
dried green or white 
type of Welsh 
onion 
7-week-old male Sprague-
Dawley rats /
Blood-plasma, liver
Effect on hyperlipidaemia 
induced by high-fat high-
sucrose diet 
Yamamoto & 
Yasuoka, 2010* 
Onion peels freeze-
dried concentrated 
Male healthy smokers (30-60 
years) /
Effect on cardiometabolic 
risks Lee et al., 2011b 
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powder (capsules) Blood-plasma/serum 
Cold-water, hot-
water, ethanolic 
extract
(A. fistulosum) 
Male BALB/c mice (CT-26 
mouse tumor model) /        
Tumor tissue samples 
Inhibition of colorectal 
tumor growth  
Arulselvan et al., 
2012* 
Onion juice Male Wistar rats / Blood-plasma, liver, kidney 
Cadmium-induced organ 
toxicity and dyslipidaemia Ige & Akhigbe, 2013 
Onion peel extracts, 
freeze-dried powder 
in capsules 
Healthy normal-weight 
women (20-25 year) /
Blood-plasma/erythrocyte 
Lipid profile and 
antioxidative status Kim et al., 2013* 
Onion peel extract, 
freeze-dried powder 
Male Sprague–Dawley rats 
(high fat diet) /
Blood-plasma/serum, adipose 
tissues 
Antiobesity effects  (3T3-L1 
preadipocytes and 
adipogenesis) 
Moon et al., 2013 
Onion ingredient 
HPP-freeze-dried 
powder 
Male Wistar rats (high-
cholesterol diet) /
Blood-plasma/erythrocyte, 
liver, adipose tissues 
Fatty acid metabolism Colina-Coca et al., 2014* 
Onion skin powder Male Sprague-Dawley rats / Blood-serum, cells 
Modulation on BCRP and 
MRP 4 Lin et al., 2014* 
Quercetin-rich 
onion skin extract 
in powder 
Overweight-to-obese patients 
with (pre-) hypertension (25–
65 year) /
Blood-plasma/serum, urine 
Blood pressure and 
endothelial function Brüll et al., 2015* 
Yellow onion juice 
Healthy subjects 
(aged between 40 and 80) / 
Blood-plasma/serum/ 
erythrocytes 
Modulation of oxidative 
stress in bone disorders Law et al., 2016 
Quercetin-rich 
onion peel extract 
(capsules) 
Overweight and obese 
subjects (males and females) /          
Blood, anthropometric 
measurement 
Effects on the body 
composition Lee et al., 2016 
Onion peel extract 
Male C57BL/6J mice (high 
cholesterol diet) / 
Blood-serum, livers, faecal 
samples 
Hypocholesterolemic effect Kang et al., 2016 
Onion juice + 
cinnamon 
Female Wistar rats exposed to 
power frequency electric and 
magnetic fields /
Blood-serum 
Sex hormones and total 
antioxidant capacity Mansouri et al., 2016 
Onion powder 
Sprague–Dawley rats (high-fat 
diet) /
Blood-plasma, livers 
Metabolic, histologic, and 
inflammatory features of 
NAFLD 
Emamat et al., 2016 
Onion skin extract 
powder 
Overweight-to-obese patients 
with (pre)hypertension /      
Blood-plasma/serum 
Serum leptin and 
adiponectin concentrations Brüll et al., 2016* 
Onion peel derived 
extracts 
4-week-old male C57BL/6
mice /  Blood-plasma, WATs
Mechanisms of adipocyte 
browning using 3T3-L1 cells Lee et al., 2017 
Onion powder 
Male Sprague–Dawley rats 
(high-fat, high sugar diet) / 
Blood-plasma, livers 
Prevention of NAFLD. 
Biochemical parameter, 
Hepatic TNF-α Gene 
Expression and 
histopathological features 
Emamat et al., 2017 
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RESEARCH QUESTIONS 
1. What would be the impact of an onion ingredient in the prevention of risk factors associated
to the development of atherosclerosis and liver dysfunction?
Objective 1 addresses the question. Alteration of cardiovascular and hepatic parameters, 
inflammation and oxidative stress biomarkers and the modifications of the vascular response 
in mesenteric microvessels are primary indicators of the onset of atherosclerosis and liver 
disease  Research Papers I and II revealed the positive effect of onion used as a functional 
ingredient in these biomarkers and the vasculature of hypercholesterolemic Wistar rats. 
2. Would metabolomics offers new insights for the study of nutraceuticals and the effects on
health? More precisely, is a Wistar rat diet-induced model of hypercholesterolemia suitable
to evaluate the preventive effect of processed onion intake on metabolic impairments?
Objective 2 and 3 address these questions. The application of metabolomics in diet-related 
disease provides new insights for the elucidation of mechanism of action implicated in the 
pathologies and the potential detection of biomarkers  Research Papers III and IV show 
that a multi-metabolomic platform applied to describe the metabolic impairments caused by 
a high-cholesterol diet, evidenced the model’s capability and described the impact caused by 
onion supplementation. 
3. The use of non-targeted approaches generate new hypothesis for the study of onion
properties in vivo. How does processed onion affect plasma and liver profiles in
hypercholesterolemia and associated metabolic impairments?
Objective 3 and 4 address the question. The value of applying metabolomics has been 
demonstrated by indicating metabolites and showing pathways of interest modified by the 
supplementation with functional ingredients  Research Papers IV and V show the changes 
induced by the consumption of the onion ingredient in the plasma and liver metabolic profile 
of hypercholesterolemic Wistar rats. 
4. Are changes in lipid mediators honest indicators in the inflammatory process associated
to hypercholesterolemia and could these changes be modulated by onion intake? If so,
would the changes in lipid mediators be directly associated with the positive effect found
in the vasculature and biomarkers of hypercholesterolemic rats fed with onion?
Objective 5 and 6 address these questions. Lipid mediators are chemical messengers released 
in response to biological stress or injury, and they are also critical in resolving inflammation 
 Research Paper VI shows the changes in oxylipins and sphingolipids of 
hypercholesterolemic Wistar rats in different biological matrices and evaluates the effects of 
onion as a functional ingredient on those changes. The positive effects found in the 
vasculature and other biomarkers of hypercholesterolemic Wistar rats after onion 
consumption have not been associated to changes in oxylipins and sphingolipids in plasma. 
However, the modulation of some oxylipins in liver and sphingolipids in various tissues 
pointed to interesting changes. 
5. Does the measurement of faecal bile acids inform about the changes induced by the onion
ingredient?
Objective 7 addresses the question. Faecal bile patterns offers a snap shot at the endpoint 
of the metabolism that can contribute to the detection of important imbalances not only 
related to the hepatic and intestinal functions but also to other metabolic disorders  
Research Paper VI shows the role of dietary onion on faecal bile acid content in 
hypercholesterolemic rats. 
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OBJECTIVES 
Cardiovascular disease (CVD) and liver pathologies are prevalent diseases influenced by 
several factors, which can be conditioned and modified by nutritional interventions. The 
nutritional and bioactive properties of onion have a promising value in the prevention of some 
risk factors and the reduction of imbalances associated to these pathologies. However, the 
underlying mechanisms are complex and require novel high throughput analytical screening to 
reveal unsubstantiated alterations amenable to dietary intervention. 
The main objective of this work is to explore the potential preventive effect of a high-
pressure processed onion ingredient in cardiovascular and liver impairments associated to diet-
induced hypercholesterolemia. To achieve this, the application of metabolic phenotyping 
initiates the exploration of both the mechanism of action underlying the hypercholesterolemic 
model and the search of altered metabolites and metabolic routes modified in response to onion 
consumption. 
To achieve this goal the following specific objectives were established: 
1. Assess inflammation, oxidative stress and vascular reactivity associated to
hypercholesterolemia and evaluate the changes induced by onion supplementation.
2. Describe the metabolic changes induced in hypercholesterolemia by plasma non-targeteted
fingeprinting using LCMS, CEMS, GCMS analytical platforms.
3. Evaluate the changes induced by the onion ingredient in the metabolomic profile of plasma
in hypercholesteromic Wistar rats.
4. Develop a protocol suitable for liver in non-targeted analysis to evaluate the changes
induced by the onion ingredient in the metabolomic profile of liver in hypercholesteromic
Wistar rats.
5. Analyse the oxylipin profiles and their potential implication in liver inflammation
associated to hypercholesterolemia and describe the changes induced by onion
supplementation.
6. Describe the changes in sphingolipids of different biological matrices in
hypercholesterolemic Wistar rats and study the effects of onion as a functional ingredient
on sphingolipid alterations.
7. Develop a targeted LCMS method for the analysis of bile acids in faeces and evaluate the
impact of onion consumption on bile acid excretion in hypercholesterolemic Wistar rats.
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PREGUNTAS CIENTÍFICAS 
1. ¿Qué efecto produce el consumo de un ingrediente de cebolla en relación al desarrollo de
aterosclerosis y la disfunción hepática?
El Objectivo 1 aborda esta cuestión. Alteraciones en parámetros cardiovasculares y 
hepáticos, así como en los biomarcadores de inflamación y estrés oxidativo y la modificación 
de la respuesta vascular en microvenas mesentéricas, actúan como marcadores del inicio de 
aterosclerosis y de las enfermedades hepáticas  Los Artículos I y II muestran el efecto 
positivo de la ingesta de cebolla, en forma de ingrediente funcional, en múltiples 
biomarcadores y en el sistema vascular de ratas Wistar hipercolesterolémicas. 
2. ¿Contribuyen los estudios metabolómicos a generar conocimiento sobre los nutracéuticos
y sus efectos en la salud? Concretamente, un modelo de hipercolesterolemia inducido por
la dieta ¿puede resultar adecuado para evaluar los efectos derivados de la ingesta de
cebolla procesada sobre el desarrollo de desequilibrios metabólicos?
Los Objectivos 2 y 3 abordan estas cuestiones. El empleo de técnicas metabolómicas en 
enfermedades relacionadas con la dieta permite generar conocimiento dirigido a la 
elucidación de los mecanismos implicados en las patologías y en la detección de sus 
correspondientes biomarcadores  Los Artículos III y IV muestran que una multiplataforma 
de análisis metabolómico ha permitido describir los cambios causados por una dieta rica en 
colesterol a nivel metabólico, evidenciado la capacidad del modelo para describir el impacto 
causado por la suplementación con cebolla.  
3. El empleo de técnicas de análisis no dirigidas contribuye a la generación de nuevas
hipótesis en el estudio de las propiedades de la cebolla in vivo. ¿Cómo afecta el consumo
de cebolla procesada en los perfiles plasmáticos y hepáticos de ratas hipercolesterolémicas
y en los desequilibrios metabólicos asociados?
Los Objectivos 3 y 4 abordan esta cuestión. El potencial de la aplicación de técnicas 
metabolómica ha sido demostrado indicando metabolitos y rutas metabólicas de interés que 
han sido modificados por el consumo del ingrediente funcional  Los Artículos IV y V 
muestran los cambios inducidos por el consumo del ingrediente de cebolla en el plasma y el 
hígado de ratas Wistar hipercolesterolémicas. 
4. Cambios en mediadores lipídicos podrían actuar como indicadores clave en los procesos
de inflamación asociados a hipercolesterolemia ¿Pueden dichos cambios ser modulados
por la ingesta de cebolla? De ser así, ¿puede encontrarse una asociación directa entre los
cambios en mediadores lipídicos y los efectos positivos descritos en el sistema vascular y
ciertos biomarcadores de las mismas ratas hipercolesterolémicas alimentadas con cebolla?
Los Objectivos 5 y 6 abordan estas cuestiones. Los mediadores lipídicos actúan 
como mensajeros químicos liberados en respuesta al estrés y/o daño, además de jugar 
un papel crítico en la resolución de los procesos de inflamación  El Artículo VI 
muestra los cambios en oxilipinas y esfingolípidos en diferentes muestra biológicas 
de ratas hipercolesterolémicas, evaluando el efecto del consumo de cebolla en forma 
de ingrediente funcional en estos cambios. Los efectos positivos encontrados en el 
sistema vascular y en ciertos biomarcadores evaluados en las ratas 
hipercolesterolémicas, no han sido directamente asociados con cambios en oxilipinas 
y esfingolípidos determinados en plasma. No obstante, ciertas oxilipinas 
cuantificadas en el hígado así como esfingolípidos determinados en distintos tejidos, 
mostraron cambios interesantes. 
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5. La determinación de ácidos biliares en heces ¿podría proporcionar información sobre los
cambios inducidos por el ingrediente de cebolla?
El Objectivo 7 aborda esta cuestión. El perfil de ácidos biliares en heces ofrece información 
sobre la fase final de las reacciones del metabolismo, pudiendo contribuir a la detección de 
importantes desequilibrios relacionados con la función hepática, intestinal y otros desórdenes 
de carácter metabólico  El Artículo VI muestra el efecto del consumo de cebolla, como 
parte habitual de la dieta, en el contenido de ácidos biliares en heces de ratas 
hipercolesterolémicas. 
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OBJETIVOS 
Las enfermedades cardiovasculares y hepáticas son patologías prevalentes, afectadas por 
múltiples factores, que pueden ser influenciados y modificados mediante intervención 
nutricional. Las propiedades nutricionales y bioactivas de la cebolla, resultan prometedoras en 
la prevención de factores de riesgo y la disminución de alteraciones asociadas a dichas 
patologías. No obstante, los mecanismos de acción involucrados son complejos y requieren del 
empleo de técnicas de screening analítico, que permitan descubrir las alteraciones 
potencialmente regulables a través de una modificación en la dieta.  
El objetivo principal de esta Tesis es explorar el potencial efecto preventivo y la 
repercusión de un ingrediente de cebolla, procesado por altas presiones, en los desequilibrios 
cardiovasculares y hepáticos asociados al desarrollo de hipercolesterolemia, inducida por la 
dieta. Para alcanzar dicho objetivo se han empleado técnicas de fenotipado metabólico que han 
permitido iniciar la investigación de los mecanismos de acción involucrados en el modelo de 
hipercolesterolemia, y en la búsqueda y detección de metabolitos y de las rutas metabólicas 
alterados y modificables en respuesta al consumo de cebolla.  
Con esta finalidad, se establecieron los siguientes objetivos específicos: 
1. Evaluar marcadores de inflamación, estrés oxidativo y la reactividad vascular, asociados a
hipercolesterolemia, evaluando los cambios inducidos por la suplementación con cebolla.
2. Describir los cambios metabólicos inducidos en plasma, con la aplicación de técnicas de
análisis no dirigidos (fingerprinting) y con el empleo de distintas plataformas analíticas
LCMS, CEMS, GCMS.
3. Evaluar los cambios inducidos por el ingrediente de cebolla en el perfil metabólico del
plasma en ratas Wistar hipercolesterolémicas.
4. Desarrollar un protocolo para efectuar el análisis no dirigido de tejido hepático, y
posteriormente evaluar los cambios inducidos por el ingrediente de cebolla en el perfil
metabólico del hígado en ratas Wistar hipercolesterolemicas.
5. Analizar el perfil de oxilipinas y su potencial implicación en la inflamación hepática
asociada a hipercolesterolemia, describiendo así los cambios inducidos por el consumo de
cebolla.
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6. Describir los cambios en esfingolípidos en diferentes muestras biológica en ratas Wistar
hipercolesterolemicas, estudiando los efectos del consumo de cebolla en las modificaciones
del perfil de esfingolípidos.
7. Desarrollar un método de análisis dirigido a la cuantificación de ácidos biliares en heces,
evaluando así el impacto del consumo de cebolla en la excreción de ácidos biliares en ratas
Wistar hipercolesterolemicas.
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OVERVIEW OF THE EXPERIMENTAL WORK	  
This PhD Thesis is based on the evaluation of the metabolic-driven impact of processed 
onion in the prevention of cardiovascular and liver diseases. The research has been conducted 
at the following research centres:  
(i) the research group Quality and Functionality of Plant Foods (BIOACTIVEG) at the
Department of Food Characterization, Quality and Safety at Institute of Food Science, 
Technology and Nutrition (ICTAN), Spanish National Research Council (CSIC), Madrid, 
Spain. 
(ii) the group of research in Vascular Pharmacology and Metabolism at the Department of
Pharmacology, Faculty of Medicine, Autonomous University of Madrid (UAM), Madrid, 
Spain.  
(iii) the Center for Metabolomics and Bioanalysis (CEMBIO) at the Faculty of Pharmacy,
San Pablo CEU University, Madrid, Spain. 
(iv) the Integrative Molecular Phenotyping (IMP) group at the Department of Medical
Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden. 
A brief overview of the experimental work undertaken for the realization of this PhD 
Thesis is presented below, showing the process to obtain the onion product and summarizing 
the techniques and analysis performed. Detailed information and descriptions about the 
analytical platforms and the methodologies, together with the interpretation of the results, are 
presented in the corresponding “research paper” within each chapter. 
Firstly, the production of the functional onion ingredient used during the animal 
experiment and its characterization was carried out at the ICTAN-CSIC. The selection of this 
onion product was based on a previous work addressing the effects of high-pressure 
processing (HPP) and stabilization procedures in Allium cepa L. var. cepa ‘Recas’. These 
findings have already been published and form part of the PhD Thesis “Evaluación 
de las propiedades antiiflamatorias, antioxidantes e hipolipidémicas de cebolla 
procesada como ingrediente funcional in vitro y en un modelo animal”. Thus, the present 
PhD Thesis continues the study initiated to obtain and characterize a stable functional onion 
ingredient, rich in bioactive compounds, by testing its properties and functionality in vivo. 
Chapter  3  
80	  
1. Production of the onion functional ingredient and diets
Briefly, onion (Allium cepa L. var. cepa, ‘Recas’) was processed by HPP and stabilized by
freeze-drying and pulverization. Figure 3.1 of the workflow summarizes the steps followed to 
obtain the functional ingredient.  
Figure 3.1. Workflow to obtain a stable high-pressure processed onion ingredient 
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An approximate amount of 2000 g of onion powder was prepared for the in vivo study and 
kept at -20ºC until use. This onion powder was characterized by determining its nutritional 
composition (protein, lipids, carbohydrates, total fructans and dietary fibre− 
soluble/insoluble), phytochemical content (total phenols, flavonoids, total ACSOs, sulphur-
compounds, ascorbic acid and total vitamin C) and in vitro antiinflammatory and antioxidant 
activities (hyaluronidase inhibiting activity, NO•, ABTS•+, and DPPH• scavenging capacity, 
ferric reducing antioxidant power, and antioxidant capacity by photochemiluminescence). The 
detailed composition of this ingredient, and the methodologies utilized for the analysis, can be 
found in the corresponding research papers. 
Commercial rat pellets and three semi-synthetic diets based on the AIN-93M semi-purified 
rodent diet were ordered from Panlab, SLU (Barcelona, Spain). The final experimental diets 
were prepared weekly by adding the corresponding amount of cholesterol, cholic acid and the 
onion ingredient and kept at 4ºC. The prepared diets were portioned into individual daily bags 
to record the consumption during the experiment. It is important to mention that the amount 
of maize starch in the diets was adjusted in each diet to compensate for the addition of 
cholesterol, cholic acid and the onion powder.  
Table 3.1. Experimental diets (detailed composition described on the research papers) 
2. Animal model and experimental design
The present study was approved by the Spanish Ministry of Science and Innovation
Advisory Committee [project AGL2010-15910 (subprogram ALI)] and by the Ethics 
Committee of the Complutense University of Madrid (Spain). All experiments were 
performed in compliance with the Directive 2010/63/UE regarding the protection of animals 
used for scientific purposes. Twenty four male Wistar rats with a body weight of 
approximately of 250 g were obtained from Harlan Laboratories Models (Harlan, SL, 
Barcelona, Spain). 
The animals were fed for 3 days with the commercial rat pellets for adaptation to 
environmental conditions and then distributed into three groups of eight animals each and 
each group with approximately the same average body weight. The rats were housed 
I Control (C) diet composed of a homogeneous mixture of 100 % rodent diet 
II High-cholesterol (HC) diet control diet with 2 % cholesterol and 0.5 % cholic acid 
III High-cholesterol enriched 
with onion (HCO) diet 
HC diet with 10 % onion powder, balancing the dietary 
fibre with cellulose powder 
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individually in metabolic cages, in a temperature-light controlled room and fed on the control 
diet for 4 days. After this time, the experimental feeding period began and lasted for seven 
weeks, during which water and food were provided daily ad libitum (Figure 3.2).  
Figure 3.2. Experimental design A) 8 week-old Wistar rat in a regular cage B) Metabolic cages C) 
Rats in metabolic cages in a temperature/light controlled room D) Bags of the daily 
portions of the three different experimental diets 
In order to evaluate food digestibility, food intake and faecal weight were recorded daily 
and body weight was recorded weekly. Individual volume of urine was also checked daily. 
Both faeces and urine (with the addition of NaN3) were kept at −20 ºC (Figure 3.3). 
Figure 3.3. Sample collection. A) Urine collected from one rat over a 24 h period B) Faeces from one 
rat after 24 h C) Complete set of samples of urine and faeces as collected each day 
At the end of the experimental feeding, in order to avoid inter-assay variations that could 
affect the comparison of data from the different groups, animals in fasting conditions were 
anaesthetized and euthanized by extracting blood by cardiac puncture, taking one animal at a 
time randomly, from each of the three groups.  
Blood was collected from the heart with a syringe and injected into tubes 
with EDTA as anticoagulant. 
Plasma was recovered after centrifugation (1500 g, 15 min) at 4ºC and  
immediately stored in aliquots at −80ºC until analysis. 
Erythrocytes fraction was also kept at −80ºC. 
A	   B	   C
A	  
B	  
C D
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Mesentery and omentum specimens were obtained and placed 
into ice-cold Krebs-Henseleit solution (KHS; composition in 
mM: NaCl 119, KCl 4.6, CaCl2 1.5, MgCl2 1.2, NaHCO3 24.9, 
glucose 11, KH2PO4 1.2 and EDTA 0.027). Samples were 
transported to the laboratory at the Faculty of Medicine (UAM) 
for dissection of mesenteric arteries within 2 h of collection. 
The other organs and tissues (liver, spleen, heart, kidneys, lungs, 
caecum, intestine, testicles, brain and adipose tissue) were collected, 
the fat removed and weighed before being frozen in liquid nitrogen 
and stored at −80ºC in sterile material until analysis. 
A representation of the rat anatomy is presented in Figure 3.4, indicating the organs 
collected and used in the metabolomics studies. 
Figure 3.4. Scheme of the rat physiology, showing in bold all organs collected and in red the 
organs utilized for either targeted or non-targeted studies presented in this PhD 
Thesis 
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3. Analysis and techniques applied to address the in vivo functionality of the processed
functional ingredient of onionThe work has been divided into three sections organized according to the sequence of
research and the analytical methodology followed. A general overview of the research papers 
generated from these studies can be found in Table 3.3. 
3.1. SECTION I: Biochemical, vascular and microbiological analyses 
Biochemical parameters, enzyme activities, vascular reactivity and microbiological 
modifications were evaluated. More detail descriptions about the methodology followed for 
each analysis is detailed in the corresponding chapters. 
3.1.1. Biochemical Analysis 
3.1.1.1. Lipid profile: Total cholesterol (TC), HDL-cholesterol (HDL-C), LDL-cholesterol 
(LDL-C) and triacylglycerols (TG) in plasma were measured in a COBAS 
INTEGRA 400 plus system (Roche Diagnostics Ltd., Rotkreuz, Switzerland). The 
HDL-C and LDL-C fractions were obtained using precipitating reagent 
(SPINREACT, SA/SAU, Girona, Spain).  
3.1.1.2. Other biochemical parameters: Glucose, urea, uric acid, creatinine, albumin, 
alanine aminotransferase (ALT/GPT, EC 2.6.1.2), aspartate aminotransferase 
(AST/GOT, EC 2.6.1.1), gamma-glutamyl transpeptidase (GGT, EC 2.3.2.2) and 
total bilirubin were measured in rat plasma samples using a COBAS INTEGRA 
400 plus system (Roche Diagnostics Ltd., Rotkreuz, Switzerland). 
3.1.2. Oxidative stress parameters 
3.1.2.1. Antioxidant enzyme activities 
Superoxide dismutase (SOD, EC 1.15.1.1), Catalase (CAT, EC 1.11.1.6), 
Glutathione peroxidase (GPx, EC 1.11.1.9) activities in erythrocytes and liver were 
determined using Assay Kits. Total protein content in the liver homogenates was 
also measured using a commercial protein assay kit (Bio-Rad Protein Assay Kit, 
Bio-Rad Laboratories). 
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3.1.2.2. Protein carbonyl content 
Protein carbonyls were measured in liver homogenates (Cayman Protein Carbonyl 
Colorimetric Assay Kit, 10005020). 
3.1.2.3. NADPH oxidase activity 
The activity of NADPH oxidase (NOX) was measured in mesenteric microvessels 
by lucigenin-derived chemiluminiscence. 
3.1.2.4. Other measurements of antioxidant activity 
2,2´-azinobis (3-ethylbenzothiazoline-6-sulfonic acid) radical cation (ABTS.+) 
scavenging capacity and ferric reducing antioxidant power (FRAP) in plasma and 
caecum were measured by methods adapted to 96-well microplate format in the 
laboratory. 
3.1.3. Inflammation and cardiovascular risk biomarkers 
Interleukin-1 alpha (IL-1α), interleukin-1 beta (IL-1β), interleukin-6 (IL-6), interleukin-
10 (IL-10), interferon-gamma (IFN-γ), tumour necrosis factor alpha (TNF-α), leptin, 
monocyte chemoattractant protein-1 (MCP-1) and vascular endothelial growth factor 
(VEGF) were determined in plasma using a Rat Cytokine/Chemokine magnetic bead panel 
kit (RECYTMAG-65K; EMD, Millipore Corp, Missouri, USA)	   and measured using a 
Luminex xMAP® bead-based technology.  
The cardiovascular biomarkers plasminogen activator inhibitor 1 (PAI-1), tissue 
inhibitor of matrix metalloproteinases type 1 (TIMP-1) and von Willebrand Factor (vWF) 
were determined with a Milliplex® Map Rat Cardiovascular Panel 1 (RCVD1-89K). 
The adhesion molecules, soluble intercellular adhesion molecule-1 (sICAM-1) and 
soluble E-selectin (sE-selectin), were also quantified in rat plasma with Milliplex® Map 
Rat Cardiovascular Panel 2 (RCVD2-89K), (EMD, Millipore Corp, Missouri, USA). 
3.1.4. Vascular reactivity 
Arterial ring segments (2 mm long) from the third branch mesenteric arteries were 
mounted on microvascular wire myographs (J.P. Trading, Aarhus, Denmark) for isometric 
tension recordings. Contractile and relaxation responses to K+ and noradrenaline were 
determined as well as the response to cumulative additions of acetylcholine. The effects of 
superoxide scavenging and inhibition of NOX on endothelium-dependent and -independent 
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responses were determined with TEMPOL or apocynin, and sodium nitroprusside, 
respectively. 
3.1.5. pH and microbiological analyses 
pH of the caecal content was measured using a microelectrode (Crison micropH2000). 
The bacterial charge and the microbiological culture used for their growth are specified 
in Table 3.2. Colony-forming units were defined as colonies measuring at least 1 mm in 
diameter. 
Table 3.2. Determinations of bacterial charge estimated to determine the prebiotic effect 
Bacteria type Agar type / Tª Agar type Specifications 
Total aerobic bacteria count PCA / 30ºC Plate count agar;  
Cultimed-Panreac, Spain 
Enterobacter spp. VRBG / 30ºC 
Violet Red Bile Glucose 
agar; Cultimed-Panreac, 
Spain 
Lactobacillus spp. MRS / 30ºC Man, Rogosa and Sharpe 
agar; Merck, Germany 
Bifidobacterium MRS / 37ºC Man, Rogosa and Sharpe 
agar; Merck, Germany 
β−glucuronidase (+) Escherichia coli Coli ID / 47 ºC ChromID Coli; 
Biomérieux, España S.A. 
Total coliform bacteria count Coli ID /47 ºC ChromID Coli; 
Biomérieux, España S.A. 
Sulphite-reducing Clostridium spp. SPS / 46ºC 
Sulphite Polymixin 
Sulfadiazine agar; 
Cultimed-Panreac, Spain 
3.2. SECTION II: Non-targeted metabolomics studies: Fingerprinting 
In order to describe the metabolic impairments associated to hypercholesterolemia and the 
potential modulating effects of the onion ingredient, the metabolic profiles of plasma and liver 
of the C, HC and HCO-fed rats were analysed by a multiplatform approach for metabolic 
fingerprinting using three different techniques: LC−, CE− and GC− separation techniques 
coupled to mass spectrometry. The general sequence followed in non-targeted metabolomics 
is summarized in this section.  
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As no single analytical approach can capture all metabolites in one sample, the following 
metabolomics platforms were applied to obtain a greater coverage of the metabolome in the 
Wistar rats. 
3.2.1. LC-MS Analysis 
LC–QTOF–MS system, composed of a UHPLC system 
(Agilent 1290 Infinity LC System) coupled with a Q-TOF 
LC/MS (6550 iFunnel) system (Agilent Technologies), was 
used to analyse plasma samples. 
LC–QTOF–MS system, composed of a UHPLC system 
(Agilent 1200 LC System) coupled with a Q-TOF LC/MS 
6520 system (Agilent Technologies), was used to analyse 
liver tissue samples. 
These LC-MS platforms were run in negative and positive ionization mode, allowing 
for the analysis of a wide range of metabolites, in particular non-polar and semi-polar 
compounds, as well as compounds that are either non-volatile or difficult to volatize and 
therefore undetectable by GC-MS. 
3.2.2. CE-MS Analysis 
CE–TOF–MS accomplished by an Agilent 7100 Capillary 
Electrophoresis system coupled to a TOF mass 
spectrometer (6224 Agilent), was used to analyse plasma 
and liver tissue samples. 
This platform targets the separation of small, water-soluble ions, mainly amino acids. 
Agilent 6550 iFunnel Q-TOF LC/MS System	  
Agilent 6520 Accurate-Mass Q-TOF LC/MS System	  
Agilent 7100 CE/6224 TOF LC/MS system	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3.2.3. GC-MS Analysis 
GC–EI–Q–MS composed of an Agilent GC 
system−7890A interfaced with a 5975C inert mass 
spectrometer with a triple-Axis detector (Agilent 
Technologies), was used to analyse plasma and liver 
tissue samples. 
The analytical approach includes low-polarity volatile metabolites of lipids and esters, and 
high-polarity metabolites of amino acids and organic acids converted into volatile derivatives. 
Agilent 7890A GC−5975C Q-MS System	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General workflow for non-targeted metabolomics studies 
The general workflow followed in non-targeted metabolomics studies can be schematized 
in five principal stages (Figure 3.5). Each of these stages can be split in several steps 
according to the material used, analytical platform and objective of the study. As a step 
previous to the analyses, the preparation and use of quality control (QC) samples must be 
considered. These QCs are required for the extraction procedure and to follow and monitor 
the analytical procedure. 
Figure 3.5. Workflow applied in non-targeted metabolomics studies 
(I) Sample extraction follows standard protocols in order to obtain the greatest response
to a maximum number of metabolites, which can be measured by the selected
analytical platform in the next step.
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(II) According to the objective, the treated samples are run (simultaneously or not) in
optimized platforms (method, column, conditions, etc.) to acquire data for screening.
(III) A molecular feature extraction is performed by the use of software, creating raw data
for further processing. This processing combines several steps (normalization,
scaling, filtering, cleaning, etc.) in order to obtain reliable and manageable data.
Once cleaned, data are subjected to multivariate analysis and several chemometric
tools.
(IV) Metabolites statistically indicated as potential markers in the study allow for the
creation and discrimination of models. The distinct metabolites are further
investigated to be identified chemically or structurally through the exploration and
comparison of databases, libraries, MS/MS and/or injection of standards.
(V) After metabolite identification, the compounds are related to their corresponding
biochemical pathway and their regulation is interpreted in a biological context.
The interpretation of these results leads to the next stage of hypothesis generation, which 
relies on a further validation of these results. 
3.3. SECTION III: Targeted metabolomics studies: Profiling 
The process of inflammation in the course of hypercholesterolemia and the assimilation of 
nutrients are outstanding sources of information to elucidate the mechanism of action 
involved in the onset and progression of atherosclerosis and liver impairments. Lipid 
mediators, including oxylipins and sphingolipids, as well as bile acids, some of which were 
indicated by the non-targeted approaches, were selected for analysis and determination 
through the application of targeted approaches. 
Thus, three different LC−MS approaches were optimized to address the changes in these 
specific pathways from different biological samples. The general workflow utilized in target 
studies can also be found in this section. 
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3.3.1. LC−MS Quantitative Analysis of oxylipins 
3.3.2. LC−MS Analysis of sphingolipids 
3.2.3. LC−MS Analysis of bile acid 
HPLC-MS/MS, composed of an Agilent 1200 LC 
MSD System and 6530A-QTOF accurate mass 
(Agilent) in negative ESI mode, was used for the 
analysis of bile acids in faeces. 
Agilent 1200 LC MSD 6530A-QTOF MS 
ACQUITY UPLC System/Xevo® TQ-S 
(Waters).
UPLC-MS/MS composed of an ACQUITY 
UPLC System and Xevo® TQ-S (Waters) in 
negative ESI mode, was used for the analysis 
of ω-6 (AA-, LA-, DHGLA-derived) oxylipins 
and ω-3 (α-LA-, EPA- and DHA-derived) 
oxylipins in plasma and tissues (heart, liver, 
spleen and brain).	  
ACQUITY UPLC System/Xevo® TQ MS 
UPLC-MS/MS composed of an ACQUITY 
UPLC System and Xevo® TQ (Waters) in 
negative ESI mode, was used for the analysis 
of sphingolipids (sphingoid bases, ceramides, 
sphingomyelins, hexosylceramides, 
lactoylceramides) in plasma and tissues (heart, 
liver, spleen and brain).	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General workflow followed in targeted metabolomics studies 
The general workflow utilized in target studies can be outlined as follows (Figure 3.6). 
Identified compounds or a family of chemically or pathway related metabolites are defined as 
targets of the study.  
Figure 3.6. Workflow applied in targeted metabolomics studies 
(I) Preparation of known standards (used as internal, external and surrogated standards)
and calibrations curves are prepared prior the analysis.
(II) Sample treatment, which aims to clean samples, remove interferences and includes
the addition of IS to both trace the procedure and quantify the compounds.
(III) Data acquisition is targeted and MS calibrated to detect the metabolites of interest.
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(IV) Data treatment includes the creation of methods for extraction of metabolites of
interest, peak integration, concentration calculations and dismissal of the metabolites
outside the analytical criteria established (LOD, LOQ, reproducibility, etc.).
(V) Statistic analysis reveals the direction of the regulation and the magnitude of
changes, providing solid results for further interpretation.
  The preparation and use of QC samples is required for the extraction procedure and to 
trace the procedure throughout the instrumental analysis. 
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Table 3.3. Overview of the research papers included in the PhD Thesis 
Metabolomic-driven evaluation of processed onion in the prevention of cardiovascular and 
liver disease in a model of diet-induced hypercholesterolemia 
SECTION I – 
BIOCHEMICAL, VASCULAR AND MICROBIOLOGICAL 
ANALYSES 
This section contains two chapters corresponding to a primary evaluation of the vascular and 
hepatic status induced by the high-cholesterol diet and the preventive role of onion on well-
known biomarkers of oxidative stress, vascular reactivity and specific markers of hepatic and 
CVD functions. 
Chapter 4. High-cholesterol diet enriched with onion affects endothelium-dependent 
relaxation and NADPH oxidase activity in mesenteric microvessels from 
Wistar rats  
(Research Paper I) 
Chapter 5. Dietary onion ameliorates antioxidant defence, inflammatory response, and 
cardiovascular risk biomarkers in hypercholesterolemic Wistar rats 
(Research Paper II) 
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http://www.nutritionandmetabolism.com/content/11/1/57RESEARCH Open AccessHigh-cholesterol diet enriched with onion affects
endothelium-dependent relaxation and NADPH
oxidase activity in mesenteric microvessels from
Wistar rats
Diana González-Peña1, Javier Angulo2, Susana Vallejo3, Clara Colina-Coca1, Begoña de Ancos1,
Carlos F Sánchez-Ferrer3, Concepción Peiró3 and Concepción Sánchez-Moreno1*Abstract
Background: The aim of the present study was to examine the effects of onion as functional ingredient on the
oxidative status, lipoprotein levels (total cholesterol-TC, HDL-C, LDL-C), triacylglycerides (TAG) and vascular reactivity
of mesenteric arteries in hypercholesterolemic Wistar rats.
Methods: Twenty-four animals were fed with three different diets [control, high-cholesterol diet (HC) and high-cholesterol
enriched with onion diet (HCO)]. After seven weeks of experimental feeding the rats were euthanized for blood and tissues
collection. TC, HDL-C, LDL-C and TAG were measured, and 2,2'-azinobis-(3-ethylbenzothiazoline-6-sulfonic acid)
radical cation (ABTS•+) scavenging capacity and ferric reducing antioxidant power (FRAP) were determined in
plasma. Superoxide dismutase (SOD) and glutathione peroxidase (GPx) enzyme activities were assayed in erythrocyte
lysates. Endothelium-dependent vasodilation to acetylcholine was evaluated in mesenteric arterial segments. NADPH
oxidase (NOX) was also measured by lucigenin-derived chemiluminiscence.
Results: The dietary cholesterol content significantly affected plasma lipoprotein levels, increased superoxide
generation from NOX, and caused impaired endothelium-dependent vasodilation in the rat mesenteric arteries.
Onion ingredient improved antioxidant status in HCO group, as it was evidenced by ABTS•+ and FRAP values and
SOD and GPx enzyme activities compared to the HC-fed group, reduced the increment in NOX activity and
reversed endothelial dysfunction promoted by the HC diet. Scavenging of superoxide with TEMPOL or inhibition
of NOX with apocynin improved endothelium-dependent vasodilation only in HC-fed rats.
Conclusions: Enrichment of diet with onion as functional ingredient could be proposed as a complementary
approach to prevent or partially modulate vascular dysfunction, reducing some of the risk indexes linked to initial
development of atherosclerosis.
Keywords: Onion, Functional foods, Dietary cholesterol, Mesenteric microvessels, NADPH oxidase(99 - 110)
Metabolomic-driven evaluation of precessed onion in the prevention of cardiovascular and 
liver disease in a model of diet-induced hypercholesterolemia 
SECTION I  Chapter 5 
Dietary onion ameliorates antioxidant defence, inflammatory 
response, and cardiovascular risk biomarkers in 
hypercholesterolemic Wistar rats 
C. Colina-Coca, D. González-Peña, B. de Ancos, C. Sánchez-Moreno
Under Review in: 
Free Radical Biology & Medicine 
REF: FRBM-D-17-00282 

Graphical Abstract 
Highlights 
 Onion ingredient enhanced antioxidant defence mechanisms in high-cholesterol-
fed rats
 Hepatotoxicity evidenced by plasma ALT and AST levels was prevented by onion
 Onion supplementation ameliorated inflammatory response associated with
atherogenesis
 Inflammation and cardiovascular risk biomarkers were positively modulated by
onion
 Beneficial and pathogenic gut microflora was modified by onion ingredient
(113 - 150)
1 
Dietary onion ameliorates antioxidant defence, inflammatory response, and cardiovascular risk 
biomarkers in hypercholesterolemic Wistar rats 
Clara Colina-Coca, Diana González-Peña, Begoña de Ancos, Concepción Sánchez-Moreno* 
Institute of Food Science, Technology and Nutrition (ICTAN), Spanish National Research Council 
(CSIC), ES-28040 Madrid, Spain 
*Correspondence to: Concepción Sánchez-Moreno, Institute of Food Science, Technology and
Nutrition (ICTAN), Spanish National Research Council (CSIC); José Antonio Novais 10, ES-28040 
Madrid, Spain. Tel.: +34 915492300; Fax: +34 915493627; E-mail address: 
csanchezm@ictan.csic.es 
2 
Abstract 
Hypercholesterolemia is a major risk factor for the development of atherosclerosis and endothelial 
dysfunction; onion supplementation has been proposed as nutritional intervention to prevent or 
improve some of its associated biological impairments. The objective of this study was to investigate 
the effects of onion as a functional ingredient on antioxidant defence, inflammatory response, and 
cardiovascular risk biomarkers in hypercholesterolemic male Wistar rats.  
Rodents (n = 24) were fed three different diets: control (C), high-cholesterol (HC), and high-
cholesterol enriched with onion (HCO). After 7 weeks of experimental feeding, blood and organs 
were collected. Antioxidant enzymes were measured in erythrocytes and liver, whereas plasma was 
used for the analysis of cytokines, chemokines, and adhesion molecules, among other cardiovascular 
parameters. Furthermore, caecum and faeces were analysed to evaluate the changes produced on the 
microflora. Rats fed the HC diet significantly decreased erythrocyte SOD, CAT and GPx activities 
compared with the C group. Interestingly, the HCO group showed a significant increase in SOD, CAT 
and GPx activities compared with the HC group. Plasma inflammatory parameters, namely IL-10, 
MCP-1, VEGF, s-ICAM-1, sE-selectin, PAI-1, v-WF, and TIMP-1 were significantly increased in 
the HC group and onion enrichment modulated this increment. Additionally, the HCO diet reduced 
the presence of sulphite-reducing Clostridium spp. versus the HC diet. Taken together, these results 
suggest an improvement on the antioxidant and antiinflammatory response as well as on the 
cardiovascular risk biomarkers promoted by the onion ingredient. 
Keywords: Functional ingredient; Antioxidant enzymes; Protein carbonyls; Oxidative stress; 
Cytokines; Adhesion molecules 
Metabolomic-driven evaluation of processed onion in the prevention of cardiovascular and 
liver disease in a model of diet-induced hypercholesterolemia 
SECTION II – 
NON-TARGETED METABOLOMICS STUDIES 
(FINGERPRINTING) 
This section comprises three chapters based on corresponding research papers. 
These studies describe metabolic impairments associated to hypercholesterolemia followed by 
the potential modulating effects of onion by analysing plasma and liver samples by non-targeted 
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Abstract 
Purpose The aim was to investigate the impact of hyper-
cholesterolemic diet on the metabolome of male Wistar rats 
by a multiplatform metabolomic fingerprinting.
Methods Male Wistar rats were fed with two different 
diets [control (C) and high-cholesterol diet (HC)—contain-
ing 2 % cholesterol and 0.5 % cholic acid]. After 7 weeks 
of experimental feeding, the rats were euthanized for blood 
collection and plasma recovery. The metabolite fingerprint 
was then achieved by applying a multiplatform comprising 
LC–MS, GC–MS and CE–MS.
Results Multivariate statistical analysis showed a clear 
separation between the C and HC groups. Individual dif-
ferences in metabolites were evaluated using univariate sta-
tistical analysis, and multiple metabolites were identified 
and confirmed in the plasma. A global profiling integrates 
for the first time pathways affected by high-cholesterol diet 
intake and allowed us to elucidate some of the associated 
alterations underlying the hypercholesterolemia event in 
Wistar rats.
Conclusions HC feeding stimulated the alteration of mul-
tiple pathways in Wistar rats, warning of the risk of devel-
oping important diseases, which can be modulated by the 
diet. Further studies are required to investigate the possi-
bilities to revert or ameliorate the negative effects triggered 
by HC intake.
(155 - 168)
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A B S T R A C T
The preventive and modulating effects of onion in metabolites affected by a high-
cholesterol diet and related tomolecular pathway dysfunction were examined. Plasma obtained
from 24 maleWistar rats after seven weeks of experimental feeding was analysed through
a non-targeted multiplatform metabolomics approach based on LC-MS, CE-MS and GC-MS
methods. A cross-comparison of the three metabolic profiles [I) control (C) group, II) high-
cholesterol (HC) group and III) high-cholesterol enriched with onion (HCO) group] pointed
out two sulphurmetabolites, S-methyl-L-cysteine and S-methylcysteine sulphoxide, asmarkers
of onion intake and evidenced the possibilities to regulate key metabolites. Thus, the meth-
ylation cycle, arginine and tryptophan pathways, the modulation of 3-methylhistidine, as
well as the routes involved in the glycerophospholipids transformation have been high-
lighted. This study suggests that onion’s biologically active compounds take a prominent
role in ameliorating hypercholesterolaemia and related complications through the regula-
tion of altered metabolic pathways.
© 2015 Elsevier Ltd. All rights reserved.
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Abstract: The consumption of functional ingredients has been suggested to be a complementary
tool for the prevention and management of liver disease. In this light, processed onion can be
considered as a source of multiple bioactive compounds with hepatoprotective properties. The liver
fingerprint of male Wistar rats (n = 24) fed with three experimental diets (control (C), high-cholesterol
(HC), and high-cholesterol enriched with onion (HCO) diets) was obtained through a non-targeted,
multiplatform metabolomics approach to produce broad metabolite coverage. LC-MS, CE-MS
and GC-MS results were subjected to univariate and multivariate analyses, providing a list of
significant metabolites. All data were merged in order to figure out the most relevant metabolites that
were modified by the onion ingredient. Several relevant metabolic changes and related metabolic
pathways were found to be impacted by both HC and HCO diet. The model highlighted several
metabolites (such as hydroxybutyryl carnitine and palmitoyl carnitine) modified by the HCO diet.
These findings could suggest potential impairments in the energy−lipid metabolism, perturbations
in the tricarboxylic acid cycle (TCA) cycle and β-oxidation modulated by the onion supplementation
in the core of hepatic dysfunction. Metabolomics shows to be a valuable tool to evaluate the effects of
complementary dietetic approaches directed to hepatic damage amelioration or non-alcoholic fatty
liver disease (NAFLD) prevention.
Keywords: functional food; hypercholesterolemia; mass spectrometry; LC-MS; CE-MS; GC-MS;
metabolome; non-targeted metabolomics; non-alcoholic fatty liver disease (NAFLD)
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A B S T R A C T
The levels and roles of lipid mediators can be modiﬁed in response to nutritional stimuli. The aim of this study
was to investigate shifts in oxylipin and sphingolipid proﬁles stimulated by a hypercholesterolemic (HC)
diet along with the modulating eﬀects of onion introduced as an antioxidant functional ingredient characterized
in the diet (HCO). Oxylipin and sphingolipid proﬁles were determined in plasma and tissues from Wistar rats
using LC-MS/MS. Plasma ω-3 and ω-6 PUFA-derived oxylipins decreased in rats after 7 weeks of HC feeding,
but did not evidence a further shift with HCO diet. Onion ingredient supplementation modulated the hepatic
concentrations of prostaglandins and enhanced ω-3 oxylipins in the liver of HCO-fed rats relative to the HC
group. The HC diet induced shifts in plasma sphingolipids, increasing sphingoid bases, dihydroceramides and
ceramides, whilst the sphingomyelin, hexosylceramide and lactosylceramide families decreased. The HCO diet
modiﬁed some HC diet-induced changes in sphingolipids in liver and spleen tissue. Onion supplementation
eﬀected changes in lipid mediator levels in diet-induced hypercholesterolemic Wistar rats. The potential of
onion as regulator of pro-inﬂammatory mediators, and possible enhancer of pro-resolution pathways, warrants
further study of the interaction of functional ingredients with bioactive lipid mediators and their potential
impact on inﬂammation, oxidative stress and organ dysfunction.
Redox Biology 11 (2017) 205–212
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Abstract (50–250 words) 15 
The determination of faecal bile patterns offers new opportunities in the search for 16 
non-invasive biomarkers of disease status. The objective of this study was to describe 17 
the shifts in the faecal bile acid (BA) composition induced by feeding a high-18 
cholesterol/cholic acid diet (HC), over 7 weeks of experimental feeding in Wistar rats, 19 
evaluating the effects of onion included as a functional ingredient (HCO). A HPLC–20 
MS/MS allowed for the detection of 29 bile acids, 10 of which were tentatively 21 
identified and 12 confirmed and quantified by means of IS-calibration curves. The 22 
excretion of bile acids revealed a discriminating bile acid profile between the HC and 23 
HCO groups compared with the C group. HCO feeding indicated significant changes in 24 
specific primary and secondary BA in both unconjugated and conjugated forms caused 25 
by the addition of the onion ingredient to the diet. The results suggest the induction of 26 
microbiome modifications by the HC and HCO diets acts as a critical modifier of the 27 
faecal bile acid composition. These modifications might reflect and be linked to changes 28 
in the reabsorption of BA at an intestinal level and the processes of BA deconjugation in 29 
the course of hypercholesterolemia. 30 
Keywords: Faeces; Hypercholesterolemia; LC-MS; Profiling; NAFLD 31 
32 
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1. Introduction 33 
The secretion from the liver and absorption from the intestine of bile acids (BA) are 34 
the two major processes involved in the enterohepatic circulation, which is 35 
simultaneously coordinated by the action of lipid activated nuclear hormone receptors 36 
regulating the cholesterol metabolism and bile acid synthesis 1. However, BA are also 37 
involved in the regulation of a complex network of metabolic pathways including lipid, 38 
glucose and energy metabolism 2, where they also act as important and versatile 39 
signaling molecules and they become the specific ligands for activation of nuclear and 40 
membrane receptors 2.  41 
The balance in the content of the BA pool prevents both functional impairments and 42 
cytotoxic accumulation, thus as the bile acid pool size increases, a feedback mechanism 43 
is activated to inhibit de novo BA synthesis. Nevertheless, the equilibrium of this 44 
system is critically affected by the composition of the diet. The intake of dietary 45 
cholesterol and its supplementation with cholic acid (CA), has been assayed in several 46 
studies 3-5.  Charach et al. 6 demonstrated an inverse correlation between the degree of 47 
hypercholesterolemia and the rate of bile acid elimination, which was suggested to 48 
depend on the animal’s ability to convert cholesterol and associated with the subsequent 49 
development of atherosclerosis. Dietary supplementation of a specific bile acid has 50 
shown to increase the hepatic and serum concentrations of that bile acid administered in 51 
a dose-dependent manner, as well as their known metabolites 7, 8. Moreover, the 52 
influence of different dietary supplements on cholesterol and bile acids can promote a 53 
differential response in faecal bile acid excretion and composition. For example, the use 54 
of S-methyl cysteine sulfoxide from Allium cepa Linn. in high cholesterol diet fed rats 55 
evidenced increases in the excretion of bile acids and sterols 9.  56 
On the other hand, the consumption of onion and onion powder have been shown to 57 
exert a direct impact in the modulation of biliary cholesterol, which influence: the 58 
cholesterol nucleation and contribute to their anti-lithogenic potential 10, 11;  the lipid 59 
profile in conditions of metabolic disorders and diseases 12 and the hepatic conversion 60 
of cholesterol to bile acids exerting hepatoprotection 13. In this regard, the 61 
hepatoprotective effect of both dietary onion and some of its principal bioactive 62 
components has consistently been shown through the enhancement of the antioxidant 63 
capability and the activities of the enzyme systems 14. In addition, a recent study by our 64 
group evidenced the preventive effect of an onion ingredient in both hepatic markers 65 
4 
 
and inflammatory responses in hypercholesterolemic Wistar rats. This could suggest a 66 
possible removal of fats in the liver, which would be directed by different mechanisms, 67 
such as the excretion of bile acids. However, multiple mechanisms and metabolic 68 
responses may be behind the development of hypercholesterolemia that remain 69 
unexplored. Overall, when disease and physiopathology are the result of a specific diet 70 
such as HC, this situation is amenable to change with the aim of improving the health 71 
status (e.g. by supplementation with onion). 72 
Therefore, the aim of the present study had a double purpose of describing the 73 
changes induced by feeding a high-cholesterol (HC) diet in the faecal BA composition 74 
during a 7-weeks experiment and the assessment of the effect of a supplementation with 75 
an onion ingredient on the excretion of BA, thus evaluating its concentration in faeces 76 
with a chronological perspective.  77 
 78 
2. Material and Methods 79 
2.1 Experimental design 80 
Twenty four male Wistar rats with a body weight of approximately of 250 g at the 81 
outset were obtained from Harlan Laboratories Models (Harlan, SL, Barcelona, Spain). 82 
The animals were housed individually in metabolic cages in a temperature-controlled 83 
room (22.5  0.5ºC) with a 12 h light12 h dark cycle. The rats were fed commercial rat 84 
pellets (Panlab, SLU, Barcelona, Spain) for the adaptation to environmental conditions 85 
and then distributed into three groups of eight animals each, according to average body 86 
weight. For the acclimatisation to metabolic cages, animals were nourish a control diet 87 
based on the AIN-93M semi-purified rodent diet 15, whose composition is specified in 88 
ESI Table 1. 89 
The three experimental semi-synthetic diets were prepared and given according to: 90 
(1) the control (C) diet, composed of a homogeneous mixture of 100 % rodent diet; (2) 91 
the high-cholesterol (HC) diet, composed by the control diet with 2 % cholesterol and 92 
0.5 % cholic acid; and (3) the high-cholesterol enriched with onion (HCO) diet, 93 
identical to the HC diet but with 10% onion powder, balancing the dietary fibre with 94 
cellulose powder. The amount of maize starch in the HC and HCO diets was adjusted to 95 
compensate for the addition of cholesterol and cholic acid in the HC diet, and onion 96 
powder in the HCO diet (ESI Table 2). The experimental period last for 7-weeks for 97 
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which water and food were provided ad libitum. Then, food consumption and faeces 98 
deposits were registered daily, while body weight was recorded weekly. 99 
The present study was approved by the Spanish Ministry of Science and Innovation 100 
Advisory Committee [project AGL2010-15910 (subprogram ALI)] and by an Ethics 101 
Committee of the Complutense University of Madrid (Spain). All experiments were 102 
performed in compliance with the Directive 2010/63/UE regarding the protection of 103 
animals used for scientific purposes. 104 
 105 
2.2 Chemicals and reagents 106 
Cholic acid (CA), chenodeoxycholic acid (CDCA), deoxycholic acid (DCA), 107 
hyodeoxycholic acid (HDCA), ursodeoxycholic acid (UDCA), taurocholic acid (T-CA), 108 
taurochenodeoxycholic acid (T-CDCA), taurodeoxycholic acid (T-DCA), 109 
taurolithocholic acid (T-LCA), glycocholic acid (G-CA), glycochenodeoxycholic acid 110 
(G-CDCA), and glycodeoxycholic acid (G-DCA) were purchased from Sigma–Aldrich 111 
(St. Louis, MO). HPLC-grade methanol was provided by Lab-Scan (Gliwice, Poland). 112 
Ethanol and formic acid were purchased from Panreac (Barcelona, Spain). Acetic acid 113 
was obtained from Merck (Darmstadt, Germany). Sep-Pak® C18 cartridges were 114 
purchased from Waters (Milford, MA, USA). 115 
 116 
2.3 Faecal sample collection and extraction of faecal bile acids (BA) 117 
Faecal samples were collected daily from individual metabolic cages, weighed and 118 
kept at 20 ± 0.5 ºC until use. Sample from selected days were individually freeze-dried 119 
using a lyophilizer (model Lyoalfa, Telstar, S.A., Barcelona, Spain). The dried samples 120 
were pulverized using a small grinder and kept in tubes at 4ºC. 250 mg of dried faecal 121 
material from the 8 rats of each group (C, HC and HCO groups) were weighed and 122 
pooled together each week obtaining a final pool of faecal powder for each group and 123 
week (3 pools per week during 7 weeks, starting at week 0). 124 
5 mg of each pool sample was weighed in a pirex tube and 0.5 mL of 50 mM sodium 125 
acetate buffer (pH 5.6) was added. The tube was top up to 2 mL with methanol and 126 
vortexed. Samples were incubated at 80ºC for 1 hour and centrifuged at 1600 g for 5 127 
min at 4ºC. Supernatants were recovered and ¼ diluted with milliQ water. SPE 128 
extraction was performed using Sep-Pak® C18 cartridges (360 mg, 55-105 µm, Waters, 129 
Milford, Massachusetts, USA) according to Kakiyama et al. 16, with minor 130 
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modifications and dried using a Speed-Vac (Savant SPD131DDA-RVT4104TRAP, 131 
Thermo). Dried samples were re-suspended in 500 µL of methanol (50%) and filtered 132 
with 0.45 µm nylon syringe filters before injection. All extractions were performed in 133 
duplicate. A general overview of the experimental workflow is represented in Fig. 1. 134 
 135 
2.4 Identification and quantification of bile acids 136 
HPLC-DAD and HPLC-ESI-QTOF-MS analysis was performed on an Agilent 1200 137 
series HPLC (Agilent Technologies, Waldbroon, Germany), comprised of a quaternary 138 
pump (G1311A) with integrated degasser (G1322A), an autosampler (G1367B), a 139 
thermo stated column compartment (G1316A) a diode array detector (DAD) (G1315B) 140 
and a hybrid mass spectrometer quadrupole-time of flight via an electrospray ionization 141 
source (ESI) with JetStream technology (Agilent Accurate Mass QTOF LC-MS, 142 
Waldbronn, Germany) in series in the same chromatographic line. Two extracts from 143 
each pool were taken and duplicate samples of 1 and 10 µL each were injected into a 144 
C18 Hypersil ODS stainless steel column (250 mm × 4.6 mm, 5 μm; Teknokroma, 145 
Barcelona, Spain). Chromatographic and operating conditions were based on Kakiyama 146 
et al. 16 and Bobeldijk et al.  17 protocols, and optimized as followed: mobile phase (A) 147 
used 5mM of ammonium acetate in water and mobile phase (B) used methanol. The 148 
gradient started after 8 min at 65% B, increasing to 75 % B (8-15 min) and 95% B (15-149 
20 min) and afterwards restored to 65% B (20-25 min). An isocratic mode was kept for 150 
the last 5 min until total run time of 30 min. The flow rate was fixed at 0.8 mL/min. 151 
HPLC-ESI-MS/MS operated in negative ion mode, with voltage set at −3500 V,  152 
fragmentor 200 V, nebulizing gas flow rate 12 L/min, nebulizer pressure 45 psig, and 153 
drying temperature 300 °C. Mass spectrometry data was acquired in the scan mode 154 
(mass range 100−1500 m/z). MS/MS collision energy was set at 35 V. Data acquisition 155 
and MS and MS/MS data were processed through MasshunterWorkstation software 156 
(version B.04.00, Agilent Technologies, Waldbronn, Germany).  157 
Identification of bile acids was carried out by comparing the mass, retention time and 158 
fragmentation pattern with those of the authentic commercial standards, and data 159 
reported in the literature for biological samples obtained from rodents. Quantification 160 
was achieved by employing calibration curves as an external standard. To optimize the 161 
method, stock solutions with 2 mg/mL were prepared for each standard. Then, 1 mL 162 
from each stock was diluted into one of the two multi-standard curves prepared to reach 163 
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a concentration range of ~35 µg/mL to 2 µg/mL and then combined into a new unique 164 
multi-standard, including all quantifiable compounds.  165 
Final determination of external curves was performed in duplicate and injected twice 166 
along the sequence. The analysis also included curves with the concentration range 167 
needed of each standard for sample quantification (20-0.3 µg/mL for HDCA and DCA; 168 
5-0.078 µg/mL for T-CA, UDCA, CA and CDCA; 500-142.85 µg/mL for CA; 5-0.156 169 
µg/mL for G-CA, G-CDCA and G-DCA; 2-0.05 µg/mL for T-CDCA, T-DCA). 170 
Samples were randomized in a sequence and injected along with the combined multi 171 
standard as QC every 12 samples to ensure the system’s performance and stability. 172 
 173 
2.5 Statistical analysis 174 
Results are reported as mean values with their standard deviation (SD). Data were 175 
analysed using two-way ANOVA or t-test for multiple or pair comparisons, as 176 
appropriate. In order to verify the homogeneity of the variances a Levene’s test was 177 
applied. Tamhane’s T2 (equal variances not assumed) or Bonferroni (equal variances 178 
assumed) post hoc tests were used to determine differences within groups (p < 0.05). 179 
Analyses were performed using the IBM SPSS Statistics 23 (SPSS Inc., an IBM 180 
Company). 181 
 182 
3. Results & Discussion 183 
 184 
3.1 Qualitative and quantitative analysis of faecal bile acids  185 
A simple HPLC–MS/MS method for the simultaneous quantification of 12 BA in 186 
samples of faeces has been developed (Fig. 2), allowing to quantify their shifts and the 187 
detection of other non-targeted BA among the three groups of experiment. A detailed 188 
list of detected compounds classified by unconjugated (primary / secondary), 189 
conjugated bile acids and unidentified compounds is shown in Table 1, specifying the 190 
sample groups where they were found and indicating the possibilities of detection with 191 
time (TiTf). Quantified peaks in the three groups over 7 weeks of experiment is 192 
summarized in Table 2, evidencing whether the influence of time or group have an 193 
impact on the final results. The putative identification of BA or the confirmation of their 194 
identities was possible through searches on databases, data reported in the literature18, 19 195 
and the use of commercial standards. Fig. 3 shows a merged extracted-ion 196 
8 
 
chromatogram (EIC) of BA for the C, HC, and HCO groups, verifying the differential 197 
profile on faecal extracts among the HC and HCO groups compared with the C group. 198 
 199 
3.2 Effect of high-cholesterol diet in faecal bile acid profile 200 
The regulation of bile acid metabolism is directly involved with the cholesterol 201 
homeostasis. Dietary cholesterol and BA affect cholesterol metabolism, modifying the 202 
composition of the major and minor BA found in different compartments, including the 203 
final excretion of faecal BA. Although most BA (95%) delivered to the intestine are re-204 
absorbed into the enterohepatic circulation, the analyses of faecal BA can offer some 205 
advantages in the search of biomarkers. 206 
In addition to the non-invasive nature of the sampling procedure, the screening of 207 
faecal BA reflects changes caused in the small intestine, and thus takes into account the 208 
changes produced by the colonic microbiota.  209 
A high-cholesterol (HC) diet containing cholic acid (CA) has been classically 210 
considered as potentially atherogenic 20 and diverse findings also established a clear 211 
relationship with hepatic damage which is characterized by steatosis, inflammation and 212 
fibrosis 20, 21. Feeding the animals with a HC diet modified the faecal BA by increasing 213 
its subsequent excretion (Table 2). Muricholic acids (MCA), hyodeoxicholic acids 214 
(HDCA) and deoxycholic acid (DCA) were the main BA found at the beginning of the 215 
experiment in all groups and remained dominant throughout the experiment in the C 216 
group. The primary BA, CA and chenodeoxycholic acid (CDCA) underwent a strong 217 
increase in HC and HCO groups, due to the dietary cholesterol/CA overload. The 218 
exceedingly high levels of CA attained were also responsible for the higher 219 
concentrations of DCA and ursodeoxycholic acid (UDCA) found in 220 
hypercholesterolemic rats. Conversely, litocholic acid (LCA) and hyodeoxycholic acid 221 
(HDCA) showed a marked and significant decrease in HC-fed group compared with the 222 
C group.  223 
The synthesis of MCA in rodents is known to be one of the most important 224 
differences with humans and a reason why part of the metabolism and physiological 225 
functions of MCA remains unclear. The supplementation with CA in mice is known to 226 
increase the absorption of cholesterol in the liver by around 60%, while MCA-BA are 227 
simultaneously reduced by 80-90% 22. In this study, , β and ω MCA were putatively 228 
identified in the faeces of Wistar rats. Nevertheless, HC-feeding caused a remarkable 229 
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and progressive increase in the excreted concentrations of MCA compared to the C 230 
group until the week-5, point from which the trend was modified and showed a partial 231 
decrease relative to the HC group. 232 
Stimulation of BA production was observed by an increased faecal BA excretion of 233 
conjugated forms. Glycine and taurine conjugated forms were only detected by feeding 234 
HC and HCO diets, thus remaining at very low levels and precluding its detection in C 235 
group during the 8 points analysed in the experiment. The concentration of BA 236 
conjugated with glycine was higher than the taurine forms in HC-fed rats. Whereas 237 
most non-conjugated BA showed a more regular trend, conjugated BA such as 238 
taurocholic acid (T-CA) or glycocholic acid (G-CA) presented marked oscillating cycles 239 
(of increasing and decreasing concentrations) when rats were fed the high cholesterol 240 
(HC- and HCO-) diets. Moreover, taurolitocholic acid (T-LCA) was not detected at any 241 
point of the experiment, whereas its unconjugated form decreased in HC group from 242 
week 1 to week 4, showing a partial recovery after that point. The concentration of most 243 
BA varied markedly between weeks in the different groups during the experiment. 244 
The rates of biosynthesis of different bile acids are known to be altered by the 245 
overload of cholesterol/cholic acid and regulated by the joint activity of CYP7A1, 246 
CYP8B1 and CYP27 enzymes which differ widely according to the animal model 3. 247 
The interest in the action of nuclear Farnesoid X receptor (FXR) and Short Heterodimer 248 
Partner (SHP) is also a priority since they are both involved in the control of bile acid 249 
synthesis 23 and describe interactions with the lipid metabolism,  which is also modified 250 
by the composition of the diet 24. However, it is important to highlight that bile acids 251 
found in rat faeces are extensively modified by the intestinal microflora, which is 252 
simultaneously modified in response to the diet and conditioned by the presence and 253 
type of BA 25. There is a complex modification of the gut microbiome when rats are fed 254 
bile acids. As an example, Islam et al., 2011, demonstrated that CA intake produced 255 
drastic increases in Clostridia 26. A study of our group also corroborated these finding 256 
by showing a 7-fold increase in sulfite-reducing Clostridium spp. seen in faeces from 257 
the same diet-induced hypercholesterolemic model. Thus, evidences suggest that the 258 
changes in faecal bile acids observed in this study should be interpreted in an integrated 259 
way, where faeces reflects the changes in BA produced in response to HC-feeding, and 260 
acts as a determinant of enzymes, nuclear receptors, the gut microbiota and its 261 
metabolites, and subsequently modifies the quantity of BA excreted. 262 
 263 
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3.2 Effect of the onion ingredient in bile acid profile of high-cholesterol fed-rats 264 
The effects of onion supplementation on lipid metabolism and its role in preventing 265 
hepatic impairments have been the objective of several studies. Nevertheless, the 266 
particular consequences of a HC diet evaluated in parallel with the effect of onion on 267 
BA excretion have not been stablished until this study. 268 
The supplementation of HC diet with the onion ingredient caused significant changes 269 
in the composition of specific BA found in the faeces (Table 2). The general trend found 270 
in the HCO group was similar to that of HC group. However, CA, MCA, CDCA and 271 
UDCA concentration increases were partial but significantly prevented in the HCO 272 
group. The trend showed by litocholic acid also revealed a partial prevention induced by 273 
the onion ingredient compared with the HC group. Likewise, the oscillating trend found 274 
in glyco- and tauro-conjugated forms seemed to be greater in HCO-fed rats compared 275 
with those rats fed the HC diet. An overview of the shifts in the pattern of faecal BA 276 
between week 0 and week 7, as a consequence of HC- and HCO-feeding is represented 277 
in Fig. 4. 278 
The consumption of garlic, onion powder and some of their component such S-279 
methyl cysteine sulphoxide has been reported to induce the enhancement of faecal sterol 280 
excretion and up-regulation of LXRα and CYP7A1 in hypercholesterolemic conditions 281 
9, 27, 28. Amelioration of cholesterol levels in response to onion consumption usually 282 
provokes an increase in its synthesis that is compensated by an increase in excretion of 283 
cholesterol and BA. Nevertheless, the addition of an onion ingredient to the HC diet in 284 
this study did not evidence an increase in the excretion of BA, except for DCA and 285 
some conjugated forms. These results support previous findings where body weight and 286 
cholesterol levels of this animal model were not improved by adding onion to the diet, 287 
whereas cardiovascular, hepatic and inflammatory benefits suggested a more complex 288 
differential mechanism active behind this model 29. 289 
According to Hagey and Krasowski 30, excreted BA are the result of the summed 290 
products of commensal bacterial modification in the small intestine; non-absorbed 291 
(passively or actively) BA along the length of the entire intestine and those bile acids 292 
trapped within or adsorbed by dietary components such as fibre. In this sense, despite 293 
the amount of dietary fibre in HCO diet compensated with cellulose powder, onion 294 
contributed to the diet with a more complex composition of dietary fibre, where fructans 295 
or fructooligosacarides with prebiotic effect were also present. Thus, the differential 296 
faecal excretion of BA might suggest an increased in the retention of BA produced by 297 
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the components of onion, which are able to stimulate the fermentative processes and the 298 
changes in microflora that promote modifications in the permeability of membranes. All 299 
these circumstances together may have driven the changes in metabolism toward an 300 
increased reabsorption of BA at an intestinal level. Fig 5 outlines the modifications 301 
found in faecal BA within each group after 7 weeks of HC and HCO-feeding. 302 
In addition, the gut microbiota is responsible for converting primary BA to secondary 303 
BA and affects the ratio of conjugated forms 31. At the end of the experiment, the HCO 304 
group showed a tendency to augment the concentration of conjugated forms compared 305 
with the HC group, which could indicate an amelioration over the negative impact of 306 
HC-feeding. Some studies have suggested that taurine-conjugated BA may help prevent 307 
the development of NAFLD 32-34. Recently, a new study suggested that development of 308 
NAFLD was partly associated with a decreased in the levels of taurine-conjugated BA 309 
and butyrate-producing microbiota 35. In this sense, the fermentation of onion products 310 
have also demonstrated that the presence of fructans increase the production of total 311 
short fatty acids, including propionate, acetate and butyrate in the caecum of rats 312 
36.Therefore, supplementation with onion might contribute to reduce BA deconjugation, 313 
which usually counts as a risk factor for worsening NAFLD. 314 
 315 
4. Conclusions 316 
A HPLC–MS/MS method for the measurement of BA in faecal samples has allowed 317 
for the description of the shifts produced over 7 weeks of HC feeding and the 318 
supplementation with an onion ingredient. Faeces samples displayed discriminating BA 319 
profiles between the HC and HCO groups relative to the C group, whereas HCO pointed 320 
to significant changes in specific primary and secondary BA in both unconjugated and 321 
conjugated forms. The results indicate that supplementation with onion might have 322 
contributed to changes in metabolism that suggest an increase in the reabsorption of BA 323 
at an intestinal level and the decrease in BA deconjugation. Furthermore, the importance 324 
and influence of diet in the microbiome is highlighted as a possible crucial modifier of 325 
the metabolic responses found in the course of hypercholesterolemia. 326 
It is remarkable that the comparison of faecal bile patterns offers a snap shot at the 327 
end point of the metabolism. This can contribute to the detection of important 328 
imbalances not only related to the hepatic and intestinal functions but also to other 329 
metabolic disorders, giving new insights about the understanding of the relationship 330 
between diseases and the search of non-invasive biomarkers. However, further studies 331 
12 
 
are also needed to facilitate the understanding about how the diet and functional 332 
ingredients such as onion may influence the enterohepatic circulation regulation and the 333 
homeostatic feedback mechanisms with the luminal microbiota that affects the BA 334 
signalling in the progression of hypercholesterolemia. 335 
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 458 
Fig. 1. Scheme of the fecal sampling procedure in the experimental design. 459 
C: control group; HC: high-cholesterol group; HCO: high-cholesterol enriched with 460 
onion group 461 
  462 
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 463 
Fig. 2. EIC of a standard mixture containing the 12 bile acids quantified. Upper 464 
numbers correspond with the bile acids identities indicated in Table 1.  465 
17 
 
 466 
Fig. 3. Masses merged into one chromatogram for comparison of the bile acids profile 467 
of the three experimental groups. 468 
C: control group; HC: high-cholesterol group; HCO: high-cholesterol enriched with 469 
onion group 470 
  471 
18 
472 
Fig.4. Representation of the changes induced by HC and HCO diets in the pattern of 473 
faecal bile acids between week 0 and week 7. 474 
C: control group; HC: high-cholesterol group; HCO: high-cholesterol enriched with 475 
onion group 476 
477 
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 478 
Fig. 5. Schematic representation of trends in primary and secondary bile acids in both 479 
unconjugated and conjugated forms, found in faecal bile acids within each group after 7 480 
weeks of experimental feeding. 481 
Red and green arrows show the comparison of HC vs. C and HCO vs. HC groups, 482 
respectively. C: control group; HC: high-cholesterol group; HCO: high-cholesterol 483 
enriched with onion group  484 
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Table 1. Bile acids detected and identified in faeces from control (C), high-cholesterol 485 
(HC) and high-cholesterol with onion (HCO) groups at Ti and Tf of the experimental 486 
feeding. 487 
Classification Compound name  Formule MW (M) [M  H] tR (min) Groups Ti - Tf 
Primary  Cholic acid 8 C24H40O5 408.57 407.2803 5.54 C, HC, HCO √- √ 
 Chenodeoxycholic acid 11 C24H40O4 392.57 391.2854 9.15 HC, HCO x- √ 
Secondary Deoxycholic acid 12 C24H40O4 392.57 391.2854 9.46 C, HC, HCO √- √ 
 Ursodeoxycholic acid 7 C24H40O4 392.57 391.2854 4.86 C, HC, HCO √- √ 
 Hyodeoxycholic acid 9 C24H40O4 392.57 391.2854 5.82 C, HC, HCO √- √ 
 Hyodeoxycholic acid isom.* C24H40O4 392.57 391.2854 6.17 C, HC, HCO √- √ 
 ω-Muricholic acid DB* C24H40O5 408.57 407.2803 3.96 C, HC, HCO √- √ 
 -Muricholic acid DB* C24H40O5 408.57 407.2803 4.21 C, HC, HCO √- √ 
 β-Muricholic acid DB* C24H40O5 408.57 407.2803 4.64 C, HC, HCO √- √ 
 Lithocholic acid DB  C24H40O3 376.57 375.2905 16.4 C, HC, HCO √- √ 
Conjugates Glycocholic acid 2 C26H43NO6 465.62 464.3018 3.39 HC, HCO x- √ 
 Glycochenodeoxycholic acid 5 C26H43NO5 449.62 448.3068 4.33 HC, HCO x- √ 
 Glycodeoxycholic acid 6 C26H43NO5 449.62 448.3068 4.57 HC, HCO x- √ 
 Taurocholic acid 1 C26H45NO7S 515.70 514.2844 3.24 HC, HCO x- √ 
 Taurochenodeoxycholic acid 3 C26H45NO6S 499.70 498.2895 4.01 HC, HCO x- √ 
 Taurolithocholic acid 10 C26H45NO5S 483.70 482.2946 5.87 C, HC, HCO x- x 
 Taurodeoxycholic acid 4 C26H45NO6S 499.70 498.2895 4.20 HC, HCO x- √ 
Unknown Unknown   407.2803 2.99 HC, HCO x- √ 
 Unknown   407.2803 3.35 HC, HCO x- √ 
 Tauroursodeoxycholic acid *   498.2895 2.83 HC, HCO x- √ 
 -Tauromurocholic acid *   514.2844 2.77 C, HC, HCO √- √ 
 β- Tauromurocholic acid *   514.2844 3.07 HC, HCO x- √ 
 Taurohycholic acid*   514.2844 4.10 C, HCO √-√ 
    514.2844 4.27 C, HC, HCO √- √ 
 Unknown   464.3018 2.85 HC, HCO x- √ 
 Unknown   498.2895 2.99 HC, HCO x- √ 
 Taurohyodeoxycholic acid*   498.2895 3.38 HC, HCO x- √ 
 Unknown   375.2905 16.75 C √- √ 
      HC, HCO √- x 
 Unknown    375.2905 18.41 C √-√ 
      HC, HCO √- x 
MWmolecular weight; Ti initial time; Tf –final time; tR retention time; 488 
NumberedCompounds were identified by comparison with commercial standards. Numbers 489 
correspond with standard bile acids peaks shown in Fig. 2.  490 
*Compounds tentatively identified by literature review 491 
DB Compounds tentatively identified by using databases 492 
 493 
 494 
 495 
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Table 2. Quantified bile acids in faeces from control (C), high-cholesterol (HC) and high-cholesterol with onion (HCO) groups over 7 weeks of 
experimental feeding 
Compound name 
Group  
Week 0 Week 1 Week 2 Week 3 Week 4 Week 5 Week 6 Week 7 
Cholic acid 8         
C 0.480 ± 0.26a n.d. 0.279 ± 0.05a 3.375 ± 0.71a* 0.286 ± 0.02a* 0.414 ± 0.12a 0.385 ± 0.03a 0.715 ± 0.05a* 
HC 0.284 ± 0.02a 245.744 ± 21.35a* 192.136 ± 43.37b 234.352 ± 37.20b 243.029 ± 0.74c 230.271 ± 41.85b 246.662 ± 7.20c 200.351 ± 4.34c* 
HCO 0.479 ± 0.20a 184.453 ± 37.84a* 208.449 ± 24.41b 175.184 ± 28.03b 203.440 ± 12.77b 200.965 ± 12.69b 140.794 ± 30.59b 152.392 ± 2.21b 
Chenodeoxycholic acid 11         
C n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. 
HC n.d. 3.242 ± 0.11a 3.018 ± 0.42a 4.668 ± 0.36b* 5.647 ± 0.20b 4.906 ± 0.73a 5.181 ± 0.30b 4.409 ± 0.15b 
HCO n.d. 3.140 ± 0.10a 3.094 ± 0.46a 3.506 ± 0.48a 3.773 ± 0.01a 4.178 ± 0.13a 3.397 ± 0.54ª 3.415 ± 0.001a 
Deoxycholic acid 12         
C 2.452 ± 0.50a 2.579 ± 0.18a 2.908 ± 0.04a 2.664 ± 0.15a 2.808 ± 0.117a 2.739 ± 0.18a 2.192 ± 0.007a 2.574 ± 0.11a 
HC 3.409 ± 0.21b 17.469 ± 2.13bc* 6.271 ± 0.95b* 7.144 ± 1.18b 4.021 ± 0.102b 8.340 ± 0.78b* 10.181 ± 0.72b 10.437 ± 0.70b 
HCO 3.455 ± 0.25b 13.112 ± 2.49b* 12.545 ± 2.18bc 16.251 ± 0.45c 13.741 ± 0.179c 16.383 ± 0.96c 15.091 ± 2.68c 20.262 ± 0.21c* 
Ursodeoxycholic acid 7         
C 0.114 ± 0.06a 0.114 ± 0.01a 0.150 ± 0.01a 0.196 ± 0.02a 0.265 ± 0.060a 0.218 ± 0.11a 0.335 ± 0.07a 0.205 ± 0.02a 
HC 0.222 ± 0.00b 0.737 ± 0.03c* 0.844 ± 0.15b 1.614 ± 0.17c* 1.927 ± 0.144c 2.476 ± 0.21b* 2.543 ± 0.07c 2.424 ± 0.002c 
HCO 0.140 ± 0.003ab 0.411 ± 0.19b 0.865 ± 0.13b 1.096 ± 0.28b 1.470 ± 0.099b 2.288 ± 0.07b* 1.764 ± 0.24b* 1.760 ± 0.11b 
Hyodeoxycholic acid 9         
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C 6.969 ± 1.55a 4.920 ± 0.56b 8.608 ± .007* 7.476 ± 1.24b 6.639 ± 0.04c 6.072 ± 0.89b 6.946 ± 0.63b 6.332 ± 0.30b 
HC 6.124 ± 0.02a 0.282 ± 0.002a* n.d. 1.699 ± 0.13a 1.044 ± 0.00a* 1.867 ± 0.20a* 2.077 ± 0.30a 1.605 ± 0.41a 
HCO 6.698 ± 1.31a n.d. n.d. 2.142 ± 0.22a 1.889 ± 0.01b 2.164 ± 0.25a 1.865 ± 0.24a 1.481 ± 0.17a 
Hyodeoxycholic acid          
(Iso.)                       C 2.152 ± 0.98
a 2.033 ± 0.15b 3.432 ± 0.006b 3.140 ± 0.65b 2.875 ± 0.037c 2.562 ± 0.29b 3.415 ± 0.45b 2.482 ± 0.17b 
HC 2.216 ± 0.21a 2.160 ± 0.21b 1.457 ± 0.25a 0.669 ± 0.07a 0.619 ± 0.003b 0.536 ± 0.06a 0.760 ± 0.14a 0.552 ± 0.11a 
HCO 2.539 ± 0.22a 1.430 ± 0.26a* 1.656 ± 0.28a 0.486 ± 0.10a* 0.452 ± 0.021a 0.466 ± 0.12a 0.389 ± 0.006a 0.500 ± 0.15a 
Glycocholic acid 2         
C n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. 
HC n.d. 4.411 ± 0.22a 2.515 ± 0.60a* 5.034 ± 0.53a* 4.905 ± 0.30a 3.319 ± 0.51a* 3.067 ± 0.08a 3.887 ± 0.09a 
HCO n.d. 7.077 ± 1.13a 5.727 ± 0.49b 3.959 ± 0.48a* 5.756 ± 0.13b* 5.329 ± 0.16b 2.436 ± 0.41a* 6.770 ± 0.64b* 
 
Glycochenodeoxycholic 
acid 5 
        
C n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. 
HC n.d. 0.307 ± 0.057a 0.099 ± 0.01a* 0.559 ± 0.01b* 0.610 ± 0.04b 0.511 ± 0.08 0.457 ± 0.03b 0.502 ± 0.03a 
HCO n.d. 0.304 ± 0.08a 0.373 ± 0.01b 0.219 ± 0.09a  0.428 ± 0.003a n.d. 0.213 ± 0.04a 0.777 ± 0.17a* 
Glycodeoxycholic acid 6         
C n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. 
HC n.d. 0.872 ± 0.08b 0.127 ± 0.01a* 0.357 ± 0.31b* 0.318 ± 0.01a 0.191 ± 0.04* 0.218 ± 0.03b 0.273 ± 0.001a 
HCO n.d. 0.258 ± 0.05a 0.292 ± 0.002b 0.124 ± 0.19a* 0.355 ± 0.01b* n.d. 0.073 ± 0.01a 0.254 ± 0.04a* 
Taurocholic acid 1         
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C n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. 
HC n.d. 2.206 ± 0.11a 0.535 ± 0.10a* 0.943 ± 0.18a 1.590 ± 0.08a* 0.756 ± 0.13a* 0.773 ± 0.16a 1.807 ± 0.39a* 
HCO n.d. 3.287 ± 0.75a 1.706 ± 0.31b* 0.710 ± 0.14a 2.975 ± 0.12b* 0.898 ± 0.01a* 0.704 ± 0.17a 9.738 ± 0.97b* 
Taurochenodeoxycholic 
acid 3 
        
C n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. 
HC n.d. 0.085 ± 0.01a n.d. 0.072 ± 0.01a 0.095 ± 0.02a n.d. n.d. 0.079 ± 0.001a 
HCO n.d. 0.113 ± 0.02a 0.113 ± 0.02 0.134 ± 0.02b 0.129 ± 0.01b n.d. n.d. 0.278 ± 0.03b 
Taurolitocholic acid 10         
 n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. 
 n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. 
 n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. 
Taurodeoxycholic acid 4         
C n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. 
HC n.d. 0.235 ± 0.01b n.d. 0.038 ± 0.01a 0.043 ± 0.01a n.d. n.d. 0.105 ± 0.01a 
HCO n.d. 0.101 ± 0.02a 0.085 ± 0.01 0.162 ± 0.03b* 0.204 ± 0.01b n.d. n.d. 0.122 ± 0.02a 
Values are expressed as the mean ± SD; n.d.non detected; * indicates significant difference between consecutive weeks; Mean values within a column with unlike 
superscript letters were significantly different (P< 0.05). 
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Electronic supplementary information (ESI) 
Table 1. Composition of the experimental diets [control (C), high-cholesterol (HC) and high-
cholesterol enriched with onion (HCO)] 
Ingredient (g/kg) C HC HCO 
Onion powder   100 
Casein 200 200 200 
Sucrose 100 100 100 
Maize starch 470.49 445.49 368.69 
Soya oil 50 50 50 
Maize oil 80 80 80 
Mineral mixture* 35 35 35 
Vitamin mixture† 10 10 10 
Cellulose powder 50 50 26.8 
Choline bitartrate 2.5 2.5 2.5 
tert-butylhydroquinone 0.010 0.010 0.010 
L-cystine 2 2 2 
Cholesterol  20 20 
Cholic acid  5 5 
* Mineral mix for the AIN-93M diet, g/kg (AIN-93M-MX): calcium carbonate anhydrous, 357.00; 
potassium phosphate monobasic, 250.00; potassium citrate, tripotassium monohydrate, 28.00; 
sodium chloride, 74.00; potassium sulphate, 46.00; magnesium oxide, 24.00; ferric citrate, 6.06; zinc 
carbonate, 1.65; sodium meta-silicate 9H2O, 1.45; manganous carbonate, 0.63; cupric carbonate, 
0.30; chromium potassium sulfate 12H2O, 0.275; boric acid, 0.0815; sodium fluoride, 0.0635; nickel 
carbonate, 0.0318; lithium chloride, 0.0174; sodium selenate anhydrous, 0.01025; potassium iodate, 
0.0100; ammonium paramolybdate 4H2O, 0.00795; ammonium vanadate, 0.0066; powdered sucrose, 
209.806. 
† Vitamin mix for the AIN-93M diet, g/kg (AIN-93-VX): niacin, 3.000; calcium pantothenate, 
1.600; pyridoxine-HCl, 0.700; thiamin-HCl, 0.600; riboflavin, 0.600; folic acid, 0.200; biotin, 0.200; 
vitamin B12 (0.1%), 2.500; vitamin E (all-rac--tocopheryl acetate, 500 IU/g), 15.000; vitamin A 
(all-trans-retinyl palmitate, 500,000 IU/g), 0.800; vitamin D3 (400,000 IU/g), 0.250; vitamin K1, 
0.075; powdered sucrose, 974.655. 
‡ Diet energy content was calculated using the factors 16.73 kJ/g (4 kcal/g) for protein, 15.69 kJ/g 
(3.75 kcal/g) for monosaccharides, 16.53 kJ/g (3.95 kcal/g) for disaccharides, 17.49 kJ/g (4.18 
kcal/g) for starch, 8.37 kJ/g (2 kcal/g) for dietary fibre, and 37.65 kJ/g for fat. Control diet, 18540.9 
kJ/kg (4431.4 kcal/kg); HC diet, 18856.6 kJ/kg (4506.8 kcal/kg); HCO diet, 18642.4 kJ/kg (4455.6 
kcal/kg). 
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Table 2. Nutritional composition, phytochemical compounds, and antioxidant activity of onion powder 
 Onion powder 
Protein (g/100 g) 9.75 ± 0.08 
Lipids (g/100 g) 1.30 ± 0.06 
Carbohydrates (g/100 g) 80.10 ± 2.89 
  Glucose (g/100 g) 27.7 ± 1.73 
  Fructose (g/100 g) 20.7 ± 0.46 
  Sucrose (g/100 g) 4.3 ± 0.11 
  Total fructans (g/100 g) 4.2 ± 0.10 
  Total dietary fibre (g/100 g) 23.2 ± 1.15 
    Soluble fibre (g/100 g) 3.2 ± 0.09 
    Insoluble fibre (g/100 g) 20.0 ± 0.17 
Ash (g/100 g) 4.63 ± 0.07 
Total phenols (mg GAE/100 g) 1629.6 ± 60.0 
Quercetin 3-glucoside (mg/100 g) 32.22 ± 0.90 
Quercetin 4′-glucoside (mg/100 g) 950.00 ± 2.99 
Quercetin 3,4′-diglucoside (mg/100 g) 1368.89 ± 8.77 
Quercetin 7,4′-diglucoside (mg/100 g) 31.56 ± 0.33 
Quercetin 3,7,4′-triglucoside (mg/100 g) 9.16 ± 0.32 
Isorhamnetin 4′-glucoside (mg/100 g) 45.16 ± 1.54 
Isorhamnetin 3,4′-diglucoside (mg/100 g) 32.00 ± 0.19 
Total ACSOs (mg BCSOE/100 g) 4120.89 ± 89.43 
Propionaldehyde (mg/100 g) 245.04 ± 39.61 
1-Propanethiol (mg/100 g) 23.54 ± 0.90 
Hexanal (mg/100 g) 0.04 ± 0.001 
2-Methyl 2-pentenal (mg/100 g) 10.80 ± 0.67 
Propyl thioacetate (mg/100 g) 0.45 ± 0.03 
Dimethyl trisulfide (mg/100 g) 66.41 ± 5.02 
Dipropyl disulfide (mg/100 g) 89.45 ± 3.29 
Methyl propyl trisulfide (mg/100 g) 42.28 ± 2.14 
Dipropyl trisulfide (mg/100 g) 25.50 ± 2.45 
Ascorbic acid (mg/100 g) 62.31 ± 0.77 
Total vitamin C (mg/100 g) 104.26 ± 4.07 
Scavenging of NO• (μmol TE/100 g) 1706.00 ± 49.61 
ABTS•+ (μmol TE/100 g) 4936.67 ± 72.65 
DPPH• (μmol TE/100 g) 1135.00 ± 82.21 
FRAP (μmol TE/100 g) 12245.14 ± 60.45 
Values are expressed as the mean ± SD (n = 3). 
GAE, gallic acid equivalents; ACSOs, S-alk(en)yl-L-cysteine sulfoxide; BCSOE, S-Butyl-L-
cysteine sulfoxide equivalents; NO•, nitric oxide radical ABTS•+, 2,2′-azinobis(3-
ethylbenzothiazoline-6-sulfonic acid) radical cation; DPPH•, 2,2-diphenyl-1-picrylhydrazyl radical; 
FRAP, ferric reducing antioxidant power; TE, trolox equivalents 
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GENERAL DISCUSSION 
The transformation of onion products has been developed in order to attend the consumer 
demand in the modern day market. The latest demands rely on the addition of value to regular 
products and by-products of manufacturing procedures, by both optimizing the processing and 
improving the quality, nutritional composition and content of phytochemicals. This stimulates 
the application of high-pressure (HP) processing which combined with other preserving 
technologies creates a stable and easy-to-use product. The transformation of fresh onion into a 
HP-processed onion ingredient offers advantages over the fresh products such as the 
conservation of its composition (diminishing the loss of phytochemicals produced by other 
technologies or processing methods) as well as providing a greater bioaccessibility of the active 
components. Its final presentation as a dry powder form also facilitates its conservation, storage 
and offers great versatility of use due to its facility to be added daily in cuisine not only as a 
flavouring agent but also as a functional ingredient. In contrast with the market of fresh 
products, the demonstration of added value in the functional ingredients must be endorsed by 
solid scientific evidence, which in the final instance will justify the corresponding health claim 
for commercialization. 
The study of the biological responses caused by the consumption of this HP-processed onion 
in vivo has verified certain health benefits directly related to the prevention of risk factors 
associated to prevalent diseases such as liver and CVD. Due to the association between NAFLD 
and atherosclerosis it is interesting to study in conjunction both pathologies since they share 
common risk factors such as oxidative stress (Polimeni et al., 2015). The hypercholesterolemic 
and potentially pro-atherosclerotic diet (HC) incorporated in the experimental design has been 
directly linked to imbalances in oxidative stress defence mechanisms and inflammatory 
reactions that lead to abnormal metabolic responses. The changes induced in organ morphology 
were outstanding showing an evident hepatomegaly and spleen dystrophy in comparison to the 
control group (Figure 11.1). The plasma and liver fingerprinting also distinguished clear 
differential patterns reflecting the multiple changes produced in the metabolome. According to 
previous research by our group, the characterization of this ingredient and its evaluation in vitro 
showed antioxidant and antiinflammatory capacities likely related to the prevention of certain 
disorders in vivo (González-Peña et al., 2013). This has been supported by other onion products 
previously described in the scientific literature (Roldán et al., 2008; Roldán-Marín et al., 2009; 
Roldán-Marín et al., 2009b; Suleria et al., 2015). The addition of the onion ingredient in a HC 
diet for seven weeks improved the antioxidant defence mechanisms, ameliorated hepatotoxicity 
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and positively modulated the inflammatory response of certain markers associated with 
atherogenesis in the diet-induced hypercholesterolemic rats. 
 
 
 
 
 
It is interesting to note that most of the benefits derived from the intake of onion in 
pathological circumstances have been related to the amelioration of hypercholesterolemia, 
which is clearly recorded by a decrease in cholesterol or lipid levels, and the enhancement of 
the antioxidant defence system. These ameliorative effects have generally been linked to the 
presence of flavonoids, FOS and organosulfur compounds (Griffiths et al., 2002; Roldán-Marín 
et al., 2012). It is probable that the functions of the onion component go beyond these effects 
in complex synergistic and interacting mechanisms modulating the outcome. This singularity 
has been demonstrated in our experimental model, where the vascular and hepatic 
improvements produced by onion supplementation were revealed by certain plasma markers, 
but could not be directly correlated to a decrease in total cholesterol levels found in plasma and 
liver. 
Even though it may result obvious that additional investigation is required to understand the 
complexity of the mechanism of action involved in this pathological model, it is worth 
remarking that while the study of isolated functions is useful to a certain extent, to ascertain 
what occurs in the whole living system requires a complex projection in both the design and 
workflow applied. Studying the properties of onion products, it was observed that although the 
benefits of onion are related to several pathologies, research in this field has made little 
progress, focusing on the systematic repetition of analyses of usual parameters related to the 
hypolipidemic and antioxidant capacities (e.g. Corzo-Martínez & Villamiel, 2012; Kang et al., 
2016; Kim & Noh, 2016; Lu et al., 2015; Roldán-Marín et al., 2012). Advancement in the 
knowledge of the mechanisms involved in a living system does not necessarily follow a straight 
line and from time to time requires a change of perspective, taking a step aside, to analyse what 
A C B D 
Figure 11.1. Livers (A-B) and spleens (C-D) collected from Wistar rats after 7 weeeks of  
 experimental feeding. A-C) Control rats B-D) Hypercholesterolemic rats 
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other changes are simultaneously occurring and then to focus the research on those pathways 
or functions most affected by the particular conditions. This will be the approach of the new 
research. 
In light of this projection, the present PhD Thesis has been divided into three different 
phases. The first phase is based on the confirmation of the forced pathological circumstances 
and the effect of the onion supplementation on known biomarkers (section I). The second phase 
focuses on the description of the general metabolic alterations promoted by a 
hypercholesterolemic diet and the subsequent effect of the onion ingredient on the metabolic 
responses associated to vascular and hepatic impairments (section II) and the third phase 
analyses some of the specific altered pathways to obtain more detailed information on 
downstream metabolites (section III). Thus, this research concentrates on obtaining specific 
information that confirms an initial basic hypothesis and moves from the particular to the 
general (applying non-targeted metabolomics) with the aim to generate information to help 
create new hypothesis. It then moves back again from the general to the particular to initiate 
new research lines to elucidate some of the possible underlying mechanisms. 
Another noteworthy aspect in this study is the statistical analysis applied and the mode of 
interpreting the results. In this sense, the effect of HC feeding was unbiased by comparing the 
HC-fed group with the C group. Nevertheless, the extent to which the onion ingredient may 
affect the regulation induced by HC-feeding is analysed from two different angles. On the one 
hand, the differences found between the HCO-fed group and the HC-fed group indicate big 
changes in magnitude and significance in the metabolic pattern and thus, changes in the possible 
underlying activities that lead to those metabolites. However, on the other hand, small changes 
should not to be overlooked since they could reflect a big difference in the system function, 
being easily and unfortunately under evaluated by comparing HCO-fed group vs. HC-fed group. 
Thus, the relative comparison of the HCO and HC groups in relation to the C group reveals 
more subtle changes that may have biological significance. In this regard, the statistics applied 
to the global metabolomics analysis support a direct multiple comparison of the three groups, 
highlighting relevant changes between the HCO and HC groups. The analysis of lipid 
mediators, which are found in very low concentrations (10-6 to 10-9) but which may act as very 
important signalling mediators, focuses on the significance of the fold changes generated by 
comparison of the HC and HCO groups relative to the C group. 
Additionally, it is interesting to highlight that the objective of this experimental design was 
to show a preventive effect following regular onion consumption. Although blood and organs 
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were examined at the end of the experimental feeding, the results obtained differ slightly with 
those which pursue a direct measure of effect reversion. The present design cannot ensure that 
feeding this onion ingredient (though likely) would revert the stages of established pathological 
situations but it does provide evidence about the positive influence on a delay in onset and 
deceleration in the progression of the pathology. 
Therefore, the originality of this PhD Thesis relies on several aspects that gave rise to seven 
research papers. Each of these research papers presents new work that provides insight 
regarding the effects of the onion ingredient. Due to the novelty of these findings some of the 
results are presented as large sets of descriptive data which cannot be compared with former 
studies. From all the results, four aspects need to be emphasised and stand out in particular due 
to either the approach utilized or to the effect exerted by the onion ingredient:  
 The onion diet enrichment preserved endothelium dependent relaxation functions in the 
mesenteric arteries of Wistar rats fed a daily high-cholesterol diet, and modulated 
positively cardiovascular risk biomarkers such as MCP-1, s-ICAM, sE-selectin, IL-10, 
VEGF, PAI-1, vWF, TIMPs related to endothelial dysfunction and the coagulation 
system. 
 Metabolomics was used as a research engine to explore unknown effects produced by 
onion consumption in relation to vascular and hepatic dysfunction. It has provided a 
wide description of the changes stimulated in the plasma and liver metabolome of 
hypercholesterolomic rats, facilitating lists of metabolites and indicating pathways that 
need further exploration and may lead to new lines of research. 
 The role of onion as a regulator of proinflammatory mediators and possible enhancer of 
pro-resolution pathways is underlined. The analysis of lipid mediators produces relevant 
information to help elucidate the interactive effect of functional ingredients within the 
diet and the potential impact on mechanisms that may lead to organ dysfunction. 
 Changes in the gut microflora were explored indirectly, firstly, by analysing microbial 
composition of faeces at the beginning and at the end of the experimental feeding and 
secondly, by exploring changes in the excretion of bile acids. These studies attract 
attention to the influence of onion modifying the microbiome, and how diet induces 
changes in a microbiome and is able to interact and modulate the progression of disease. 
In addition, to distinguish between the two pathologies under study, the most relevant 
findings from different parts of the investigation have been integrated allowing us to obtain the 
following pictures on the mechanism whereby the onion supplementation has had an effect: 
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 Onset and progression of hypercholesterolemia toward CVD.
The induced endothelial dysfunction found in this hypercholesterolemic model fitted with
the pathological status indicated by multiple markers. Likewise, the effects observed in the 
group of rats fed the onion ingredient reveals the counteracting effects of onion in the 
progression of the pathophysiological framework toward atherosclerosis.  
The results obtained suggest a possible decrease in nitric oxide NO production and 
bioavailability promoted by ROS such as O2●
  in the hypercholesterolemic group, the greater 
generation levels of which were confirmed by the activity of NADPH oxidase. These negative 
outcomes were also reflected by the activities of SOD, CAT and GPx enzymes. Nevertheless, 
these activities were shown to be partially stabilized by the enhancement of the antioxidant 
defence system and a significant drop of NOX activity produced by onion supplementation. 
The described oxidative mechanisms may be also connected to the dyslipidemic status, which 
in turn is linked to endothelial dysfunction.  
The endothelial impairments are additionally characterized by an increase in the plasma 
ADMA levels. ADMA is known to compete with L-arginine for the binding site on eNOS and 
its uncoupling results in O2 production and a decrease in NO (Park & Parck, 2015). 
Interestingly, the increase of ADMA in the blood stream of the hypercholesterolemic rats was 
controlled significantly by the addition of onion, at the same time that arginine plasma 
concentration was found to increase. Additionally, the dysregulation of the kyrunenine levels 
was ameliorated in the group fed the onion ingredient, thus improving the efficacy of onion by 
keeping the altered concentrations of relevant markers similar to the control group. These facts 
reinforce the possible contribution of the onion ingredient via regulation of cytokines that help 
suppress the impact of high cholesterol in the pathogenesis of atherogenesis. In this regard, 
proinflammatory cytokines such as TNF-, IL-1 and IFN tended to be increased by the high-
cholesterol diet and ameliorated by the onion ingredient.  
In addition, the present work suggests that the regulation of NF-kB (which is involved in 
arterial inflammation) may have been affected by several factors that were positively modulated 
by the onion ingredient supplementation. Among these factors, the increased production of 
ROS and lipids that induced proinflammatory changes in the endothelial phenotype and the 
inflammation mediated by cytokines and adhesion molecules are strongly indicated as potential 
modifiers. 
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The significant decrease of MCP-1, sICAM-1 and E-selectin produced by onion indicated a 
decline in the progression of atherosclerosis, suggesting improvements in the endothelial 
function (as was confirmed by the study of vascular reactivity). In addition to MCP-1 levels, 
the response of VEGF and the decrease in PAI-1 and vWF concentrations in the HCO group 
may have contributed to the prevention of microvascular complications and an improvement of 
the anticoagulation system. 
Therefore, taken as a whole, this suggests that the onion ingredient may not only contribute 
to improving the microcirculation by acting as a potential exogenous NO pathway activator and 
ROS scavenger, but also by maintaining ADMA, kyrunenine, some cytokines, chemokines and 
adhesion molecules at normal levels in the course of hypercholesterolemia. In addition, it acts 
as a modifier of the methylation cycle, the arginine and tryptophan pathways as well as the 
routes involved in the transformation of glycerophospholipids.  
 Hepatic dysfunction induced by hypercholesterolemia 
As previously mentioned, but now focusing on the induced liver dysfunction, the diet 
enrichment with the onion ingredient (HCO) produced significant improvements by 
ameliorating hepatotoxicity, decreasing oxidative stress and modulating inflammation in the 
liver. The elevated circulating levels of ALT and AST and the activity of enzymes such as CAT, 
SOD and GPx measured in liver, reflect the development of liver injury caused by the HC 
feeding and the simultaneous amelioration produced by the addition of the onion ingredient. 
Furthermore, liver protein carbonyls, which are identified as biomarkers for protein damage 
caused by oxidized amino acid residues in stress conditions, revealed that the HCO feeding 
produced a significant decrease compared with the HC diet, which was significantly correlated 
with liver SOD activity and liver GPx activity. 
Additionally, most acute and chronic liver diseases are characterized by inflammation which 
shows enhanced expression of various pro- and antiinflammatory cytokines in the liver (Tilg, 
Kaser & Moschen, 2006). However, it should be born in mind that the interpretation of cytokine 
levels is controversial since the same mediators intervene in both hepatic inflammation and 
damage, as well as possible regeneration (Tilg, 2001). Among these cytokines, special attention 
must be drawn to TNF and IL-10, which play important roles in inflammation and both of 
which were found with modified levels in the group supplemented with the onion ingredient of 
this study. However, these changes might reflect the positive modulation of other mediators, 
which simultaneously induced a decline in TNF and IL-10 levels. Although some of the 
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benefits of the consumption of onion were linked to liver function instead of vascular 
dysfunction, it is very important to remember that amelioration of liver impairment will also 
have a positive impact on prevention of cardiovascular disease. 
Furthermore, the non-targeted metabolomics approach in liver tissues indicated that specific 
metabolites such as hydroxybutyrylcarnitine and palmitoylcarnitine along with some glucosyl 
forms, methylated and free fatty acids, all tentatively identified, were significantly affected by 
the HC diet, and reflected an impact in response to onion consumption at the core of hepatic 
dysfunction. 
Among the disturbances induced by the HC diet in the lipids profile, the modification of free 
fatty acids in plasma and liver attracted an interest to study the changes in the AA pathway. In 
this respect, although the hepatoprotective effect triggered by the intake and metabolism of the 
onion ingredient could not be directly linked with improvements in the hepatic lipid profile with 
direct removal of lipids (total cholesterol, LDL, TAG), interesting findings were found in some 
lipid mediators such as oxylipins and sphingolipids. The changes observed in oxylipins as 
oxidation products of fatty acids [arachidonic acid (AA), linoleic acid (LA), α-linolenic acid 
(α-LA), eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA)] have newly attracted 
our interest concerning the potential protective effect for health of onion. 
Whereas the onion ingredient did not revert the decline in circulating oxylipins in the 
hypercholesterolemic rats, it did ameliorate HC diet-related changes in the hepatic 
concentrations of PGs (PGD2 and PGE2 as well as PGD1 and PGE1, both COX metabolites 
derived from AA and DHGLA, respectively) and modified the concentration of some 
CYP450/LOX derived oxylipins in the liver of HCO-fed rats. In this case, a common link might 
also be established between the inhibition of NF-κB, the subsequent COX-2 activity and the 
final PGs concentration. Additionally, the levels of ω-3-derived oxylipins were increased, 
which encourages further investigation of the effect of onion on pro-resolution pathways. 
Likewise, the levels of Cer and other sphingolipids such as HexCer and LacCer in the HCO-
fed rats suggest a significant amelioration in the liver associated to the intake of the onion 
ingredient. However, certain modifications could be interpreted as a metabolic response to 
offset the diet-induced hepatic steatosis and inflammation, rather than a plausible direct impact 
on the metabolite synthesis or transformation. 
Therefore, whereas the changes found in the eicosanoid and other PUFA-derived oxylipins 
and the sphingolipid metabolism are not suggested to be the principal modifiers of the 
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vasculature of this model, the role played by these metabolites in both the progress of 
inflammation and the potential resolution in organs may be crucial. All these findings help to 
conclude that the consumption of onion as a functional ingredient may be useful to ameliorate 
the impact of hypercholesterolemia in liver inflammation. However, as the chemistry behind 
these metabolites is very complex, a focused study of the synthetic pathways of both oxylipins 
and sphingolipids is still necessary for a comprehensive interpretation of the data. Accordingly, 
this warrants further study of the interaction of functional ingredients with bioactive lipid 
mediators and their potential impact on inflammation and organ dysfunction. 
Finally, the analysis of faeces also indicated changes in the hypercholesterolemic rats that 
compromised the liver functions. In parallel, the onion ingredient contributed to changes in 
metabolism that suggest an increase in the reabsorption of bile acids (BA) at an intestinal level 
and a decrease in BA deconjugation, which highlights the importance and influence of diet in 
the microbiome as a potentially crucial modifier of the metabolic responses found in the course 
of hypercholesterolemia. However, it is clear that to facilitate the understanding about how 
onion may influence the enterohepatic circulation regulation and the homeostatic feedback 
mechanisms with the luminal microbiota that affects the bile acid signalling in the progression 
of hypercholesterolaemia requires extensive and more exhaustive investigation. 
Apart from the interest relative to these pathologies, during the search for biomarkers of 
onion consumption throughout this PhD Thesis, it has become evident that the analysis of 
metabolites directly derived from onion metabolism should be addressed by direct targeted 
approaches. However, the detection of some of these compounds by non-targeted approaches 
may serve to emphasize the importance of key metabolites. This was the case for S-methyl-L-
cysteine and S-methylcysteine sulphoxide, the detection of which was possible in plasma 
samples applying non-targeted CEMS. 
In general terms, it is worth remarking that elucidating the effects of processed onion, as for 
any other functional ingredient, in the metabolic responses triggered at the core of 
hypercholesterolemia and vascular and/or hepatic dysfunctions is exceedingly complex and 
requires an extensive view of all the modifications and adaptations of functions that are 
provoked by the imbalance. In addition, as it has been stressed in the research papers, the 
chemical diversity and large differences in the concentration range detected in the analysis of 
biological samples evidences the fact that no single technique is capable of detecting all the 
metabolites involved. This supports the need to utilize complementary approaches for 
metabolic screening to increase the metabolome coverage. At the same time, it must remain 
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clear that each analytical technique has different capabilities and is only suitable for the analysis 
of a specific range of compounds. Therefore, in order to consider the strengths and weaknesses 
of each platform is essential to choose the right analytical technique in accordance with the 
specific groups or families of compounds which are to be detected and quantified. 
Even so, despite the complexity, with the technology currently available, investigation of 
the response of entire living systems to a specific diet is not only a realistic objective but also 
is within the budget of scientific investigation. With this availability, the techniques may help 
comprehend both the aetiology of disease as well as the modulatory influence of the diet in the 
progression of disease, the amelioration or reduction of symptoms and the speed of progression 
of the impairments produced by disease or an unbalanced diet.  
Therefore, the present PhD Thesis supports the use of metabolomics and the movement 
towards the application of systems biology in the field of nutrition. This movement will help 
identify the association between dietary patterns and risk factors of disease. In addition, it will 
allow for the development of nutritional strategies to help enhance general public health as well 
as manage pathologies or fulfil specific health requirements. As a result, not too far into the 
future, the integration of data into the formulation of predictive models and model-based 
personalized diagnostics could be achieved. 
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FUTURE PROSPECTS 
To fully understand the complex mechanisms of action behind this functional onion 
ingredient in hypercholesterolemia and its repercussion in CVD and liver dysfunction further 
research in greater depth is required at both the in vitro and in vivo level. However, the present 
project has established some basis to redirect the focus of new work. Of the multiple lines of 
investigation to continue the research, the options offered by metabolomics are outstanding.  
In general terms, the identities putatively assigned to metabolites need to be confirmed as 
well as the downstream metabolites in the pathways of interest by means of targeted analysis. 
This validation of the models is an essential primary step that needs to be taken before going 
any further. When confirmed, this would guide future planning of new experiments in vitro to 
verify the influence of the onion ingredient on metabolic reactions and enzyme systems, starting 
at a simple and progressing towards more complex levels of organization (cell-tissue-organs-
organ systems-organisms), to finally upgrade the research to the highest level of 
experimentation in humans. In addition, the exploration and identification of unknown 
significant compounds by both LCMS and CEMS, although a laborious task, would provide 
novel and valuable information. An additional step would be to follow the specific pathways in 
different organs, tissues and fluids such as plasma/serum or urine, permitting a correlation 
between the metabolites considered as potential metabolic markers and then to correlate these 
with other biochemical markers of interest for the pathology under analysis such as 
inflammation, vascular and hepatic dysfunction, etc. This practice will facilitate the 
extrapolation of the modifications occurring at an organ level to modifications quantifiable in 
bio-fluids, thus avoiding the need to apply invasive practices. 
In another category, the research on biomarkers of onion intake by targeted approaches 
orientated to identify the different families of metabolites will facilitate the assessment of 
individual diets and the effects of supplementation with complementary dietary ingredients. 
This could lead to the design of dietary interventions aimed to diminish hepatic damage and 
subsequent vascular deterioration, both associated to NAFLD and cardiometabolic 
dysfunctions. 
The progress offered by the use of the new technologies such as metabolomics opens the 
door to multiple new lines of investigation, and the results presented in this PhD Thesis is a 
contribution to the interest in the application of global approaches to characterize the changes 
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at multiple functional levels which efficiently permits the assessment of the effects of functional 
ingredients, such as the onion ingredient presented in this research project. 
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CONCLUSIONS 
This PhD Thesis comprises seven complementary research papers interpreting the effects 
of an onion ingredient at the core of diet-induced hypercholesterolemia. These studies have 
been presented in three sections, from which the following conclusions can be extracted: 
SECTION I – Biochemical, vascular, and microbiological analyses 
 Feeding the animals with a diet composed of cholesterol (2%) and cholic acid (0.5%)
for seven weeks leads to hypercholesterolemia, oxidative stress, inflammation, vascular
impairments and liver dysfunction.
 The onion ingredient enhanced the antioxidant defence mechanisms, ameliorated
hepatotoxicity and improved the inflammatory response associated with atherogenesis
in the hypercholesterolemic rats. This was reflected by an increase in the activity of
CAT, SOD and GPx enzymes in both erythrocytes and liver, a reduction of ALT and
AST in plasma, and a modulation of cardiovascular risk biomarkers such as MCP-1, s-
ICAM, sE-selectin, IL-10, VEGF, PAI-1, vWF, TIMPs related to endothelial
dysfunction and the coagulation system.
 Onion ingredient enrichment of the hypercholesterolemic diet modulated vascular
dysfunction, reducing some of the risk indexes linked to initial stages of atherosclerosis.
Preservation of the endothelium dependent relaxation functions in the mesenteric
arteries and in the activity of NOX was observed.
 Diet enrichment with onion promoted beneficial modification in gut microflora. Initial
phases of the onion supplementation showed increases in Lactobacillus spp. and
Bifidobacterium spp., while the pathogenic Clostridium spp. decreased after seven
weeks of experimental feeding.
SECTION II – Non-targeted metabolomics studies: Fingerprinting 
 Plasma fingerprinting of hypercholesterolemic rats permitted the description of
circulating metabolic changes induced by a high-cholesterol diet. A series of changes
occurred in the metabolome of Wistar rats which indicated key metabolites and
metabolic routes, the monitoring of which could contribute to the prevention of vascular
and hepatic impairments.
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 The intake of the onion ingredient was associated with modulations of the metabolic
profile of hypercholesterolemia. The study underlines the need to study in depth the
methylation cycle, arginine and tryptophan pathways, the modulation of 3-
methylhistidine, as well as the routes involved in the glycerophospholipids
transformation. S-methyl-L-cysteine and S-methylcysteine sulphoxide were indicated as
potential metabolites to be targeted in the evaluation of biomarkers of onion intake.
 The hepatic metabolic signature of hypercholesterolemic Wistar rats and the changes
induced by the onion ingredient indicated metabolite candidates for group
discrimination (C, HC, HCO). The energy and lipid metabolism including perturbations
in the TCA cycle and β-oxidation, as well as the bile acid synthesis and possibly the
methionine metabolism, reflected a significant impact in response to onion
consumption. Hydroxybutyrylcarnitine, palmitoylcarnitine, some glucosyl forms, and
methylated and free fatty acids were the main tentatively identified metabolites affected
by the consumption of the onion ingredient.
SECTION III – Targeted analysis metabolomics studies: Profiling 
 The shifts in plasma ω-3 and ω-6 PUFA-derived oxylipins induced by the
hypercholestolemic diet and the onion ingredient are described. The onion ingredient
enrichment modulated the hepatic concentrations of prostaglandins and enhanced ω-3
oxylipins in the liver of the hypercholesterolemic rats.
 The high-cholesterol diet induced a specific plasma sphingolipid pattern with increased
sphingoid bases, dihydroceramides and ceramides, while the sphingomyelin,
hexosylceramide and lactosylceramide families decreased. Onion supplementation
modified some changes in sphingolipids induced by the hypercholesterolemic diet in
liver and spleen tissue.
 Onion is proposed for study as a regulator of proinflammatory mediators, and possible
enhancer of pro-resolution pathways.
 Specific primary and secondary bile acids (BA) in both unconjugated and conjugated
forms indicated that onion supplementation might increase the BA reabsorption at
intestinal level and decrease the BA deconjugation in the course of
hypercholesterolaemia. The microbiome modification induced by the onion ingredient
as a critical modifier of the faecal bile acid composition is proposed.
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CONCLUSIONES 
La presente Tesis Doctoral se compone de siete artículos científicos cuyo contenido es 
complementario, permitiendo así lograr una interpretación integrada sobre los efectos de un 
ingrediente de cebolla en hipercolesterolemia inducida por la dieta. Estos estudios han sido 
estructurados en tres secciones, de las cuales, se pueden obtener las siguientes conclusiones: 
SECCION I – Análisis bioquímicos, vasculares y microbiológicos 
 La administración de una dieta compuesta por colesterol (2%) y ácido cólico (0.5%)
durante siete semanas indujo el desarrollo de hipercolesterolemia, estrés oxidativo,
inflamación, alteraciones vasculares y disfunción hepática en ratas Wistar.
 La ingesta del ingrediente de cebolla mejoró los mecanismos de defensa antioxidante,
redujo el nivel de hepatotoxicidad y mejoró la respuesta inflamatoria asociada con
aterogénesis en las ratas hipercolesterolémicas. Dichos cambios fueron reflejados por
un aumento en la actividad de las enzimas catalasa (CAT), superóxido dismutasa (SOD)
y glutation peroxidasa (GPx) en eritrocitos e hígado, una disminución de los niveles de
alanina transaminasa (ALT) y aspartato transaminasa (AST) en plasma, y la modulación
de biomarcadores de riesgo cardiovascular, como la proteína quimiotáctica de
monocitos-1 (MCP-1), molécula de adhesión intercelular (s-ICAM), selectina E (sE-
selectin), interleucina 10 (IL-10), el inhibidor del activador de plasminógeno-1 (PAI-1),
el factor de Von Willebrand (vWF) y los inhibidores tisulares de metaloproteinasas
(TIMPs), todos relacionados con la disfunción endotelial y el sistema de coagulación.
 La suplementación de la dieta hipercolesterolémica con el ingrediente de cebolla
moduló el grado de disfunción vascular inducido, reduciendo algunos índices de riesgo
relacionados con estadios iniciales de aterosclerosis en las ratas hipercolesterolémicas.
También se observó el mantenimiento de la función de relajación dependiente de
endotelio en las arterias mesentéricas y en la actividad de NOX.
 La suplementación con el ingrediente de cebolla indujo modificaciones beneficiosas en
la microflora del tracto intestinal. Fases iniciales de la suplementación con cebolla
mostraron aumentos en Lactobacillus spp. y Bifidobacterium spp., mientras que los
patógenos Clostridium spp. disminuyeron tras siete semanas de alimentación
experimental.
Capítulo 12 
 
294 
 
SECCION II – Análisis metabolómicos no dirigidos: Fingerprinting 
 El análisis por fingerprinting del plasma de ratas hipercolesterolémicas permitió 
describir cambios metabólicos inducidos por la dieta rica en colesterol. Los cambios 
ocurridos en el metaboloma de ratas Wistar indicaron metabolitos clave en rutas 
metabólicas, cuya monitorización puede contribuir en la prevención de alteraciones 
vasculares y hepáticas. 
 La ingesta del ingrediente de cebolla fue asociada con la modulación del perfil 
metabólico inducido en hipercolesterolemia. El estudio evidencia la necesidad de 
estudiar en profundidad el ciclo de la metilación, las rutas metabólicas de la arginina y 
del triptófano, la modulación de 3-metil histidina, así como las rutas involucradas en la 
transformación de glicerofosfolípidos. S-metil-L-cisteina y S-metilcisteina sulfóxido 
son indicados como metabolitos candidatos de evaluación, mediante análisis dirigidos 
en la búsqueda y confirmación de biomarcadores de la ingesta de cebolla. 
 El perfil metabólico del hígado en ratas Wistar hipercolesterolémicas y los cambios 
inducidos por el ingrediente de cebolla mostraron metabolitos candidatos para la 
discriminación entre los grupos en estudio (C, HC y HCO). El metabolismo energético 
y lipídico, incluyendo la alteración en el ciclo de los ácidos tricarboxílicos y la β-
oxidación, así como la síntesis de ácidos biliares y el metabolismo de la metionina 
reflejaron un impacto significativo, en respuesta al consumo de cebolla. 
Hidroxibutirilcarnitina, palmitoilcarnitina, así como algunas formas glucosiladas, 
además de ácidos grasos libres y metilados, fueron los principales metabolitos 
tentativamente identificados  que se afectaron por el consumo del ingrediente de cebolla. 
SECCION III – Análisis metabólicos dirigidos: Profiling 
 Se han descrito diferencias en oxilipinas derivadas de ácidos grasos poliinsaturados ω-
3 y ω-6 en plasma, estimuladas por la dieta hipercolesterolémica y el ingrediente de 
cebolla. El enriquecimiento de la dieta con el ingrediente de cebolla moduló las 
concentraciones de prostaglandinas hepáticas y mejoró los niveles de oxilipinas ω-3 en 
el hígado de ratas hipercolesterolémicas. 
 La dieta rica en colesterol indujo un perfil plásmatico de esfingolípidos, caracterizado 
por un aumento en la concentración de bases esfingoides y dihidroceramidas, mientras 
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que las esfingomielinas, hexosilceramidas y lactosilceramidas disminuyeron. La 
suplementación con cebolla causó algunos cambios en los niveles de esfingolípidos 
inducidos por la dieta hipercolesterolémica en hígado y bazo. Se propone el estudio de 
la ingesta de cebolla como posible regulador de mediadores proinflamatorios y 
estimulador de las rutas de proresolución en procesos de inflamación. 
 Los ácidos biliares primarios y secundarios en forma conjugada y no conjugada 
indicaron que la suplementación con cebolla podría aumentar la reabsorción de ácidos 
biliares a nivel intestinal, modificando el nivel de conjugación en el curso de 
hipercolesterolemia. Se propone que las modificaciones en el microbioma inducidas por 
el ingrediente de cebolla pueden ser un modificador crucial de la composición de ácidos 
biliares fecales. 
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A 
AA arachidonic acid 
ABTS ●+ 2,2’-azinobis    
(3-ethylbenzothiazoline-6-sulfonic acid) 
ACh acetylcholine 
ACN acetonitrile 
ACSOs S-alk(en)yl-L-cysteine sulfoxides 
ADA American Dietetic Association 
ADMA asymmetric dimethylarginine 
AED atomic emission detector 
AI atherogenic index  
ALD alcoholic liver disease  
ALP alkaline phosphatase 
ALT alanine aminotransferase 
AMDIS Automated mass spectrometry 
deconvolution and identification system 
ANOVA analysis of variance test 
AST aspartate aminotransferase 
B 
BA bile acids 
BCRP breast cancer resistance protein 
BGE background electrolyte 
BSTFA N,O-Bis(trimethylsilyl) 
trifluoroacetamide 
C 
C control 
CA cholic acid 
CAT catalase 
CCA cholangiocarcinoma  
CDCA chenodeoxycholic acid  
CE capillary electrophoresis 
CE–LIF capillary electrophoresis – laser 
induced fluorescence 
CE–MS capillary electrophoresis coupled to 
mass spectrometry 
Cer ceramides 
CE–TOF–MS capillary electrophoresis–time 
of flight– mass spectrometry. 
mass spectrometry. 
CE–UV capillary electrophoresis –ultraviolet 
detector 
CI chemical ionization 
CID collision induced dissociation 
CoA coenzyme A 
COX cyclooxygenase  
CYP cytochrome P450 
CYP7A1 cholesterol 7-alfa-hydroxylase 
CV coefficient of variation 
CVD cardiovascular disease 
CZE capillary zone electrophoresis 
cGMP cyclic guanosine monophosphate 
D 
DA discriminant analysis 
DAD diode array detector 
DADS diallyl disulphide 
DAG diacylglycerides 
DART direct analysis in real time  
DAS diallyl sulphide 
DB database 
DHA docosahexaenoic acid 
DhCer dihydroceramides 
DHGLA dihomo-gamma-linolenic acid 
DiHETE dihydroxy-eicosatetraenoic acid 
DiHETrE dihydroxy-eicosatrienoic acid 
DiHOME dihydroxy-octadecenoic acid 
DIMS direct infusion to mass spectrometry 
DMSO dimethyl sulfoxide 
DOX doxorubicin 
DPPH•  2, 2-diphenyl-1-picrylhydrazyl 
radical 
dw dry weight 
E 
E extraction 
EDHF endothelium-derived hyperpolarizing 
factor 
EDTA ethylenediaminetetraacetic acid 
EFSA European Food Safety Authority 
EGTA ethylene glycol-bis(β-aminoethyl 
ether)-N,N,N',N'-tetraacetic acid 
EI electron impact ionization 
EIC extracted ion chromatogram 
EKODE epoxy-keto-octadecenoic acid 
EOF electroosmotic flow 
EPA eicosapentaenoic acid 
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EpDPE epoxy-docosapentaenoic acid 
EpETE epoxy-eicosatetraenoic acid 
EpODE epoxy-octadecadienoic acid 
EpOME epoxy-octadecenoic acid 
EpETrE epoxy-eicosatrienoic acid 
ERK1/2 Extracellular signal-regulated 
protein kinases 1 and 2 
ESI electrospray ionization 
EU European Union 
F 
FAME fatty acid methyl esters 
FAO Food and Agriculture Organization 
FAS fatty acid synthase 
FbF find by formula 
FDR false discovery rate 
FER food efficiency ratio 
FFA free fatty acids 
FOS fructooligosaccharides  
FRAP ferric reducing antioxidant power 
FTIR Fourier transform infrared 
spectroscopy  
FTICRMS Fourier transform ion 
cyclotron resonancemass spectrometry  
FUFOSE Functional Food Science in Europe 
FXR-α farnesoid X receptor α 
G 
G-CA glycocholic acid
G-CDCA glycochenodeoxycholic acid
G-DCA glycodeoxycholic acid
GalCer galactosylceramide
GC gas chromatography
GC–EI–Q–MS gas chromatography–
electron impact–single quadrupole–mass
spectrometry
GC–MS gas chromatography coupled to
mass spectrometry
GGT gamma glutamyl transferase
GL glycolipids
GM genetically modified
GPx glutathione peroxidase
GR glutathione reductase
GSA gas sensor array
H 
1H NMR proton nuclear magnetic resonance 
HC high-cholesterol 
HCC hepatocellular carcinoma  
HCO high-cholesterol enriched with onion 
HDCA hyodeoxycholic acid 
HDL high density lipoprotein 
HDoHE hydroxy-docosahexaenoic acid 
HEPE hydroxy-eicosapentaenoic acid 
HETE hydroxy-eicosatetraenoic acid 
HETrE hydroxyl-eicosatrienoic acid 
HexCer hexosylceramide 
HHP high hydrostatic pressure 
HHTrE hydroxy-heptadecatrienoic acid 
HMDB Human Metabolome Database 
HO-1 heme oxygenase-1 
HODE hydroxy-octadecadienoic acid 
HOTE hydroxy-octadecatrienoic acid 
HP high-pressure 
HPLC high performance liquid 
chromatography 
HPLCDAD high performance liquid 
chromatography  diodo array 
HPP high-pressure processing 
HPLC–UV–MS/MS 
(HR-MAS) NMR High resolution-magic 
angle spinning NMR spectroscopy 
HS GCMS headspace gas chromatography-
mass Spectrometry  
I 
ICAM-1 Intercellular adhesion molecule-1 
ID identification 
IEM incremental elastic modulus 
IFIC The International Food Information 
Council 
IFN-γ interferon-gamma 
IL-x interleukin-x 
ILSI The International Life Sciences 
Institute of North America  
IS internal standard 
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J 
JK Jack–Knife 
K 
KEGG Kyoto Encyclopedia of Genes and 
Genomes 
KETE oxo-eicosatetraenoic acid 
KODE oxo-octadecadienoic acid 
KOTE oxo-octadecatrienoic acid 
KYN kynurenine 
L 
LA linoleic acid 
LacCer lactosylceramides 
LC liquid chromatography 
LCAT lecithin-cholesterol acyltransferase 
LCEC liquid chromatography 
electrochemical array  
LC/ESI-MS/MS liquid chromatography 
electrospray ionizationtandem mass 
spectrometry 
LC−FTICR-MS liquid 
chromatography−Fourier transform ion 
cyclotron resonance-mass spectrometry  
LC–MS liquid chromatography coupled to 
mass spectrometry 
LC–MS/MS liquid chromatography – 
tandem mass spectrometry 
LC–NMR liquid chromatography coupled to 
nuclear magnetic resonance 
LC–QTOF–MS liquid chromatography–
quadrupole time of flight–mass spectrometry 
LDL low density lipoprotein 
LOD limit of detection 
LOQ limit of quantification 
LOX lipoxygenase  
LPA lysophosphatidic acid 
LPC lysophosphatidylcholine 
LPE lysophosphatidylethanolamine 
LPG lysophosphatidylglycerol 
LPI lysophosphatidylinositol 
LPS lysophosphatidylserine 
LTB4 leukotriene B4 
LXA4 lipoxin A4 
α-LA alpha-linolenic acid  
M 
m/z mass/charge ratio 
MALDIMS matrix assisted laser 
desorptionmass spectrometry  
MAPK mitogen-activated protein kinase 
MCA muricholic acids 
MCSO S-methyl-L-cysteine sulfoxide 
METLIN Scripps Center for Metabolomics 
and Mass Spectrometry 
MFE molecular feature extractor 
MMPs matrix metalloproteinases 
MPO myeloperoxidase 
MPP mass profiler professional 
MRM multiple reaction monitoring 
MRP 4 multidrug resistance-associated 
protein 4 
MS mass spectrometry 
MS/MS tandem mass spectrometry 
MVA multivariate analysis 
mRNA messenger ribonucleic acid 
3-MH 3-methylhistidine
N 
NA noradrenaline 
NADPH nicotinamide adenine dinucleotide 
phosphate 
NAFLD  non-alcoholic fatty liver disease  
NASH non-alcoholic steatohepatitis 
NF-κB nuclear factor kappa B  
NIH National Institutes of Health 
NIST National Institute of Standards and 
Technology 
NMR nuclear magnetic resonance 
NO nitric oxide 
NOX NADPH oxidase 
O 
ob/ob 
OCT RF Vpp octopole radio frequency 
voltage 
OPLS ortogonal partial least squares 
OPLS–DA ortogonal partial least squares – 
discriminant analysis 
Abbreviations 
302 
OSCs organosulfur compounds 
P 
PA phosphatidic acid 
PAI-1 plasminogen activator inhibitor 1 
PASSCLAIM The process for the 
assessment of scientific support for claims of 
foods 
PBM probability-based matching 
PC phosphatidylcholine 
PCA principal components analysis 
PCSO S-propyl-L-cysteine sulfoxide 
PE phosphatidylethanolamine 
PG phosphatidylglycerol 
PGs prostaglandins 
PGEx prostaglandin E 
PGDx prostaglandin D 
PGFx prostanglandin F 
PI phosphatidylinositol 
PLS–DA partial least squares – discriminant 
analysis 
ppm parts per million 
PRENCSO trans-(+)-S-(1-propenyl)-L-
cysteine sulfoxide  
PS phosphatidylserine 
PUFA polyunsaturated fatty acid 
Q 
Q quadrupole 
Q2 prediction power 
QC quality control 
QTOF quadrupole time of flight 
R 
R2 goodness of sample classification 
RI retention index 
ROS reactive oxygen species  
RP reversed phase 
RT retention time 
RTL retention time locking 
S 
S1P sphingosine-1-phosphate 
SCFA short chain fatty acids 
SD standard deviation 
SFA supercritical fluid extraction  
SHP short heterodimer partner 
SM sphingomyelins 
SMC S-methylcysteine 
SMCs smooth muscle cells  
SNP sodium nitroprusside 
SOD superoxide dismutase 
Spa sphinganine 
Spa1P sphinganine-1-phosphate 
SPE solid phase extraction 
Sph sphingosine 
SPME solid phase micro extraction  
SREBP sterol response element-binding 
protein 
SRM selected reaction monitoring 
STAT3 signal transducer and activator of 
transcription 3 
sE-selectin soluble E selectin 
sICAM-1 soluble intercellular adhesion 
molecule-1  
T 
T-CA taurocholic acid
T-CDCA taurochenodeoxycholic acid
T-DCA taurodeoxycholic acid
T-LCA taurolithocholic acid
TAG triacylglycerides
TAMs tumour-associated macrophages
TC total cholesterol
TCA tricarboxylic acid cycle
TEAC total antioxidant capacity
TG triglyceride
TIC total ion chromatogram
TIMP-1 matrix metalloproteinases type 1
TNF tumour-necrosis factor
TP total phenols
TQ total quercetin
TXA2 thromboxane A2
TXB2 thromboxane B2
3T3-L1 3-day transfer, inoculum 3 x 105 cell
line
U 
UDCA ursodeoxycholic acid 
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UHPLC ultra–high performance liquid 
chromatography 
UPLC ultra–performance liquid 
chromatography 
UPLC–MS ultra–performance liquid 
chromatography coupled to mass 
spectrometry 
UV–scaling unit variance scaling 
UV/Vis ultravioleta / visible 
V 
Var variable 
VCAM-1 vascular cell adhesion molecule 1 
VEGF vascular endothelial growth factor 
VIP variable variable influence on the 
projection  
VLDL very low density lipoprotein 
vWF von Willebrand Factor  
